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Besef 
 
niemand ontkomt eraan 
jarenlang kunnen je dagen mild zijn 
en leef je in een zachte bries 
van kleine zorgen 
en plotseling 
stormen van pijn... 
het leven is dansen 
tussen licht en donker 
tussen eb en vloed 
daartussen ligt het besef van het draaien der aarde 
 
wie alleen maar langs kalme meren gaat 
zal de vloed nooit ruiken 
en het strand niet bewandelen 
achter het terugwijkend getijde 
 
maar zeg dat niet tegen wie vecht in de branding 
- gooi dan een lijn uit. 
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Tinnitus  
Tinnitus is the perception of a pernicious, and for some disabling sound for which there is no 
acoustic source.  The most recent study on the prevalence of tinnitus reported that 16-21% of 
the adult population are bothered by tinnitus at some point in their life and 2-4% was almost 
always bothered by it (Krog et al., 2010). Earlier studies have shown that 10–15% of the 
general population experience tinnitus severely enough to seek medical attention (Heller, 
2003) and 3-5% of the population is severely impaired by the tinnitus (Davis & El Refaie, 
2000; Vesterager, 1997). Among hearing impaired individuals prevalence has been estimated 
at 75% to 80% (Adams et al., 1999). Tinnitus may be a symptom of one or more underlying 
pathologies (Newman et al., 2011). In most patients with (bilateral) tinnitus, there is no 
underlying medical condition. There are several theories on the etiology of tinnitus that is not 
explained by an underlying pathology but scientific evidence remains absent. As a result 
patients seek help in various areas of health care, but most of the therapies do not lead to 
recovery. Patients with severe tinnitus often experience affective problems, sleep difficulties 
and major impact upon concentration (Bartels et al., 2008; Davis & El Refaie, 2000; Henry et 
al., 2005). When comparing tinnitus patients to healthy controls or non-help seeking tinnitus 
sufferers, patients with tinnitus experience higher levels of depression and anxiety (Attias et 
al., 1995; Scott & Lindberg, 2000). Interference with daily activities such as social activities, 
self-care activities, and occupational activities have been demonstrated as well (Cima, 
Vlaeyen et al., 2011; Folmer et al., 1999; Hiller & Haerkotter, 2005). However, information 
on whether fluctuations in tinnitus severity are related to emotional, social and behavioral 
interference in daily life, is virtually lacking. 
 
Treatment of tinnitus 
In the Netherlands, most patients with tinnitus who do consult their GP do so within six 
months after onset of the complaints, but one quarter of the patients wait several years until 
they seek help (NIPO, 2002). A frequently consulted specialist is the ENT (ear, nose and 
throat) physician. Treatment possibilities include removal of cerumen, middle ear surgery, 
medication, and audiological rehabilitation. Audiological rehabilitation involves counseling, 
hearing aid fitting to compensate hearing loss or provide sound generators or tinnitus maskers. 
There is mixed evidence to support the clinical effectiveness of these treatments (Hoare et al., 
2010; Hobson et al., 2010). Over the years evidence regarding the efficacy of other clinical 
interventions remains sparse, but there are indications of benefit from Tinnitus Retraining 
Therapy (Forti et al., 2009; Henry et al., 2007; Henry et al., 2002; Phillips & McFerran, 
2010), Cognitive Behavioral Therapy (El Refaie et al., 2004; Gudex et al., 2009; Hesser et al., 
2011; Martinez-Devesa et al., 2010) and a combination of therapies (Hoare et al., 2010). 
Tinnitus Retraining Therapy (TRT) is based on the neurophysiologic model of tinnitus 
developed by Jastreboff (Jastreboff et al., 1996). TRT involves 1) extensive directive 
counseling about tinnitus to reduce aversive reactions to the symptom and 2) sound therapy to 
facilitate habituation to the tinnitus signal (Jastreboff et al., 1996). Evidence to support TRT is 
mostly derived from retrospective and uncontrolled trials (Hiller & Haerkotter, 2005; Hoare et 
al., 2010; Phillips & McFerran, 2010). Cognitive behavioral therapy is used to alter 
psychological processes that are considered to maintain or contribute to tinnitus-related 
complaints. This treatment usually involves psycho-education, relaxation, exposure 
techniques and behavioral reactivation. Treatments that combine counseling and audiologic 
rehabilitation are also effective (El Refaie et al., 2004; Gudex et al., 2009). Although different 
therapies can be effective in reducing distress and improving quality of life, large scale and 
well controlled trials are needed (Cima et al., 2012). A stepped-care approach in which the 
intensity of cognitive behavioral therapy varies, depending on the severity of tinnitus 
complaints has never been tested. In this thesis the cost-effectiveness of a specialized, 
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stepped-care cognitive behavioral approach with elements from tinnitus retraining therapy 
compared with care as usual in the Netherlands, was assessed in a randomized controlled trial.  
 
Quality of life  
As mentioned in the previous paragraph almost all therapies for tinnitus aim at improving 
quality of life. Quality of life as an outcome measure in cost-effectiveness analysis is usually 
expressed in a utility score, ranging from 0 to 1, where 0 represents death and 1 represents 
perfect health. A standard gamble task (SG) is considered as the gold standard for measuring 
utilities, although the time trade-off (TTO) is mostly preferred since it is easier to administer 
(Drummond et al., 2005). In a SG respondents are asked to choose between two alternatives: 
remaining in a state of ill health for sure, or an intervention with two possible outcomes, 
either restoring perfect health (p) or dying immediately (1-p). The risk a respondent is willing 
to take (p) represents the utility score. In a TTO respondents are asked to choose between 
remaining in a state of ill health for a period of time A, or being restored to perfect health for 
a shorter period of time B. The utility of the ill health state equals B divided by A. 
In most economic evaluations of health care, utilities are measured indirectly by using multi-
attribute utility instruments, such as the EuroQol 5D or the Health Utilities Index Mark III. 
These instruments consist of a multi-attribute retrospective description of health for self-
report, and a formula to convert this description into a population health utility value. This 
formula is derived using valuation techniques, such as the SG and the TTO, in the general 
population. The problem with using different multi-attribute utility measures is that each 
instrument differs in conceptualization and operationalization of health, and the valuation 
method upon which the utility scores are based. Therefore the use of utility measures in 
specific populations such as tinnitus should be tested to determine which one is most 
responsive to change. Furthermore it is well-known that problems arise when the questions to 
obtain health descriptions and health utility values are ambiguous and difficult to understand, 
or when it exceeds participants’ knowledge and the limits of memory. A problem that has 
been described is for instance that members of the general public are not able to imagine the 
experience of different health states. Many problems on self-report measures can be weakened 
by asking questions in close temporal proximity to the event of interest (Schwarz, 2011). It is 
argued that the direct measurement of people’s experienced utility may be a substitute or a 
complement to QALYs that are inferred from choices people make. It was suggested to 
measure experienced utility with the Experienced Sampling Method (ESM), but it has not 
been tested. The ESM was designed to measure hedonic and affective experience derived 
from immediate reports of current subjective experience, and is thought to be a more accurate 
reflection of experience. In this study the potential value of using the ESM to obtain 
momentary accounts of a person’s own HRQOL was explored and compared to a 
retrospective valuation of HRQOL.   
 
Cost of tinnitus 
In a cost of illness study the costs of a condition to society are calculated. The aim of such a 
study is to highlight the economic importance of a particular disease. There are two 
approaches to a cost of illness study: top-down or bottom-up. In a top-down approach the total 
costs per healthcare sector in a country are used as a starting point, and fractions of these costs 
are attributed to a specific disease. In a bottom-up approach data on healthcare consumption 
or cost data from a sample of patients are gathered and extrapolated to the total population. 
Although tinnitus treatment has been described as fragmentized and costly to both the patients 
and the society at large (Henry et al., 2005; Lockwood et al., 2002; Reich, 2002), a cost of 
illness study was not previously performed. Also, information on demographic and disease 
characteristics that might influence healthcare utilization is lacking. In this thesis, baseline 
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data from a randomized controlled trial investigating the cost-effectiveness of a specialized, 
stepped-care cognitive behavioral approach for tinnitus compared with usual care was used to 
examine the costs of tinnitus in The Netherlands from a healthcare and a societal perspective.  
 
Economic evaluation  
Cost-effectiveness of an intervention is gaining more importance in the current budget 
restraint healthcare systems. In a cost-effectiveness analysis costs and consequences of 
alternative treatment strategies are identified, measured, valued and compared. The 
incremental effectiveness of an intervention is quantified and compared with its incremental 
costs. Effectiveness can be measured using various outcomes like life years saved. In most 
guidelines the use of quality-adjusted life years (QALYs) is preferred as a measure of 
outcome since is a measure of life expectancy, weighted by a health-related quality of life. 
Quality of life is expressed in a utility score, ranging from 0 to 1, where 0 represents death 
and 1 represents perfect health. This type of a cost-effectiveness analysis is called a cost-
utility analysis. The advantage of using such a generic outcome is that it enables policy 
makers to make comparisons across different interventions and health states. In a cost-utility 
analysis the incremental costs per year spent in perfect health is calculated.  
It is recommended that economic evaluation studies are performed from a broad societal 
perspective, including all relevant costs and health effects. With regard to costs these can be 
made both inside and outside the health care sector. Costs that can arise outside the healthcare 
sector are for instance productivity costs, costs of informal care and costs of over-the-counter 
medication. With regard to the relevant health effects societal perspective implies the use of a 
valuation of perfect health and different health states by the general public and not by 
patients.  
 
Aims and outline of the thesis 
The general objective of this thesis is to evaluate the effects of tinnitus on health-related 
quality of life and costs. Furthermore, the effects of a specialized, stepped-care cognitive 
behavioral treatment were compared to care as usual. Chapter 1 to 4 were based on data from 
a randomized controlled trial. Chapter 5 and 6 were based on a study using the ESM to 
measure (aspects of) HRQOL in daily life.  
 
Chapter 1 describes the differences between the two most frequently used utility measures in 
economic analysis, the EuroQol-5D and the Health Utilities Index Mark III, in a Dutch 
population with tinnitus. Utility scores derived from both measures is examined to determine 
agreement, construct validity and responsiveness. 
 
In Chapter 2 the costs of tinnitus in the Netherlands is examined from a healthcare perspective 
and a societal perspective. In addition, the impact of both disease and demographic 
characteristics on the total healthcare and societal costs are investigated. 
 
Chapter 3 aims to assess the effectiveness of a specialized, stepped-care cognitive behavioral 
approach with elements from tinnitus retraining therapy compared with care as usual. Primary 
outcomes are health-related quality of life, tinnitus severity and tinnitus impairment. 
  
In Chapter 4 is assessed whether a specialized, stepped-care cognitive behavioral approach is 
cost-effective as compared to care as usual from a societal perspective. The primary effect 
parameter in the economic evaluation is the QALY, which is based on health state utilities 
measured with the Health Utilities Index Mark III (HUI). Costs in the analysis include 
healthcare costs, patient and family costs, and indirect costs. 
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In Chapter 5, the use of new methodology in measuring quality of life for use in economic 
evaluations is examined. The objective of this chapter is to use the Experience Sampling 
Method to explore the value of obtaining momentary, instead of retrospective, accounts of the 
description and valuation of person’s own HRQOL. 
 
In Chapter 6 the results of the Experience Sampling Method investigating the impact of 
tinnitus on daily life, are described. The objective of this study is to compare emotions, 
activities and social interactions in daily life of patients with tinnitus with a non-tinnitus 
control group. 
 
Finally, the Summary and Discussion provides a general summary and discussion of the main 
findings. Methodological issues and the implications of the findings for (clinical) practice and 
future directions are evaluated.  
 
 
 
 
CHAPTER 1
Assessment of health state in patients with tinnitus: 
a comparison of the EQ-5D and HUI Mark III
Iris H.L. Maes, Manuela A. Joore, Rilana F.F. Cima,
 Johannes W. Vlaeyen, Lucien J.C. Anteunis
Published in Ear & Hearing 2011; 32(4); 428-435
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Abstract 
Objectives Expressing the outcomes of treatment in quality-adjusted life years (QALYs) is 
increasingly important as a tool to aid decision-makers concerning the allocation of scarce 
resources within the healthcare sector. A QALY is a measure of life expectancy, weighted by 
health-related quality of life. These weights are referred to as utility scores and are usually 
measured by multi-attribute utility measures. Several studies found that different utility 
measures provide different estimates of the same person’s level of utility. The aim of this 
study was to investigate which of two widely used utility measures, the EQ-5D and the HUI 
Mark III, is preferred in a tinnitus population  
Methods Baseline and follow-up data on EQ-5D and HUI Mark III of 429 patients of a 
randomized controlled clinical trial, investigating cost-effectiveness of usual care versus 
specialized care of tinnitus, were included. Agreement, discriminative power, and 
responsiveness of the health state description and the utility scores were examined. 
Results Corresponding dimensions of the EQ-5D and HUI Mark III showed large 
correlations; although ceiling effects were more frequently observed in the EQ-5D. Mean 
utility scores for EQ-5D (0.77; SD=0.22) and HUI Mark III (0.64; SD=0.28) were 
significantly different (Wilcoxon Signed Ranks Test, P-value <0,001), agreement was low to 
moderate (ICC=0.53). Both health state description and utility scores of both measures 
discriminated between different severity groups. These groups were based on baseline scores 
of the Tinnitus Questionnaire. The HUI Mark III had a higher ability than the EQ-5D to detect 
improved patients from randomly selected pairs of improved and unimproved patients. 
Conclusion This study shows that different utility measures lead to different health state 
descriptions and utility scores among tinnitus patients. However, both measures are capable of 
discriminating between clinically different groups. The HUI Mark III is more responsive than 
the EQ-5D, and therefore preferred in a tinnitus population.  
 
Keywords: Tinnitus, outcome assessment, questionnaires, health-related quality of life. 
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Introduction 
Economic evaluation of health care is becoming increasingly important as a tool to aid 
decision-makers concerning the allocation of scarce resources within the healthcare sector. To 
make a comparison between different conditions there is a need to express the effectiveness of 
treatments in terms of quality-adjusted life years (QALYs). A QALY is a measure of life 
expectancy, weighted by health-related quality of life. These weights are referred to as utility 
scores. Utilities are mostly determined indirectly, by using quality of life measures with pre-
existing utility weights that can be attached to each permutation of responses. Unfortunately, 
the available multi-attribute utility measures, such as the EuroQol-5D (EQ-5D) and the Health 
Utilities Index Mark III (HUI Mark III), differ in the conceptualization and operationalization 
of health, and the valuation method upon which the utility scores are based. Several studies 
found that these two widely used multi-attribute utility measures, provide different estimates 
of the same person’s level of utility (Barton et al., 2008; Brazier et al., 2004; Espallargues et 
al., 2005; Feeny et al., 2004; Grieve et al., 2008; Grutters et al., 2007; Hatoum et al., 2004; 
Marra et al., 2004; Marra et al., 2005).  
As a result, these differences can lead to variations in the estimates of utilities and QALYs 
used in economic evaluations. The purpose of this study was to investigate systematic 
differences in health state descriptions and utility values obtained with the EQ-5D and the 
HUI Mark III in tinnitus patients. Subjective tinnitus is the involuntary perception of the 
concept of a sound without the presence of an external source. It is a chronic condition that is 
highly prevalent, especially among hearing impaired individuals. Studies show a prevalence 
of 10% to 20% in the general population, (Davies & Rafie, 2000). Among hearing impaired 
individuals prevalence has been estimated at 75% to 80% (Adams et al., 1999). Among severe 
sufferers tinnitus causes affective problems, major declines in concentration, sleeping 
difficulties, exhaustion and problems in (re-)directing attention (El Refaie et al., 2004; 
Erlandsson & Hallberg, 2000; Jastreboff et al., 1996; Kroner-Herwig et al., 2003; Scott et al., 
1990). These problems have detrimental effects on many areas of functioning, leading to a 
diminished quality of life. 
The aim of the current study was to determine which utility measure is preferred in a tinnitus 
population. To determine this we will assess agreement and compare the discriminative power 
and responsiveness of both measures. Moreover, we will investigate the differences between 
the descriptive system and the utility scores of the EQ-5D and the HUI Mark III. The paper is 
structured as follows. First, we will introduce the dataset that was used. Next we describe the 
EQ-5D and HUI Mark III instruments and the analyses we performed. In the results section 
we compare agreement, discriminative power and responsiveness, for the health state 
description and the utility scores, of both instruments.  
 
Methods  
Measures  
The EQ-5D consists of a visual analogue scale and five questions, each representing a 
dimension of health-related quality of life: mobility, self-care, daily activities, pain/discomfort 
and anxiety/depression (The EuroQol Group, 1990). The visual analogue scale ranges from 
best (100) to worst (0) imaginable health state. On this scale patients have to rate their own 
health state. The five questions have three response levels, which classify the severity of 
complaints on that specific dimension. The combination of levels over dimensions defines a 
universe of 243 unique health states (= 3 x 3 x 3 x 3 x 3). To determine an additive scoring 
function based on these different health states, Dolan (1997) derived preferences for these 
health states using a time trade-off  task in a representative sample of the UK population of 
2.997 respondents. In the time trade-off task the respondents were asked to choose between 
remaining in a state of ill health for a period of time A, or being restored to perfect health for 
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a shorter period of time B. The utility of the ill health state equals B divided by A. The 
possible utility scores of the EQ-5D range from –0.59 to 1.0. 
The HUI Mark III consists of 17 questions which are used to compute 8 dimensions: vision, 
hearing, speech, ambulation, dexterity, emotion, cognition, and pain/complaints. Each 
question has five or six levels and 972.000 possible health states can be formed by the levels 
of the different dimensions. A multiplicative utility scoring function was determined by 
deriving preferences from a standard gamble task and a visual analogue scale in a random 
sample of the Canadian general population of 504 respondents. In the standard gamble, 
respondents are asked to choose between two alternatives: remaining in a state of ill health for 
sure, or an intervention with two possible outcomes, either restoring perfect health (p) or die 
immediately (1-p). The risk a respondent is willing to take (p) represents their utility score. 
Possible utility scores range from –0.36 to 1.00 for the HUI Mark III (Feeny et al., 2002) . 
Differences between both measures may arise as a consequence of a difference in the 
conceptualization and the operationalization of health, and a difference in the scoring 
algorithm to calculate utilities. The EQ-5D conceptualizes health as an overall construct 
containing physical, mental, and social functioning (Brooks, 1996), while the HUI Mark III 
focuses on health ‘within the skin’, meaning that it purely focuses on the underlying level of 
impairment (Feeny et al., 1995). Also, the operationalization of health differs between the 
measures. The EQ-5D has a dimension focusing on the quality of the performance of daily 
activities, which the HUI Mark III has not. The HUI Mark III contains dimensions that are not 
present in the EQ-5D: vision, hearing, cognition and dexterity. Especially the hearing and 
cognition dimensions are likely to be relevant in a population with tinnitus. Furthermore, the 
answering scales differ. The EQ-5D has three answering levels for each item, while the HUI 
Mark III has 5 or 6 answering levels. Moreover, the answering scales are defined differently. 
The EQ-5D levels are defined as: no problems, moderate problems or severe problems. The 
HUI Mark III levels provide some explanation about what sort of complaints are associated 
with mild, moderate or severe problems. 
The scoring algorithm of both measures were derived using different methods. The EQ-5D 
UK tariff is based on time trade-off values, while the HUI Mark III scoring algorithm is based 
on standard gamble and visual analogue scale scores. It is described that the standard gamble 
leads to higher utility scores than the time trade-off, and the time trade-off leads to higher 
utility scores than the visual analogue scale (Drummond et al., 2005). Also, the scoring 
algorithms were derived in different countries (UK versus Canada). Different cultures may 
value health in different ways (Knies et al., 2009). 
The Tinnitus Questionnaire (TQ) (McCombe et al., 2001) is a measure of tinnitus-related 
distress and will serve as an external anchor to determine discriminative power and external 
responsiveness of the EQ-5D and HUI Mark III. Based on the scores of the TQ patients can 
be classified into three different severity classes: mild tinnitus complaints, moderate tinnitus 
complaints and severe tinnitus complaints.  
 
Study population and data collection 
Data were collected as part of a ongoing randomized controlled trial investigating the 
effectiveness and cost-effectiveness of an integral multidisciplinary treatment for tinnitus 
versus care as usual (Cima et al., 2009). All patients referred to the centre of audiology and 
communication (Adelante, Hoensbroek) because of tinnitus complaints, were included. 
Exclusion criteria were age (< 18 years) and not being able to read and write in Dutch.  
The EQ-5D, HUI Mark III and the TQ were administered four times during a twelve month 
period. At baseline (T0), all questionnaires were administered and completed during the first 
visit at the Audiological Centre. Respondents were assisted by a trained interviewer if 
requested. Three (T1), eight (T2) and twelve months (T3) after baseline, the patients were 
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given access to an internet based electronic environment to complete the battery of tests 
online. If patients were not able to complete the questionnaire online, a paper version was 
provided. The present study includes only patients who had fully completed both 
questionnaires at baseline and after three months. In the first three months, the intervention 
focused on audiological rehabilitation (hearing aids, sound generators) and counseling. 
 
Agreement 
First, agreement in the health state descriptions obtained with the EQ-5D and HUI Mark III 
were determined by computing frequency tables of the responses on the different dimensions 
of both measures. Kendall’s tau was computed to determine the correlation between the 
corresponding dimensions of the measures: mobility (EQ-5D) and ambulation (HUI Mark 
III), pain/complaints (EQ-5D) and pain (HUI Mark III) and anxiety/depression (EQ-5D) and 
emotion (HUI Mark III). Correlations were interpreted according to the following 
benchmarks: 0.1 to 0.3 was interpreted as small, 0.3 to 0.5 as medium and >0.5 as large 
(Cohen, 1988). Ceiling and floor effects of the EQ-5D and HUI Mark III were studied by 
calculating the proportion of patients with either the best or worst health state description. For 
patients with a ceiling effect on the EQ-5D, the responses on the dimensions of the HUI Mark 
III were presented in a frequency table.  
To assess agreement between the health state utilities of both measures, a Wilcoxon Signed 
Rank test and a paired samples t-test were used. Utility scores were tested for normality with 
a Kolmogorov-Smirnov test. The Intra-class Correlation Coefficient (ICC) was computed 
based on a two-way mixed effect model, such that the subject effect was random and the 
instrument effect was fixed. Computations were performed at the individual patient level. An 
ICC below 0.75 implies poor to moderate agreement; above 0.75 implies good agreement 
(Gross-Protney & Watkins, 1993). Furthermore, Bland-Altman plots (BAP) were computed 
with the difference between the utility scores from the EQ-5D and the HUI Mark III on the Y-
axis and the mean of the utility scores on both measures on the X-axis. All these analyses 
were performed on the baseline data. 
 
Discriminative power 
Since there is also no gold standard for measuring health state utility, construct validity is 
usually determined by the discriminative power between clinically different groups. To 
determine the discriminative power of the health state descriptions of the EQ-5D and the HUI 
Mark III, the frequencies of responses on the different dimensions were computed in 
clinically different groups based on TQ baseline scores. A score below 30 on the TQ indicates 
mild tinnitus, a score between 31 and 46 indicates moderate tinnitus and a score above 47 
indicates severe tinnitus. The discriminative power of the utility scores of the measures was 
determined by calculating the mean utility scores for these groups. Differences in mean scores 
were tested using ANOVA or the Kruskal-Wallis Test, depending on the distribution of the 
data.  
 
Responsiveness 
First, frequency tables of the health state descriptions of both measures were computed for 
patients who improved and patients who did not improve. Patients were classified as 
improved if the score on the TQ dropped 10 or more points from baseline to three months.   
Second, the health state utility scores were tested for internal and external responsiveness. 
Internal responsiveness is a distribution-based method that characterizes the ability of a 
measure to change over a particular pre-specified time frame. External responsiveness is an 
anchor-based method that describes the relationship between change in a measurement and 
change in a reference measurement of health. The two most frequently used methods for 
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determining internal responsiveness are the effect size (ES) and the standardized response 
mean (SRM) (Terwee et al., 2003). Effect size is calculated as the change in score divided by 
the standard deviation of scores at baseline. The standardized response mean is the change in 
score divided by the standard deviation of the change in score. Both the ES and the SRM were 
computed for those patients who improved and for patients who did not improve from 
baseline to three months. They were interpreted using benchmarks for effect size: 0.20 
through 0.49 is interpreted as small, 0.50 through 0.79 as moderate and ≥ 0.80 as large 
(Cohen, 1988). External responsiveness was determined by a Receiver Operating Curve 
(ROC), which determined how successfully a given score on the EQ-5D or the HUI Mark III 
could discriminate patients who improved from those who did not improve. Improvement was 
defined as a decrease in the score on the TQ of 10 or more points and was the state variable. 
Test variables were the difference scores of the EQ-5D and the HUI Mark III between 
baseline and the different follow-up measurements. The area under the ROC curve was 
interpreted as the probability of correctly identifying the improved patient from randomly 
selected pairs of improved and unimproved patients.  
 
Results 
Study population 
Of the 429 patients included in the study, 428 completed the EQ-5D and the HUI Mark III at 
baseline. Patients had a mean age of 54 years and 62.2% were male. The mean hearing loss 
over the frequencies of 1000, 2000 and 4000 Hertz was 31.50 (17.9). Not all patients 
completed the follow-up measurement at three months yet. The analyses of responsiveness in 
this paper are based on the 319 patients who fully completed the EQ-5D and the HUI Mark III 
at baseline and three months follow-up. Patient characteristics are displayed in Table 1.  
 
 
Table 1. Characteristics of the study population 
Characteristics Baseline 3 months follow-up
N 428 319
Age 
 Mean age in years (SD) 54.3 (11.8) 54.9 (11.4)
 Range 20-85 20-85
Gender 
 Male (%) 267 (62.2%) 203 (63.6%)
Living situation 
 Living alone 85 (19.8%) 62 (19.4%)
 Living together 343 (80.2%) 257 (80.6%)
Mean PTT at 1, 2 & 4 kHz (in dB) 
 Right   30.0  30.8
 Left   31.0 32.4
 Overall  31.5 31.8
Duration of tinnitus complaints 
 < 1 year (%) 126 (29.4%) 92 (28.8%)
 1-5 years (%) 167 (39.0%) 122 (38.2%)
 5-10 years (%) 60 (14.0%) 46 (14.5%)
 > 10 years (%) 75 (17.6%) 59 (18.5%)
SD = Standard Deviation; PTT = Pure Tone Treshold; dB = decibel 
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Figure 1. Percentage of responses on dimensions of EQ-5D and HUI Mark III at baseline for 
mild (N=81), moderate (N=112) and severe (N=235) tinnitus and the total group (N=428). 
 
 
Agreement 
The frequency tables in Figure 1 show most patients had complaints on the dimensions 
pain/complaints, anxiety/depression and daily activities of the EQ-5D. For the HUI Mark III 
most patients had complaints in the pain, emotion, cognition and hearing dimension (Fig. 1). 
With regard to vision, the HUI Mark III shows that approximately 80% of the patients wear 
glasses. There were large positive correlations (Kendall’s tau > 0.50) between mobility (EQ-
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5D) and ambulation (HUI Mark III) (Kendall’s tau = 0.595) and anxiety/depression (EQ- 5D) 
and emotion (HUI Mark III) (Kendall’s tau = 0.527). There was a moderate correlation  
between pain/complaints (EQ-5D) and pain (HUI Mark III) (Kendall’s tau = 0.487). In both 
measures floor effects were not observed. Ceiling effects were more frequent in the EQ-5D 
health state descriptions. The frequency table of Figure 2 shows that patients with a ceiling 
effect on the EQ-5D report most problems on dimensions that are only present in the HUI 
Mark III, such as hearing and cognition. However, they also show some problems on HUI 
Mark III dimensions that correspond with EQ-5D dimensions, such as emotion and pain. 
Both the EQ-5D and the HUI Mark III utility scores were not normally distributed (P-
value<0.001). The mean utility score for HUI Mark III was 0.64 and the mean utility score for 
the EQ-5D was 0.77. The utility scores were significantly different distributed (Wilcoxon 
Signed Ranks test, P-value<0.001). The intra-class correlation coefficient for agreement was 
0.53 (95% CI: 0.45; 0.60), which implies a poor to moderate agreement. Bland-Altman plots 
(Fig. 3) show that the difference between the EQ-5D and HUI Mark III utility scores are 
larger when the mean utility scores of both measures increases. Furthermore it shows that the 
HUI Mark III overall has lower utility scores than the EQ-5D. 
 
 
Figure 2. Ceiling effects of EQ-5D. Distribution of responses (%) on the HUI Mark III 
dimensions for those with EQ-5D = 11111 (N=108). 
 
 
Construct validity 
Patients were divided into three clinically different groups based on the TQ scores. These 
showed that 81 patients (19%) had mild tinnitus complaints, 112 (26%) patients had moderate 
tinnitus complaints and 235 (55%) patients had severe tinnitus complaints at baseline. A one- 
way analysis of variance showed that there were no differences between these groups with 
regard to age, sex or hearing loss.  
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Figure 3. Bland-Altman plot of EQ-5D utility score versus HUI Mark III utility score  
(N= 428). 
 
 
With regard to the EQ-5D, the daily activities and the anxiety/depression dimensions 
distinguish best between mild, moderate and severe groups, with more complaints in groups 
with more severe tinnitus (see fig 1). The mobility and pain/complaints dimension also 
distinguish between the different severity groups. The EQ-5D self-care dimension shows no 
complaints in the mild and moderate groups and some complaints in the severe group. With 
regard to the HUI Mark III the dimensions hearing, cognition, emotion and pain distinguish 
between groups with mild, moderate and severe tinnitus. In the other dimensions patients 
report little or no complaints.  Table 2 provides an overview of the mean utility scores for the 
different clinical groups as measured by the EQ-5D and the HUI Mark III. Both utility 
measures discriminate between clinically different groups (ANOVA P-value<0.001; Kruskal-
Wallis test P-value<0.001). Groups with more severe tinnitus had significantly lower mean 
utility scores at both baseline and after three months. 
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Responsiveness 
From baseline to three months, 112 patients improved at least 10 points on the TQ, 207 
patients showed no improvement. Figure 4 shows that after three months there were slightly 
less complaints on each of the dimensions of the EQ-5D. In the HUI Mark III dimensions, 
patients have fewer complaints on the pain, emotion and cognition dimension. With regard to 
the hearing dimension, patients show more complaints. There were no changes in 
complaints on the dimensions of the EQ-5D in patients that did not show improvement in the 
first three months. In the HUI Mark III this group showed slightly more complaints on the 
hearing, emotion and cognition dimension.   
The mean change in utility scores in patients who did not improve on the TQ was not 
statistically significant for the EQ-5D or the HUI Mark III. The mean change in utility scores 
for improved patients from baseline to three months was statistically significant for the both 
HUI Mark III (Wilcoxon Signed Ranks test, P-value<.01) and the EQ-5D (Wilcoxon Signed 
Ranks test, P-value<.05). The effect sizes of the change in health state utilities from baseline 
to three months were 0.19 (SD=0.84) for the EQ-5D and 0.21 (SD=0.75) for the HUI Mark 
III. The SRM of the change in score from baseline to three months was 0.22 (SD=0.94) for 
the EQ-5D and 0.25 (SD=0.97) for the HUI Mark III. Although all these effect sizes are 
small, the HUI Mark III is slightly more responsive than the EQ-5D in patients with tinnitus. 
With regard to the external responsiveness the area under the curve was 0.61 for the HUI 
Mark III and 0.58 for the EQ-5D (Fig. 5).  
 
Table 2. Mean utility scores for EQ-5D and HUI Mark III 
  Baseline Three months follow-up 
 
TQ 
 
N 
 
% 
ceiling 
effect 
Mean* 
(SD)
Median**
N % 
ceiling 
effect
 
Mean* 
(SD) 
Median**
     
EQ-5D Mild 81 43.2% 0.87 (.15) 0.79 55 47.3% 0.86 (.16) 0.81
 Moderate 112 33.9% 0.82 (.17) 0.80 86 38.4% 0.84 (.18) 0.80
 Severe 235 14.9% 0.71 (.24) 0.76 178 16.3% 0.71 (.25) 0.73
 Total 428 25.2% 0.77 (.22) 0.80 319 27.6% 0.77 (.23) 0.80
     
HUI  Mild 81 6.2% 0.79 (.18) 0.85 55 1.8% 0.88 (.18) 0.84
Mark III Moderate 112 2.7% 0.82 (.17) 0.78 86 2.3% 0.73 (.24) 0.79
 Severe 235 0.4% 0.55 (.30) 0.55 178 1.1% 0.54 (.30) 0.58
 Total 428 2.1% 0.64 (.28) 0.70 319 1.6% 0.63 (.28) 0.70
* All statistically significant, ANOVA p<.001 
** All statistically significant Kruskal Wallis test, p<.001
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Figure 4. Frequency of dimensions of EQ-5D of patients who improved from T0 to T1 (N= 
112) 
 
 
 
Figure 5. External responsiveness of EQ-5D and HUI Mark III from baseline to three months 
(N= 319)  
CHAPTER 1 
26 
 
Discussion 
We investigated agreement, construct validity and internal and external responsiveness of the 
health state description and utility scores based on the EQ-5D and the HUI Mark III in 
patients with tinnitus. The results of this study provide insight into the differences between 
the two widely used utility measures, in patients with tinnitus. Our main findings are the 
following.  
First, although corresponding dimensions showed large correlations, in the EQ-5D health 
state description ceiling effects were much more frequently observed. Ceiling effects of the 
EQ-5D are already reported in other studies (Luo et al., 2009; Grutters et al., 2007; Bharmal 
& Thomas, 2006). Because of the presence of these ceiling effect, it was suggested not to use 
the EQ-5D in relatively healthy populations (Kopec & Willison, 2003). Patients with perfect 
health according to the EQ-5D, reported substantial problems on both corresponding as non-
corresponding dimensions of the HUI Mark III. From this, we can conclude that both the 
operationalization of health in items, such as the answering scale used, seem to cause 
differences between these two measures. It also illustrates one of the disadvantages of the EQ- 
5D for otherwise healthy populations, but characterized (in part) by a cognitive and/or sensory 
dysfunction. 
Second, the utility scores of the EQ-5D were higher than the utility scores of the HUI Mark 
III. These findings are in line with the literature (Luo et al., 2009; Grutters et al., 2007; Marra 
et al., 2005; Oostenbrink et al., 2002). Part of the differences between utility scores can be 
explained by the differences in health state descriptions, but it is unclear to what amount. 
Differences could also result from the differences in the utility scoring function. Although in 
general the time trade-off (used for the EQ-5D) leads to lower scores than the standard 
gamble (used for the HUI Mark III), the HUI Mark III utility scores were considerably lower 
than the EQ-5D utility scores in the present study. The utility scoring function of the EQ-5D 
is additive, assuming no interaction for preferences among attributes at all. The HUI Mark III 
uses a multiplicative scoring function, with the effect that the level of impairment in one 
dimension is dependent on the level of impairment in another dimension. The utility scores of 
the HUI Mark III are expected to be lower, since they take into account the effect of 
comorbidity.   
Third, both measures have discriminative power regarding the health state description. The 
corresponding dimensions show the most differences between clinically different groups 
based on severity of the tinnitus. The HUI Mark III also shows a large effect on the hearing 
and cognition dimension. This is in line with our expectation, since tinnitus is more prevalent 
in patients with hearing complaints. Furthermore, tinnitus leads to problems in concentration 
and redirecting attention.  
Fourth, health state utility scores of both measures also have discriminative power in groups 
with more severe tinnitus. These findings are in line with other studies that reported 
discriminative power of both measures (Fisk et al., 2005; Marra et al., 2004). One study 
reported discriminative power of only the HUI Mark III (Grutters et al., 2007). In this study 
the utility scores of the HUI Mark III are lower than the EQ-5D utility scores for each tinnitus 
severity group.   
Fifth, both the EQ-5D and the HUI Mark III show some improvement in the different 
dimensions from baseline to three months. The HUI Mark III shows more complaints in the 
hearing dimension. This could be a result of the fact that treatment in the first three months is 
especially aimed at audiological rehabilitation, drawing their attention to the hearing loss and 
complaints.  
Sixth, the HUI Mark III and the EQ-5D both measured statistically significant change in the 
mean utility scores of improved patients after the first three months, in which the first level of 
treatment was finished. In two other studies that compared both measures in a population of 
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patients with hearing loss, only the HUI Mark III was able to measure statistically significant 
improvement (Grutters et al., 2007; Barton et al., 2004). An integral multidisciplinary 
treatment for tinnitus is aimed at improving quality of life, while hearing aid fitting will be 
most noticeable in the hearing dimension which is only represented in the HUI Mark III. In 
the present study, the HUI Mark III had a higher ability to detect improved patients, from 
randomly selected pairs of improved and unimproved patients. A possible explanation for the 
lack of sensitivity to measure change in the EQ-5D, is the occurrence of a ceiling effect in 
25% of the population at baseline. If such a large proportion of patients report perfect health 
at baseline, it is unlikely to find a considerable utility gain from any intervention. 
A shortcoming of this study is the fact that it did not allow us to estimate an instrument order 
effect. In all subjects the Tinnitus Questionnaire was administered first, followed by the HUI 
Mark III and the EQ-5D. The extent, to which a change in instrument order would influence 
differences in the health state description and health state utility, is unknown.  
In conclusion, the results on agreement, construct validity and responsiveness show 
substantial differences between the health descriptions, as well as the utility scores, between 
the EQ-5D and the HUI Mark III. Differences in conceptualization and operationalization of 
health explain part of the differences in the utility scores between both measures. It remains 
unclear how the scoring differences of both measures are responsible for the differences 
between the utility scores. According to the results of this study, both the EQ-5D and the HUI 
Mark III can be used in a tinnitus population, although researchers should be aware of the 
possible ceiling effects of the EQ-5D. This contributes to the evidence that there may not be a 
superior instrument for measuring health state utility. For now, researchers should use a 
measurement tool that best fits the condition under investigation. Despite considerable 
overlap between both measures, we recommend the HUI Mark III as the tool of preference in 
patients with tinnitus, since it is the most sensitive to change in the condition and is less 
affected by ceiling effects.  
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Abstract 
Objectives The aim of this study was to examine the costs of tinnitus from a societal 
perspective. Furthermore, the impact of disease characteristics and demographic 
characteristics on these costs were examined.  
Methods A bottom-up Cost Of Illness (COI) study was performed using the baseline data on 
a cost-questionnaire of a randomized controlled trial investigating the (cost-)effectiveness of 
an integral multidisciplinary treatment for tinnitus versus care as usual. Mean yearly costs 
were multiplied by the prevalence figure of tinnitus for the adult general population in order 
to estimate the total cost of illness of tinnitus to society. Several questionnaires measuring 
disease and demographic characteristics were administered. As cost data usually are not 
normally distributed, a non-parametric bootstrap resampling procedure with 1,000 simulations 
was performed in Excel to determine statistical uncertainty of the cost estimates per category. 
The impact of disease characteristics and demographics on costs in patients with tinnitus was 
investigated using a multivariate regression analyses. 
Results Total mean cost of illness was €6,6 billion (95% CI: €1,7 billion - €11,3 billion). 
The larger part of total COI was not health care related. Total mean healthcare costs were €1,9 
billion €0,8 billion - €3,3 billion). The most important predictor of both healthcare costs and 
societal costs was tinnitus severity. Other significant predictors of higher both healthcare and 
societal costs were shorter duration of tinnitus and more severe depression as measured with 
the Hospital Anxiety and Depression Scale. From a societal perspective age was also an 
important predictor.  
Conclusion The economic burden of tinnitus to society is substantial and severity of tinnitus 
is an important predictor of the costs that patients make. 
 
Keywords: Tinnitus, cost of illness, healthcare costs, societal costs 
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Introduction 
Tinnitus is the perception of a sound for which there is no acoustic source. It is a common 
chronic health problem of which prevalence has been estimated to be 10-20% in the general 
population (Andersson, 2002; Davis & El Refaie, 2000). In most cases the symptoms have no 
identifiable/detectable organic cause and cannot be explained by conventional medical or 
psychiatric diagnoses. The absence of a known effective treatment often leads to referrals to a 
variety of caregivers in an unstructured and non-standardized way (Hoare et al., 2010). 
Patients seek help in various areas of health care, but most of the therapies do not lead to 
recovery.  As a result, tinnitus treatment has been described as fragmentised and costly to 
both the patients and the society at large (Henry et al., 2005; Lockwood et al., 2002; Reich, 
2002). However, empirical evidence supporting this claim is lacking. 
To our knowledge, this is the first Cost Of Illness (COI) study for tinnitus. There are two 
approaches to a COI study: top-down or bottom-up. In a top-down approach the total costs per 
health care sector in a country are used as a starting point, and fractions of these costs are 
attributed to a specific disease. However, the use of national health care expenditures may 
either under or overestimate total direct costs. Also, the exclusion of cost categories that are 
not included in national health care expenditures (i.e. travel expenses) also biases the 
estimates of COI since different disease categories may absorb different non-health care costs. 
Finally, in a top-down COI study all costs are attributed to the primary diagnosis and tinnitus 
is often not recognized as such. A bottom-up approach in which health care consumption or 
cost data of a sample of patients are gathered and extrapolated to the total population, is more 
appropriate in patients with tinnitus.    
Although no COI studies have been performed in a tinnitus population, there are several 
bottom-up studies on costs or health care utilization in patients with other medically 
unexplained somatic symptoms, like fibromyalgia (Berger et al., 2007; Boonen et al., 2005; 
Cronan et al., 2002; Robinson et al., 2003; Walen et al., 2001; Wolfe et al., 1997), chronic 
low back pain (Boonen et al., 2005; Gore et al.) and irritable bowel syndrome (Johansson et 
al., 2010; Maxion-Bergemann et al., 2006; Nyrop et al., 2007). Boonen et al. (Boonen et al., 
2005) found that health care costs and productivity losses are higher in patients with chronic 
low back pain or fibromyalgia than in patients with a specific inflammatory rheumatic 
disorder. Studies investigating health care utilization in irritable bowel syndrome revealed that 
age, comorbidity and severity of symptoms were related to higher health care costs 
(Johansson et al., 2010; Maxion-Bergemann et al., 2006; Nyrop et al., 2007). In patients with 
fibromyalgia, illness costs have also shown to be associated with psychological comorbidity, 
especially depression (Berger et al., 2007; Robinson et al., 2003; Wolfe et al., 1997).  
In the present study the costs of tinnitus in the Netherlands were examined from a health care 
and a societal perspective. In the latter perspective,  health care costs, out-of-pocket costs and 
productivity losses are taken into account. In addition, we investigated the impact of both 
disease and demographic characteristics on the total health care and societal costs.  
 
Methods 
Study Design 
This study is part of a randomised controlled clinical trial investigating the effectiveness and 
cost-effectiveness of an integral multidisciplinary treatment for tinnitus versus care as usual 
(Cima et al., 2009; Cima et al., 2012). The study population consisted of patients referred to a 
audiological secondary care facility (Adelante Audiology and Communication, Hoensbroek, 
the Netherlands) because of their tinnitus complaints. All health care professionals in the 
surrounding region who have contacts with tinnitus patients were informed on the study. This 
was done to ensure that the study was easy accessible for all patients. The present study 
includes only the baseline measurement to ensure that there is no treatment effect on the costs. 
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Measures 
Societal costs associated with tinnitus were measured using a self-administered cost 
questionnaire with a recall period of three months. We distinguished between three categories 
of societal costs: health care costs, patient and family costs and indirect costs. Health care 
costs included contacts with the general practitioner practice, medical specialists in the 
hospital, care provided by other health care professionals, and medication. The unit costs of 
all health care costs were adopted from the Dutch guideline for cost research (Hakkaart - van 
Roijen et al., 2010) unless stated otherwise (Table 2). Whenever necessary, unit costs were 
converted to the reference year 2009 by means of index numbers. Patient and family costs 
included e.g. travel expenses, costs of over the counter medication, costs of sports or 
meditation activities for relieving the tinnitus, the use of ear candles and ‘other costs’ 
associated with tinnitus. The cost questionnaire also included the PRODISQ items 
(Koopmanschap, 2005) to measure loss of productivity (indirect costs). The costs of loss of 
productivity of paid work were quantified using the human capital approach, which takes into 
account absence from work as a result of illness, disability or premature death (Drummond et 
al., 2005). The cost of an hour of productivity loss was based on the mean hourly salary costs 
for men and women from the Dutch guideline for cost research (Hakkaart - van Roijen et al., 
2010).  
Tinnitus severity or distress due to the tinnitus was assessed using the Tinnitus Questionnaire 
(TQ) (McCombe et al., 2001). The TQ consists of 52 items rated on a 3-point scale and 
assesses the psychological distress associated with the tinnitus. Psychometric properties of the 
TQ have proven excellent in different languages (Baguley et al., 2000; McCombe et al., 
2001). Based on the scores from the Tinnitus Questionnaire, patients were classified into three 
different severity classes. A TQ score below 30 points was defined as mild tinnitus 
complaints, a TQ score from 30 to 46 was defined as moderate tinnitus complaints and a TQ 
score of more than 47 was defined as severe tinnitus complaints.  
 Anxiety and depressive symptoms were measured with the Hospital Anxiety and Depression 
Scale (HADS) (Spinhoven et al., 1997), which consists of 14 items that have to be rated from 
0=’usually’ to 4=’not at all’. Patients with higher scores have more complaints.   
Health-related quality of life was measured with the Health Utilities Index Mark III (HUI 
Mark III) (Horsman et al., 2003). This is a 17-item questionnaire to assess generic health 
related quality of life on eight dimensions: vision, hearing, speech, ambulation, dexterity, 
emotion, cognition, and pain/complaints. A multiplicative utility scoring function can be used 
to determine a single utility score based on these dimensions. Possible utility scores range 
from -0.36 to 1.00 (Feeny et al., 2002), with -0.36 being the worst imaginable health state en 
1 the best imaginable health state. 
In addition, items on general characteristic (age, sex, education), and duration of tinnitus 
complaints were added to the questionnaire. Duration of tinnitus complaints was scored in one 
of four categories: < 1 year, 1-5 years, 5-10 years and >10 years. Hearing loss was measured 
using pure tone audiometry and was defined as the Bilateral Pure Tone Average (BPTA) at 1, 
2 and 4 kiloHertz (kHz).  
 
Statistical analysis 
The mean costs per three months per patient were multiplied by four to obtain mean yearly 
costs per patient (van Asselt et al., 2007). Referral by a GP was necessary for seeking 
treatment in the secondary care setting. In some cases the baseline measurement took place 
more than three months after the referral to Adelante as a result of a waiting list. Therefore, it 
was assumed that all patients visited the GP at least once in the year preceding inclusion. For 
patients who did not report a GP contact in the retrospective cost questionnaire, one GP 
contact was included in the annual costs. Since inclusion of patients was scattered over three 
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years, there was no structural seasonal effect in the three months covered by the baseline 
measurement. Mean annual costs per patient were multiplied by the prevalence figure of 
tinnitus for the adult general population in order to estimate the total cost of illness of tinnitus 
to the Dutch society.  Approximately 30% of individuals perceive tinnitus at some point in 
their life and 10–15% experience tinnitus severely enough to seek medical attention 
(Axelsson & Ringdahl, 1989; Heller, 2003). Earlier studies have shown that 3-5% of the 
population has severe tinnitus (Davis & El Refaie, 2000; Vesterager, 1997). Since Adelante 
Audiology and Communication is a secondary care setting, the base case analysis was based 
on the assumption that our sample is representative for a total prevalence of 10%, with 4% 
having severe complaints and 6% having mild to moderate complaints. In 2009, the Dutch 
adult population aged 20 years and older consisted of 12,552,000 residents (Central Bureau of 
Statistics, 2009). When applying the prevalence rate of 4% severe with severe complaints and 
6% with mild to moderate complaints to this population, it can be derived that 539,736 adults 
had severe tinnitus complaints and 753,120 adults had mild to moderate complaints. The total 
annual health care costs due to tinnitus were compared with the total health care expenditure 
in the Netherlands in 2009 (84 billion, (Central Bureau of Statistics, 2009)). Several 
sensitivity analyses were performed. The first sensitivity analysis shows the impact of varying 
prevalence rates (5% and 15% instead of 10%). A second sensitivity analysis illustrates the 
impact of varying the proportion of patients with severe complaints (3% and 5% instead of 
4%). A third sensitivity analysis shows the impact of not extrapolating the costs of 
productivity losses to yearly costs.  
To study the impact of tinnitus severity on costs, the patients were classified into three 
different severity classes based on the scores from the TQ, as described in the previous 
paragraph. Differences in demographics between these groups were tested with an ANOVA 
for the continuous variables and a Chi-square test for the categorical variables. All data were 
tested for normality with a Kolmorgorov-Smirnov test. As cost data usually are not normally 
distributed, a nonparametric bootstrap resampling procedure with 1,000 simulations was 
performed in Excel to determine statistical uncertainty of the cost estimates per category 
(Briggs et al., 1997; Efron & Tibshirani, 1993). The differences in costs between the severity 
classes were studied by calculating confidence intervals from the bootstrapping procedure. If 
the 95% bootstrapped confidence intervals (95% BCI) did not overlap, it was concluded that 
the means were significantly different.  
The impact of disease characteristics and demographics on costs in patients with tinnitus was 
investigated with a multivariate regression analysis. A log transformation was performed on 
the cost data to resemble normality. Dependent variable was either health care costs or 
societal costs. Factors that have been tested were tinnitus severity (TQ-score), age, sex, 
duration of tinnitus complaints, educational level, health-related quality of life (HUI utility 
score), depression or anxiety (HADS score) and BPTA 1,2,4 kHz. A backward elimination 
procedure was applied including covariates with p≤0.1. 
 
Results 
Study population 
Demographic data of the total group and the different severity groups are shown in Table 1. 
Patients had a mean age of 54 years and 62.5% were male. The mean BPTA 1,2,4 kHz was 31 
dB hearing loss. There were no differences between the groups with regard to age, sex or 
mean hearing loss. However, there was a significant difference between the groups with 
regard to the duration of tinnitus complaints (χ2=9.57 ; p=0.04) and the education level 
(χ2=36.17; p=0.00). In the group with mild complaints, there were more patients with a high 
education. In the group with severe complaints there were more patients with a low education. 
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With regard to duration of tinnitus complaints, in the group with mild complaints there were 
more patients who had tinnitus complaints for less than a year.  
 
 
Table 1. Summary of baseline characteristics on the total group and different severity groups 
based on the scores of the Tinnitus Questionnaire  
 Total Mild Moderate Severe p*
N 492 96 128 268 
Age in yrs (SD) 54,2  (11,5) 54.4 (11.9) 53.9 (11.2) 54.3 (11.6) 0.95
Gender (% male) 62.5 64.6 61.4 61.9 0.87
Education (%)  0.00
Low 45.8 27.1 28.1 44.8 
Middle 27.5 38.6 31.5 29.9 
High 26.7 56.0 25.4 18.7 
Duration  (%)  0.05
Less than 1 yr 30.3 36.5 23.6 31.3 
1 to 5 yrs 38.6 27.1 41.7 41.4 
More than 5 yrs 31.0 36.5 34.6 27.2 
BPTA (1, 2, 4 kHZ) 30.8 (17.7) 28.7 (15.6) 29.5 (17.4) 32.3 (18.5) 0.15
*Chi square tests (α= .05) for categorical variables, ANOVA for continuous outcomes 
 
 
Cost of tinnitus 
Table 2 displays the mean annual tinnitus related health care consumption and health care 
costs. On average, patients visited a health care professional 21.1 times (95% BCI (10.4 – 
34.4). Health care professionals that were visited most frequently were the general 
practitioner, the ENT specialist and the clinical physicist in audiology. The ENT specialist 
was visited by 54% of the patients and the clinical physicist in audiology by 24% of the 
patients. All other health care professionals were visited by less than 1% up to 17% of the 
patients. The total tinnitus related health care costs per patient were €1,544 (95% BCI: €679 - 
€2,647). The highest health care costs were associated with care by medical specialists (mean 
cost per patient €771; 95% BCI: €338 - €1,367). Mean costs per patient related to general 
practitioner care were €225 (95% BCI: €162 – €306). Visits to other health care professionals 
amounted to mean costs of €527 per patient (95% BCI: €133 – €989). On average patients 
spent €21 on medication (95% CI: €1 - €46)   
Table 1b shows the mean annual out of pocket costs, production losses and societal costs per 
patient. On average, the out of pocket costs were quite small (€69; 95% CI: ), but ranged from 
€0 to €6,832. Most out of pockets costs were made in the category ‘other costs’, by 11% of 
the patients. ‘Other costs’ were for instance costs of food supplements and alternative 
therapies (up to €270), head-phones (up to €65), ear protection (up to €170) or sound isolation 
materials for walls, floors and ceilings (up to €1,500). Patients reported to have been absent 
from their job as a result of the tinnitus for 15.41 days or 123 hours. Mean annual costs 
associated with these production losses amounted to €3,702 per patient (95% CI: €520 - 
€6688) . Mean societal costs per patient were €5,315 (95% CI: €1319 - €9001) per year.  
Total mean societal cost of illness of tinnitus in the Dutch population was €6.8 billion (95% 
CI: €3.9 billion- €10,8 billion).  The larger part of total societal cost of illness was not health-
care related. Total mean health care costs of tinnitus were € 1.9 billion (95% CI: €1.4 billion - 
€2.5 billion). This amounts to 2.3% of the total Dutch health care expenditure in 2009. 
The results of the sensitivity analyses are shown in figure 1. In the first sensitivity analysis 
total health care costs range from €1,7 billion to €2.0 billion and the total societal costs range 
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from €6,4 billion to €7,2 billion. In the second sensitivity analysis, differences in prevalence 
especially impact on the total societal costs. Depending on different prevalence figures, while 
the health care costs range from €1.0 billion to €2.9 billion and societal costs range from €3.3 
billion to €10.0 billion. In the third sensitivity analysis, productivity losses are not 
extrapolated to yearly costs. This only impacts on the societal costs that are €3.2 billion in this 
scenario.  
 
0 2 4 6 8 10 12
Productivity losses not multiplied by four
Sensitivity analysis III
Prevalence 15%
Prevalence 10%
Prevalence 5%
Sensitivity analysis II
Prevalence 10% with 5% severe
Prevalence 10% with 3% severe
Sensitivity analysis I
Base Case     
(prevalence of  10% with 4% severe)
billion €
Health care costs
Societal costs
Figure 1. Sensitivity analysis of total cost of tinnitus  
 
 
The impact of tinnitus severity on costs 
Table 2 gives an overview of the total tinnitus related healthcare costs and the costs per 
discipline for each tinnitus severity group. Although there were slightly more contacts with 
the general practitioner for the group with severe complaints, no significant differences in the 
total general practitioner care costs between the three severity groups were observed. Also, 
there were more contacts with the general practitioner assistant (95% BCI: 0.50 – 1.19 for 
moderate versus 1.33 – 2.34 for severe) and subsequently this was more costly in the group of 
patients with the severe complaints (95% BCI: €7 – €17 for moderate versus €19 – €33 for 
severe). With regard to the care by medical specialists, again the group with severe 
complaints had more contacts in the hospital and also made more costs compared to the 
groups with mild and moderate complaints. There were significantly more visits to the ENT 
specialist and the neurologist in patients with more severe complaints. As a result the mean 
costs for the ENT specialist (95% BCI: €278– €484 for moderate vs. €524 – €710 for severe) 
and the neurologist (95% BCI: €8 – €60 for moderate vs. €69 – €237 for severe) were higher 
for patients with severe complaints. Other healthcare professionals (such as the clinical 
physicist in audiology, psychologist, physiotherapist and company doctor), were visited more 
often in the group with moderate and severe complaints than in the group with mild 
complaints. This resulted in significantly higher mean costs in the group with moderate com- 
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plaints (€540) compared to mild complaints (€182), but not in the group with severe 
complaints (€854) compared to moderate complaints (€539). The higher costs are especially 
the result of patients with more complaints having more contacts with psychologists, social 
workers and clinical physicists in audiology. Table 2 also shows that although patients with 
severe complaints on average use more medication than those in the mild and moderate 
group, this is however not significantly more costly. 
In Table 2 the out-of-pocket costs and the productivity losses are shown for each tinnitus 
severity group. There were no differences between the groups with regard to the overall out-
of-pocket costs. However, the mean costs of the travel expenses were higher in the group with 
severe complaints (95% BCI: €3 – €6 for moderate versus €8 – €11 for severe). Also the 
group with moderate and severe complaints had more expenses with regard to the use of 
sports facilities (95% BCI: €4 - €28 and €10 - €98, respectively) for relieving the tinnitus than 
patients with mild complaints (95% BCI : €0 – €3). Finally, the productivity losses were 
higher in the group with moderate (€4781; 95% BCI: €2599 - €7266) and severe complaints 
(€5,105; BCI: €3,679 - €6,620) as compared to the group with mild complaints (€1,222; 95% 
BCI: €360 - €2,412) because there were more patients on sick leave as a result of the tinnitus 
in these groups.   
 
The impact of disease characteristics and demographics on costs 
The determinants of costs are shown in Table 3. The most important predictor of healthcare 
costs was tinnitus severity. More severe complaints are significantly related to higher 
healthcare costs. Other significant predictors of higher healthcare costs were shorter duration 
of complaints and a more severe depression score on the HADS. With regard to the societal 
costs severity of tinnitus complaints was the most important predictor. Other significant 
predictors of higher societal costs were a younger age, shorter duration of complaints and a 
more severe depression score on the HADS.   
 
 
Table 3. Results of multivariate regression analysis after backward elimination of 
covariates with p≤0.1 
Dependent  
variable Independent variables
 
R2 B P-value
Healthcare costs (N=409) Constant 0.27 5.194 .00
 TQ score .317 .00
 Age -.102 .02
 Duration (1-5 yrs) -.215 .00
 Duration (> 5 years yrs) -.268 .00
 HADS depression .131 .01
  
Total costs (N=424) Constant 0.24 6.790 .00
 TQ score .197 .00
 Age -.237 .00
 Duration (1-5 yrs) -.118 .01
 Duration (> 5 years yrs) -.213 .00
 HADS depression .203 .00
TQ=Tinnitus Questionnaire; HADS=Hospital Anxiety and Depression Scale 
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Discussion 
To our knowledge, this is the first study to examine the health care utilization and costs of 
patients with tinnitus from a societal perspective. Moreover we included an analysis of the 
impact of demographics and disease characteristics on costs. 
With regard to health care utilization, tinnitus sufferers seem to be a heterogeneous group as 
they seek help in various areas of health care. However, the larger proportion of patients 
(>50%) seek help in three different caregivers, namely the GP, the ENT specialist and the 
clinical physicist in audiology. The mean annual health care costs of tinnitus are €1,544 per 
patient. Literature on other medically unexplained disorders that are comparable to tinnitus in 
the Netherlands found more or less the same results. The annual costs of fibromyalgia were 
estimated at €1,311 and the cost of chronic low back pain at €1,104 in 2002 (Boonen et al., 
2005). The mean annual productivity costs are €3,702 for patients with tinnitus. These costs 
are higher than the productivity losses of comparable disorders. The productivity costs of 
fibromyalgia and CLBP were €2,573 and €2,939 respectively (Boonen et al., 2005).  
When applying a prevalence of 10%, with 4% having severe complaints to the Dutch adult 
population in 2009, mean societal cost of illness was €6,8 billion. Comparing this to the cost 
of illness of borderline personality disorder in a Dutch population, the costs of tinnitus are 3 
times as high. The total societal cost of borderline personality disorder were €2,2 billion in 
2000 (van Asselt et al., 2007). The prevalence of borderline personality disorder is 1% which 
means that the mean costs per patient are considerably higher than in patients with tinnitus 
(van Asselt et al., 2007). With a prevalence rate of 4.8% the societal costs of social phobia in 
the Netherlands 2003 were €136 million per million inhabitants, which is approximately €1,7 
billion for the total population (Acarturk et al., 2009). A top-down study of low back pain in 
the Netherlands reported total societal costs of €3,5 billion in 2007 (Lambeek et al.).  
Patients with severe complaints had significantly more health care costs than patients with 
mild and moderate complaints. There were no differences between the groups with regard to 
out of pocket costs. Productivity losses were significantly higher in the moderate and severe 
groups than in the mild group. Severity of tinnitus was the most important positive predictor 
of health care costs. Other significant predictors were duration of complaints, depression 
scores and age. For societal costs the most important predictor was age. This is probably the 
result of the fact that almost three quarter of these costs are explained by the losses in 
productivity. 18% of the patients in this study were 65 or older and therefore had no 
productivity losses. 
The findings of this study are in line with a studies investigating the relation between health 
care utilization or costs and disease characteristics in other studies (Berger et al., 2007; 
Johansson et al., 2010; Maxion-Bergemann et al., 2006; Nyrop et al., 2007; Robinson et al., 
2003; Walen et al., 2001; Wolfe et al., 1997). Future research could also take into account the 
relation between income and health care and societal costs. This was not possible in the 
current study since a substantial proportion of the patients did not provide information on 
their level of income.  
The patient sample here may not be representative of the entire tinnitus population. Therefore 
extrapolating mean costs per patient to the total population could have led to bias. First, we 
included patients from a secondary care setting, which could mean that the symptoms these 
patients experience are more severe than the symptoms of patients that seek help in a primary 
care setting. However, measures were taken to ensure that the health care facility was easy 
accessible to all patients. Moreover, it was a large sample (N=492) and a substantial number 
of patients (N=96) with mild complaints were included in the study. The health care costs 
range from €1.0 billion to €2.9 billion, and the societal costs range from €3.2 billion to €10.0 
billion, depending on the assumption made to extrapolate the costs to the total population. 
Second, it is possible that costs that are made in the three months previous to the start of 
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treatment are not representative for the whole preceding year. There were some costs, for 
instance the costs of sound isolation, that are probably made only once. On the other hand, it 
could be that other patients also made these costs because of the tinnitus complaints at some 
point in the preceding year.   
Another drawback of the study is the fact that a cost-questionnaire with a recall period of 
three months was used. It entirely relies on the patient’s memory and also on the patient’s 
judgment of what costs are related to the tinnitus and what costs are not. However, a three 
month recall period is generally thought of as acceptable (Severens et al., 2000; van den Brink 
et al., 2004) and it was clearly stated to all participants that we were interested in tinnitus-
related costs only. Each question contained a remark that the focus was on tinnitus-related 
costs.   
Summarizing the aforementioned findings one can conclude that the economical burden of 
tinnitus to society is substantial and that severity of tinnitus is an important predictor of the 
costs that patients make. 
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Abstract 
Background Up to 21% of the adult population has at least once in their lifetime been 
bothered by tinnitus, which is one of the most distressing and debilitating audiological 
problems. The lack of medical cures and standardized practice often result in costly and 
prolonged referral trajectories, and unnecessary suffering. A stepped-care approach, with a 
basic cognitive behavioral therapy program for all patients, and a follow-up approach for 
patients with more severe tinnitus complaints, is presently investigated.  
Methods 741 adults (>18 years) with a primary complaint of tinnitus were assessed for 
eligibility to enter a randomized controlled trial, comparing Specialist Care (SC) consisting of 
cognitive behavioral therapy (CBT) with elements of sound-focused tinnitus retraining 
therapy (TRT) with Usual Care (UC). Primary outcomes were health-related quality of life 
(HUI), Tinnitus Severity (TQ), and Tinnitus impairment (THI), which were assessed pre-
treatment, and at 3, 8 and 12 months after randomization. Multilevel Mixed regression was 
used for intention to treat analyses; final analysis included all participants for whom we had 
baseline data on primary and secondary outcomes. This study is registered; number 
NCT00733044. 
Findings 492 patients, blinded for treatment allocation, were randomly assigned to either 
UC (n=247) or SC (n=245), pre-stratified on tinnitus-severity and hearing impairment, 
completed baseline measurements, and were included in final analyses. Overall, adjusted 
mean changes were higher in the SC group than in the UC group at 12 months for HUI 
(between-group difference=0.059 [95% CI 0.025 -0.094]), TQ (between-group difference=-
8.062 [95% CI: -10.829; 5.295]) and THI (between-group difference=-7.506 [95% CI: -
10.661; 4.352]), with effect sizes of 0.24, 0.43 and 0.45 (Cohen’s d) respectively. Moreover, 
SC generates greater improvements in general negative emotional states, level of tinnitus-
related catastrophic thinking, and tinnitus-related fear than UC. Additionally, the treatment 
was effective irrespective of initial tinnitus severity levels. No adverse events or harmful side-
effects were reported throughout the trial. 
Interpretation A specialized CBT-based treatment might be the treatment of choice for 
milder forms of tinnitus suffering as well as for more severe tinnitus incapacitation, and hence 
may be considered for widespread implementation. 
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Introduction 
Sixteen to 21% of the adult population is at one point in life bothered by tinnitus (Krog et al., 
2010),  the perception of a noxious disabling internal sound without an external source. 
Although often not recognized by the general public, tinnitus is one of the most distressing 
and debilitating audiological problems, affecting almost all aspects of daily life (Cima, 
Vlaeyen et al., 2011; Javaheri et al., 2000). Cognitive impairments and negative emotions 
associated with tinnitus are shown to be most troubling for patients and their families (El 
Refaie et al., 2004; Hallam et al., 2004). 
Since tinnitus is not easily objectified, and medical curative efforts have been unsuccessful, 
the effective management of tinnitus complaints has been a challenge, requiring a multitude 
of disciplines and usually prolonged trajectories (Cima et al., 2009). Evidence for a uniformly 
successful treatment of tinnitus is lacking, and current usual care practices for tinnitus 
primarily consist of fragmentized interventions; often resulting in communicating to patients 
that nothing can be done about the tinnitus, but learn to live with it (Cima et al., 2009). The 
lack of standardized practice presents difficulties in unifying assessment, treatment, 
identifying subsets of patients with differential clinical demands, and in comparing clinical 
and research outcomes (Hoare et al., 2010). 
Two main tinnitus-treatment approaches can be distinguished. First, sound-based therapies, 
such as tinnitus retraining therapy (TRT), involve tinnitus-masking methods on the sound-
perception-level in combination with structured counseling sessions (Jastreboff & Hazell, 
2004; Phillips & McFerran, 2010). This approach, commonly based on Jastreboff’s neuro-
physiological model (Jastreboff & Hazell, 1993), is aimed at ameliorating tinnitus distress, 
through education and exposure to a neutral external sound. By habituating tinnitus-patients 
to this neutral sound, which is hypothesized to generalize to the threatening tinnitus-sound, 
tinnitus annoyance is expected to diminish. Supporting evidence for the TRT approach is 
scarce, and most of the published reports derive from retrospective and uncontrolled trials 
(Hiller & Haerkotter, 2005; Hoare et al., 2010; Phillips & McFerran, 2010). A second main 
approach is cognitive behavioral therapy (CBT) for tinnitus (Kroner-Herwig et al., 2003; 
Martinez-Devesa et al., 2010; Zachriat & Kroner-Herwig, 2004). CBT is a more 
comprehensive form of psychotherapy aimed at modifying dysfunctional beliefs and 
behaviors. Typically, CBT for tinnitus includes psycho-education, relaxation, exposure-
techniques, and behavioral reactivation, often in combination with mindfulness-based 
training. Although, CBT-based tinnitus-treatment approaches have shown to reduce suffering 
and improve quality of life, large scale and well-controlled trials are still needed (El Refaie et 
al., 2004; Hesser et al., 2011; Kroner-Herwig et al., 2003; Martinez-Devesa et al., 2010). The 
premise that the intensity of CBT-treatment can vary depending on severity of tinnitus-
complaints, has never been tested. 
We developed a novel multidisciplinary tinnitus-treatment protocol; a stepped-care CBT 
based approach with elements from TRT. A stepped-care approach is a framework for 
organizing health services based on individual patients' needs, with a gradual increase in the 
intensity of the care at each level (Von Korff & Moore, 2001). The main aim of the current 
study was to investigate the effectiveness of a this new specialized tinnitus-treatment protocol 
versus care as usual, using a randomized controlled design (Cima et al., 2009). 
 
Methods 
Aims and hypotheses 
We hypothesized that [a] Specialized care (SC) would be more effective than Usual Care 
(UC) in increasing generic health-related quality of life, reducing distress caused by the 
tinnitus, and reducing tinnitus-related impairment, and [b] SC would be more effective than 
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UC in reducing general negative affect, the level of catastrophic mis-interpretations of 
tinnitus, and tinnitus-related fear. 
 
Study design  
A two group, two-stepped care, single-centre randomized controlled trial was carried out with 
adult tinnitus patients, with 3 follow-up assessments at 3, 8 and 12 months after 
randomization (see Appendix B for specifics on data collection). Tinnitus patients referred to 
our centre were invited for a first off-centre baseline assessment contact, after which they 
were randomly allocated to either Usual Care (UC) or Specialized Care (SC). The Medical 
Ethical Board of the Rehabilitation Foundation Limburg reviewed and approved of the study 
protocol (METC-SRL: 11/09/2006) and trial funding was supported by Netherlands 
Organization for Health Research and Development (ZonMw; 945-07-715). The trial has been 
registered at ClinicalTrial.gov (NCT00733044). 
 
Participants 
Adult patients referred to our centre with a primary complaint of subjective tinnitus were 
eligible for inclusion. Patients were excluded when unable to read and write in Dutch, when 
health problems, such as terminal illness or physical problems impairing travelling to our 
centre, prevented participation, and when they had undergone treatment at our centre within 5 
years prior to trial enrolment. Patients were assessed by an ENT-physician to rule out 
otological pathology requiring immediate medical care. Informed consent was obtained 
before assessment and trial-entry; both patients and assessors were blinded for treatment 
allocation.  
 
Randomization and blinding 
Treatment allocation was by randomization, pre-stratified on both tinnitus-severity 
(stratification cut-off point at 47 points on the tinnitus questionnaire) and hearing impairment 
(stratification cut-off point at the pure-tone average (PTA) of 60 dB hearing level in worst 
ear), giving four strata. Within each stratum, patients were randomized to one of both 
treatment arms in blocks of 4 patients. The randomization procedure was performed by one of 
the independent research assistants at an off-centre location, after receiving informed consent 
and baseline assessment. 
Patients were blinded for treatment allocation. Prior to trial enrolment patients were informed 
they would be allocated to one of two different treatments, aimed at tinnitus management, 
using a client-centered, stepped-care approach. They were also aware that by giving their 
consent they would not be informed as to which treatment they were allocated to. Early in the 
intervention-procedure detailed information about the treatment received was unveiled, while 
the participants remained blind to the content of the alternative treatment. 
 
Intervention-procedures 
Systematic review 
Panel 1 provides a systematic review on current treatment approaches in tinnitus 
management. The combination of two main theoretical models and treatment approaches was 
found to be novel, and not studied before (Cima et al., 2009).  
 
Overview 
Both UC and SC were setup in a stepped-care manner (see figure 1). Both step-1 and step-2 in 
UC and SC were finalized after 8 months followed by a no-contact period of 4 months up 
until the last follow-up assessment. Step-2 treatment had a duration of 12 weeks maximally in 
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both UC and SC. Case Report Forms (CRF) were used for each patient to standardize 
treatments and for trial purposes, replacing the medical charts. Each CRF included extensive  
protocols for each separate professional, including supporting staff, and for multidisciplinary  
patient-related activities.  
 
 
 
Figure 1. Flowchart 
 
 
Care as Usual (UC) 
The UC procedure entailed a standardized protocol modelled after the average care as is 
usually provided by secondary-care audiological centres across the Netherlands. A qualitative 
study was carried out by means of a telephone survey, including all audiological centres 
(n=26) currently operative in the Netherlands. The number of professionals involved and 
counseling hours were averaged and discipline-type and healthcare activities were categorized 
by two independent raters, resulting in the UC treatment protocol (see PANEL 2). 
Step-1 of UC treatment consisted of a standard audiological intervention. For patients with 
mild complaints, treatment ended after the first step, while they remained in the trial for 
follow-ups. When tinnitus suffering was more severe (as measured at baseline and after 
audiological counseling), patients entered step-2 treatment.  
 
Specialized Care (SC) 
The first step of SC-treatment consisted of multidisciplinary diagnostics and specific TRT-
based counseling elements, carried out in a cognitive behavioral framework (including 
audiological rehabilitation when necessary). For patients with mild complaints this basic 
intervention was expected to suffice, and they were measured for follow-ups only. When 
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tinnitus suffering was more severe (as measured at baseline and after psychological 
screening), patients entered step-2 treatment, which consisted of three 12-week group-
treatment options; Program A for patients suffering from tinnitus on a moderate to severe 
level, Program B for severe tinnitus complaints, and program C for severely hearing impaired 
tinnitus patients (see PANEL 3).  
 
 
PANEL 1: Research in Context 
Systematic Review  
A rather broad range of search terms to include all relevant studies performed on tinnitus and group 
treatment. All Systematic reviews, reviews, and meta analyses were included as well. Search terms: 
Tinnitus AND Trial AND review (OR management OR care, OR specialized clinic,, OR 
multidisciplinary, OR therapy, OR treatment, OR systematic, OR meta analysis, OR cognitive 
behavioral, OR psychological, OR relaxation OR education OR quality of life, OR stress, OR 
distress, OR coping, OR anxiety, OR depression, OR chronic, OR pain, OR costs, OR cost analysis, 
OR effects, OR outcome assessment OR sound therapy OR TRT) NOT (Complementary Therapies, 
OR Acupuncture, OR Ginko biloba, OR surgery, OR pharmacology). It is important to note that he 
second search term ‘Trial’ includes studies using other methodological designs than RCT only, this 
according to the MeSH thesaurus. Population: Adult tinnitus population. Intervention: 
Multidisciplinary care, specialized clinic, cognitive behavioral therapy, psychological treatment, 
relaxation, education, tinnitus retraining, TRT (sound therapy). Outcome Measures: Quality of life, 
stress/distress, depression, anxiety, coping. Tinnitus distress/handicap/impairment. Methodological 
filters: Systematic review, RCT, follow-up of cohort design, case control study. Databases: 
Medline (1980 – present), Psychinfo (1972-present), Psyarticles, Cinahl (1982 – 2005), ERIC 
database (1966 – 2005/09), Econlit, DARE database, Education Resources Information Centre, 
Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, Cochrane 
Controlled Trials Register, Cochrane Methodology Register, NHS Economic Evaluation Database, 
Health Technology Assessment Database, Cochrane Database of Methodology Reviews (CDMR). 
Number of manuscripts retrieved: After performing the first search strategy described above a total 
number of 216 manuscripts were retrieved (Medline: 125; Psychinfo: 20; Psyarticles: 3; Cinahl: 14; 
ERIC: 11; Econlit: 2; DARE: 36; Cochrane: 5). Validity assessment: Two independent reviewers 
assessed all studies for inclusion quality. Included were: systematic reviews, meta analyses, 
reviews, RCT’s and other trials comparing different treatment combinations based on group 
treatments, including behavioral modification, relaxation, attention diversion and exposure, 
biofeedback, coping strategies, specific tinnitus management programmes, and multidisciplinary 
approaches. Not included were studies on pharmacological treatment, complementary or alternative 
treatments, and studies based on animal-models and neuro-magnetic stimulation. Results: The total 
amount of selected manuscripts was 22, of which 8 systematic reviews, 9 RCT studies, 3 follow-up 
or case control studies, and 1 controlled but not randomized and 1 evaluation of current practice. 
Interpretation 
The combination of 2 main theoretical models, and treatment approaches, Cognitive Behavioral 
Therapy (CBT) and Tinnitus Retraining therapy (TRT) was found to be novel. CBT for tinnitus 
seems the most promising approach in diminishing tinnitus related distress and decrease main 
complaints of patients. The use of sound generating devices, whether masking devices, wearable 
players or hearing aids,  even when combined with directive counseling sessions, have of yet not 
been proven to be effective as a single treatment approach. (as is the case in TRT based approaches) 
effects seem modest at best. Treatment strategy might be best organized integrally, using a 
standardized approach in diagnostics, treatment and assessments because of the fact that using the 
approaches serially and at random might lead to unwanted increase of health utilization and costs. 
Moreover, a CBT based framework in tinnitus management is advisable.  
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PANEL 2. Usual Care Treatment protocol
 
Contact 
(min) Professional Activities 
St
ep
 1
 (T
0 
– 
T
1)
 
Audiological 
diagnostics  
(105) 
Audiological 
assistant 
Pure tone and speech audiometry, Tympanometry 
(stapedial reflexes) 
Tinnitus analyses: Pitch Mask Frequency and 
Minimum Masking Level 
Uncomfortable Loudness Level measurement 
Hearing aid check and optimisation (if present) 
Questions about duration and location of the tinnitus 
Clinical physicist 
in audiology 
(CPA) 
 
Individual consult by clinical physicist in audiology  
Audiological anamnesis 
Assessment of audiometry and explanation 
Information about tinnitus and hearing loss 
Assessment severity of complaints 
When indicated: prescription hearing aid / prescription 
tinnitus masker* 
Audiological 
rehabilitation 
(30) 
Audiology 
assistant 
Check up after 8 weeks of hearing aid-usage 
Hearing aid check and optimisation 
 
 
Audiological  
Follow-up 
(40) 
Audiology 
assistent 
Pure tone and speech audiometry, Tympanometry 
(stapedial reflexes) 
Uncomfortable Loudness Level measurement  
Hearing aid check and optimisation (if present) 
Tinnitus analyses: Pitch Mask Frequency and 
Minimum Masking Level 
  CPA Individual consult by clinical physicist in audiology  
When indicated:  
Referral to social work 
St
ep
 2
 (T
1 
– 
T
2)
 
Intake  
Social work 
(60) 
Social worker General inventory of complaints and use of hearing 
aids/maskers  
When indicated:  
Social work trajectory of maximum 9 follow-up 
contacts 
Follow-up  
Social work  
(60) 
Social worker Maximum 9 contacts including 
Counseling sessions 
Telephone contacts 
Extraneous appointments with third parties 
House calls 
 
 
Treatment fidelity 
Treatment fidelity was assessed by a post-hoc investigation of CRF’s, patient-attendance lists, 
and electronic databases, on a random sample of 40 cases per condition, in order to verify 
whether both UC and SC were performed according to treatment-protocols (adherence), and 
not overly influenced (contamination) by contrasting elements from the other treatment 
(Leeuw et al., 2009).  
 
 
 
 
 
CHAPTER 3 
48 
 
PANEL 3. Specialized Care Treatment protocol 
 Contact (min) Professional Activities 
St
ep
 1
 (T
0 
– 
T
1)
 
Audiological 
diagnostics 
(105) 
Audiology 
assistant 
Pure tone and speech audiometry, Tympanometry 
(stapedial reflexes) 
Tinnitus analyses: Pitch Mask Frequency and 
Minimum Masking Level 
Uncomfortable Loudness Level measurement 
Hearing aid check and optimisation (if present) 
Tinnitus anamnesis using structured interview 
Clinical physicist 
in audiology 
(CPA) 
 
Individual consult by clinical physicist in 
 audiology ** 
Audiological anamnesis, assessment of audiometry 
and explanation 
Information about tinnitus and hearing loss 
Introduction to the neurophysiological model 
(Jastreboff, 1990) 
Reading materials and treatment rationale are 
provided 
Explanation of treatment protocol in the first step 
and explanation of stepped-care approach 
When indicated: prescription hearing aid / 
prescription sound generator* 
Audiological 
rehabilitation 
(30) 
Audiology 
assistant 
Check up after 8 weeks of hearing aid/masking 
device -usage 
Hearing aid check /masking device and optimisation 
Tinnitus 
educational 
session 
(120)  
 
Psychology 
assistant 
The basics of the TRT are explained  
The NF model is explained extensively 
Fear-avoidance is discussed 
General information about second step care is 
provided 
Patients are enabled to have a group discussion and 
ask remaining questions 
Intake 
Psychology: 
 (60) 
Psychologist When indicated by scores on TQ, THI and 
anamnesis; 
Treatment goals for step 2 are formulated in 
concordance with patient and the patient is planned 
in multidisciplinary team meeting 
St
ep
 2
 (T
1 
– 
T
2)
 
Audiological 
follow-up 
(40) 
Audiology 
assistant 
Pure tone and speech audiometry, Tympanometry 
(stapedial reflexes) 
Tinnitus analyses: Pitch Mask Frequency and 
Minimum Masking Level  
Uncomfortable Loudness Level measurement  
Hearing aid check and optimisation (if present) 
 CPA (TRT) Individual consult by clinical physicist in  
audiology ** 
Multidisciplinary 
team meeting 
(10/patient) 
 
All professionals 
involved in SC 
All tinnitus patients are discussed and, when 
indicated by scores on TQ/THI and clinical view of 
psychologist, multidisciplinary treatment goals for 
step 2 are integrated in a plan of treatment 
Group treatments 
A, B, or C 
(120/session)  
 
Psychologist 
Movement 
therapist 
Physical therapist 
1. Group sessions: CBT; Psycho education, 
cognitive restructuring, exposure techniques, 
mindfulness-based elements, stress relieve & 
attention redirecting techniques by means of  
                                                                                        EFFECTIVENESS                          
49 
 
 
Outcomes 
Stratification assessment 
To assess hearing impairment, pure tone audiometry was performed bilaterally on 1, 2, and 4 
kHz, using a mobile audiometer (Interacoustics AS208) with audiometry headphones 
(Telephonics TDH-39, Peltorcapped) and the PTA for 1, 2 and 4 kHz (stratification cut-off 
point at 60 dB hearing level in worst ear) was calculated. The Tinnitus Questionnaire was 
used to assess Tinnitus-severity at baseline (stratification cut-off point at a score of 47) (Rief 
et al., 2005). 
 
Primary outcome measures 
The HUI Mark III is a 17-item questionnaire to assess health-related quality of life or generic 
health on eight dimensions: vision, hearing, speech, ambulation, dexterity, emotion, 
cognition, and pain/complaints. Each question has five or six levels, and 972.000 possible 
health states can be computed.  Possible utility scores range from -0.36 to 1.00 for the HUI 
Mark III (Feeny et al., 2002). The HUI has shown adequate responsiveness in the tinnitus 
population (Maes et al., 2011). Tinnitus-severity was assessed by the Tinnitus Questionnaire 
(TQ) (Hallam et al., 1988). The TQ consists of 52 items rated on a 3-point scale and assesses 
psychological distress associated with tinnitus.  Psychometric properties of the TQ have 
proven excellent in different languages (Meeus et al., 2007). The Tinnitus Handicap Inventory 
(THI) is a 25 item instrument scored on a 3-label category scale. The THI assesses tinnitus-
related impairment on 3 domains; functional, emotional and catastrophic (Bartels et al., 2008; 
Newman et al., 1996; Newman et al., 1998). Both overall and subscale internal consistency 
were found to be satisfactory in the current sample.  
 
Secondary outcome measures 
Negative affect was measured with the Hospital Anxiety and Depression Scale (HADS), 
which contains 14 items and has good reliability and validity (Spinhoven et al., 1997). The 
Tinnitus Catastrophizing Scale (TCS) is an adapted version of the Pain Catastrophizing Scale 
(Van Damme et al., 2002). The TCS assesses catastrophic mis-interpretations of the tinnitus 
St
ep
 2
 (T
1 
– 
T
2)
 
Group treatments 
A, B, or C 
(120/session)  
 
Psychologist 
Movement 
therapist 
Physical therapist 
CPA 
Social worker 
Speech-therapist 
1. Group sessions: CBT; Psycho education, 
cognitive restructuring, exposure techniques, 
mindfulness-based elements, stress relieve & 
attention redirecting techniques by means of  
movement therapy, and applied relaxation (intensity 
varies across group-treatments A, B, and C) 
2. Themed group counseling sessions (including 
partners) 
 
Individual 
Trajectory in case 
of contra 
indication for 
group treatment 
(60/per discipline) 
Psychologist 
Movement 
therapist 
 
Combination of the above  mentioned group 
treatment principles applied on individual basis 
(With optional addition of  a combination of 
professionals involved in group treatments) 
* Sound-generators were prescribed when specifically asked for by the patient and were fitted by using a 
small band noise around the Pitch Match Frequency, presented slightly above hearing threshold, as measured 
with the small band noise of the sound generator.  
** Specifically the counseling elements of TRT were part of intervention; educating patients about tinnitus 
and the neuro-physiological model 
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sound and has 13 items to be rated on a 5-point scale (0 = not at all, 4 = always). The TCS has 
been tested with patients (Cima, Crombez et al., 2011), and internal consistency of the total 
TCS score in the current sample was excellent (Cronbach’s alpha = .94). The Fear of Tinnitus 
Questionnaire (FTQ) measures tinnitus-related fear. Some of the FTQ items were derived 
from the Tampa Scale for Kinesiophobia and the Pain Anxiety Symptoms Scale (McCracken 
et al., 1992; Roelofs et al., 2007). The FTQ was pre-tested with patients (Cima, Crombez et 
al., 2011), and has 17 items to be rated on a true or false scale. Internal consistency of the 
total FTQ score in the current sample was excellent as well (Cronbach’s alpha = .82). 
Demographic data were gathered by a 5-item questionnaire to establish gender, age, duration 
of complaints, educational level and adherence area. 
 
Sample size 
Only one study on quality of life of tinnitus patients receiving specialized tinnitus care was 
identified. The observed change of 0.065 in health state utility score in that study (El Refaie et 
al., 2004), with a standard deviation of 0.15, as measured with the Short Form-36 (Hays et al., 
1993), was used to calculate our sample size. Given α = 0.05 (2-sided) and power = 80%, and 
taking into account 15% loss to follow-up, this resulted in 99 patients per condition (total n = 
198).  
A post-calculation was performed mid-trial for detecting a relevant difference within the 
patient-subgroup receiving step-2 treatment. As our step-2 treatment is comparable with 
treatment in an earlier study, the effect size of d = 0.62 on the TQ in that study was used to 
compute power for our step-2 (Kroner-Herwig et al., 2003). Given α=0.05 (two-sided) and 
power = 80%, n=41 patients per condition were needed in the 2nd step of care. Assuming that 
21% of all patients entering step-1 would enter the step-2, and taking into account 15% 
attrition, n=232 patients were needed per condition in step-1 (total n = 464). The increment in 
inclusion was approved by the Medical Ethical Board (METC-SRL: 08/07/2008) and the 
steering committee of the funding party (ZonMW). 
 
Statistical analysis 
The Consolidated Standards of Reporting Trials (CONSORT) was employed to report results 
(Hopewell et al., 2008). All statistical analysis were performed with PASW SPSS statistical 
software version 18.0.(SPSS, 2009) 
 
Protocol-adherence and contamination check 
Protocol-adherence was assessed by dividing the number of required observed elements 
(essential and unique and essential but not unique), by the maximum possible number of these 
elements. Treatment contamination was assessed by dividing the number of observed not 
allowed treatment elements by the maximum number of these elements (Leeuw et al., 2009). 
To check for equality of adherence and contamination scores for both UC and SC over rated 
treatment charts an analysis of variance was carried out. 
 
Treatment outcome: intention-to-treat analyses 
Intention-to-treat analyses were employed; all patients who were measured at baseline and 
allocated to treatment were included, irrespective of their participation in subsequent 
treatment or follow-up measurements. Mixed (multilevel) regression analyses were carried 
out on all available data per outcome, without imputation of missing data, using treatment, 
time and covariates as predictors. Details of the mixed model are found in appendix A.   
 
                                                                                        EFFECTIVENESS                          
51 
 
Moderation of tinnitus-severity 
To check whether the difference between SC and UC treatment, as measured with the HUI 
(health-related quality of life) and the HADS (general negative affect), was different for 
patients suffering severely from the tinnitus (TQ) and entering step-2, than for those who 
were only mildly affected receiving step-1 care only, the interaction between tinnitus-severity 
at baseline and treatment was tested (α=.01 for the interaction test with respect to these 
outcome parameters). 
 
Role of funding source 
The funding party was not involved in study design, data collection, data analysis, data 
interpretation or the preparation of the report. Participation of RFFC, IM, MJ, LA and JWSV 
was supported by the ZonMw Grant, number: 945-07-715, and all had access to the data. All 
authors commented on drafts and approved the final report. RFFC had final responsibility for 
the decision to submit the paper for publication. There were no conflicts of interest. 
 
Results 
Flow of participants 
Figure 2 shows the flow of participants, including drop-outs, non-responders, reasons for non-
response for measurements at one of the follow-ups, and reasons for drop-out if known. Non-
response was defined as: measurements were missed at one or more of the follow-ups, 
nonetheless participants remained in the trial; drop-out was defined as: participants left the 
trial permanently and told us so. Of the 741 participants screened for eligibility, 626 were 
invited for participation, and 492 completed baseline measurements and were randomized to 
step-1 treatment; of whom 247 were allocated to UC, and 245 to SC treatment. 
Randomization and allocation took place from September 2007 until December 2009. Follow-
up measurements were completed in January 2011. 
Non-response and drop-out rates per time point did not differ between groups (α=.01, p>.20), 
as measured with logistic regression, using missingness (whether due to non-response or 
dropout) as outcome (0=not missing, 1=missing), and group, baseline covariates (age, gender, 
education, duration of complaints, tinnitus-severity at baseline and hearing loss) and scores on 
the HUI, the TQ and the THI on the previous time-point as predictors. Only age was 
predictive for missingness, with increasing age giving more missingness (p<.01 for age at 
time points 1 and 2, p>.083 for all other predictors and time points). All baseline covariates 
were included into all outcome analyses.  
From randomization to final follow-up, a loss to follow-up was observed of 34.8% and 30.2% 
in the UC and SC group respectively.  The reasons for non-response seem not to be related to 
treatment content. 
The baseline values for all variables, tinnitus characteristics, and audiological data for the 
total sample, and for UC and SC separately, are displayed in table 1.  
 
Protocol-adherence and contamination check 
Interrater-reliability between both raters for the identification of treatment-condition was 
excellent (Cohen’s kappa = .96), and good for the identification of step-2 treatment and for 
specific treatments-elements (Cohen’s kappa = .79 and .74 respectively). Analysis of variance 
indicated no significant differences between treatment-conditions in protocol-adherence and 
contamination (P>.60), using the mean scores of adherence and contamination over all rated 
CRF’s.  
In 97% of the cases correct classification of treatment-condition of the observed elements 
occurred (0=UC, 1=SC), supporting sufficient differentiation between treatment-conditions. 
On average 87.5% of essential treatment-elements (unique and not unique) occurred during 
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the delivery of both treatments (0=‘did not occur’, 1=‘did occur’) (Mean=88.4%, SD=9.02 for 
UC, and Mean=87.5%, SD=12.6 for SC), indicating satisfactory protocol-adherence. On 
average 6% (Mean=4.6% and SD=2.6 for UC, and Mean=8.1%, SD=6.1 for SC) of the 
prohibited treatment-elements occurred during treatment delivery, demonstrating absence of 
contamination.  
 
 
 
UC= Usual Care; SC=Specialized Care, T0=Month 0, T1=Month 3, T2=Month 8, T3=Month 12 
Figure 2. Flow of participants (CONSORT) 
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Table 1. Summary of demographic characteristics, baseline mean values on primary and 
secondary outcome measures, tinnitus characteristics, and audiometric data of the all 
participants, and for each group separately 
 Total (n=492) UC  (n=247) SC (n=245)
Age in yrs (SD) 54.19  (11.5) 54.63 (12.0) 53.74 (11.0)
Gender (% male) 62.6 60.7 64.6
Education (%)     
 Low 45.7 47.3 44.0
 Middle 27.7 24.5 30.9
 High 26.6 28.2 25.1
Employment  (% yes) 53.4 50.2 56.6
Duration  (%)     
 Less than 1 yr 29.9 32.7 27.2
 1 to 5 yrs 38.9 37.9 39.9
 More than 5 yrs 31.1 29.4 32.9
Mild complaints TQ<47 (%) 45.5 45.3 45.7
 Tinnitus sound: pure tone (%) 14.5 9.9 17.8
 Tinnitus left (ear/head) (%) 25.0 24.8 25.2
 Tinnitus right (ear/head) (%) 19.9 19.6 20.1
 Continuous tinnitus (%) 83.9 83.3 84.5
 Interval tinnitus (%) 6.9 3.0 10.7
 Fitting of hearing aid  (% yes) 18.5 18.2 18.6
 Fitting of sound generator (% yes) 18.9 18.6 19.2
PTA right ear (SD) 29.74 (19.4) 30.30 (20.6) 29.18 (18.2)
PTA left ear (SD) 31.05 (20.6) 30.96 (20.3) 31.14 (21.1)
PTA bilateral (SD) 30.57 (17.6) 30.77 (17.9) 30.37 (17.4)
TQ (SD) 49.05 (18.9) 48.78 (19.2) 49.32 (18.5)
TCS (SD) 21.11 (12.2) 21.36 (12.6) 20.86 (11.8)
FTQ (SD) 7.25 (3.6) 7.31 (3.7) 7.19 (3.5)
THI (SD) 38.96 (22.9) 38.65 (23.2) 39.27 (22.6)
HUI (SD) 0.635 (0.3) 0.641 (0.3) 0.629 (0.3)
HADS (SD) 12.20 (8.0) 11.79 (8.0) 12.60 (8.1)
UC=Usual Care, SC=Specialized Care, SD=standard deviation, PTA=Pure tone average  for 1, 2 and 4 kHz, 
TQ=Tinnitus Questionnaire, TCS=Tinnitus Catastrophizing Scale, FTQ=Fear of Tinnitus Questionnaire, 
THI=Tinnitus Handicap Inventory, HUI=Health Utilities Index, HADS=Hospital Anxiety and Depression 
Scale 
 
 
Treatment outcome: Intention-to-treat analyses 
Significant group differences were found on all outcomes (See Table 2 and 3, and Figure 3). 
Group differences favouring SC in health-related quality of life (HUI) were significant at the 
second and third follow-up (p<.05 and p<.01 respectively). Differences in favour of SC with 
respect to tinnitus-severity (TQ) and tinnitus-related impairment (THI) were found on all 3 
follow-ups (p<.01 at follow-up 1, and p<.001 at follow-up 2 and 3). Groups also differed, 
favouring SC, in negative affect (HADS) at the last two follow-ups (p<.001 at follow-up 2, 
and p<.01 at follow-up 3), and in tinnitus catastrophizing (TCS) and tinnitus-related fear 
(FTQ) on all three follow-ups (p < .01 at follow-up 1, p < .001 at follow-up 2 and 3). Results 
indicate that the difference between SC and UC was equal at follow-ups 2 and 3, and larger 
than at follow-up 1. This simplified treatment-effect pattern was tested against the general 
model as follows): the terms group*t1, group*t2, group*t3 were replaced with a single term 
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group*time, with time coded as 0,0,1,1 for the HUI and 0,1,2,2 for all other outcomes. For all 
six outcomes, the simplified treatment-effect pattern was supported (p>.05 for the Likelihood 
Ratio test with df=2), indicating that the outcome difference between SC and UC increased 
from baseline to month 8 and remained stable from month 8 to 12. 
 
 
Table 2. Observed means and standard deviations (SD) based on all available data for the 
outcomes at baseline,  T1 (after step 1, 3 months after baseline),  T2 (after step 2, 8 months 
after baseline) and T3 (4 months follow-up, 12 months after baseline) 
 
Baseline 
UC (n=247)
SC (n=245)
T1 
UC (n=194)
SC (n=200)
T2 
UC (n=161) 
SC (n=175) 
T3 
UC (n=161)
 SC (n=171)
 Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Primary outcomes  
Health-related QoL (HUI)  
 UC 0.641 (.30) 0.640 (.29) 0.634 (0.29) 0.631 (0.28)
 SC 0.628 (.28) 0.620 (.29) 0.656 (0.25) 0.681 (0.25)
Tinnitus Severity (TQ)  
 UC 48.87 (19.22) 45.51 (19.65) 42.36 (19.62) 42.12 (19.81)
 SC 49.39 (18.50) 42.01 (19.81) 36.47 (17.48) 33.43 (16.89)
Tinnitus impairment (THI)  
 UC 38.73 (23.20) 37.38 (23.74) 34.14 (24.60) 33.51 (23.25)
 SC 39.25 (22.65) 34.25 (23.44) 28.85 (20.51) 26.45 (18.81)
Secondary outcomes  
Negative affect (HADS)  
 UC 11.83.(8.03) 12.08 (8.75) 11.47 (8.55) 10.83 (8.03)
 SC 12.61 (8.07) 11.91 (7.96) 10.52 (7.21) 10.22 (7.01)
Tinnitus 
 catastrophising (TCS)  
 UC 21.42 (12.56) 18.65 (11.76) 17.14 (11.54) 15.95 (11.79)
 SC 20.89 (11.83) 16.20 (11.65) 12.45 (10.30) 11.73 (9.91)
Tinnitus related fear (FTQ)  
 UC 7.32 (3.66) 6.60 (3.70) 6.19 (4.06) 6.04 (4.00)
 SC 7.19 (3.54) 5.60 (3.87) 4.52 (3.50) 4.20 (3.16)
QoL=Quality of life, UC=Usual Care, SC=Specialized Care, SD=Standard deviation, HUI=Health Utilities 
index, TQ=Tinnitus Questionnaire, THI=Tinnitus Handicap Inventory, HADS=Hospital Anxiety and Depression 
Scale, TCS=Tinnitus Catastrophizing Scale, FTQ=Fear of Tinnitus Questionnaire 
 
 
Moderation of Tinnitus-severity on treatment effect 
No significant interaction effect of tinnitus-severity and treatment on the HUI or the HADS 
was found at any of the time-points (df=3, p=.26 and df=3, p=.33 respectively), indicating that 
the difference between treatment-groups as measured with the HUI or the HADS did not 
depend on the level of tinnitus-severity as measured with the TQ. 
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Table 3. Estimated Group difference (B) and 95% confidence intervals (C.I.) on primary 
and secondary outcomes at follow-up 1 (3 months),  follow-up 2 (8 months), and follow-up 
3 (12 months), based on intention to treat analysis 
Primary outcomes B 95% C.I. P E.S. 
Health-related QoL (HUI)a      
 3 months -0.01 0.06 0.04 .642 0.04
 8 months 0.04 0.01 0.07 .026 0.18
 12 months 0.06 0.03 0.09 .001 0.24
Tinnitus Severity (TQ)b 
 3 months -3.31 -5.61 -1.02 .005 0.20
 8 months -7.07 -9.56 -4.58 .000 0.41
 12 months -8.06 -10.83 -5.30 .000 0.43
Tinnitus impairment (THI)c  
 3 months -4.26 -7.07 -1.45 .003 0.32
 8 months -7.63 -10.71 -4.54 .000 0.52
 12 months -7.51 -10.66 -4.35 .000 0.45
  
Secondary outcomes B 99% C.I. P E.S.
Negative affect (HADS)d      
 3 months -0.86 -2.18 0.47 .094 0.15
 8 months -2.09 -3.51 -0.66 .000 0.35
 12 months -1.51 -2.87 -0.15 .004 0.24
Tinnitus catastrophising (TCS)e     
 3 months -2.10 -3.96 -0.25 .004 0.31
 8 months -4.68 -6.94 -2.43 .000 0.60
 12 months -3.83 -6.19 -1.48 .000 0.41
Tinnitus related fear (FTQ)f 
 3 months -0.79 -1.49 -0.08 .004 0.35
 8 months -1.55 -2.35 -0.75 .000 0.58
 12 months -1.50 -2.32 -0.69 .000 0.48
QoL=Quality of life, SD=Standard deviation, HUI=Health Utilities Index, TQ=Tinnitus Questionnaire, 
THI=Tinnitus HandicapIinventory, HADS=Hospital Anxiety and Depression Scale, TCS=Tinnitus 
Catastrophizing Scale, FTQ=Fear of Tinnitus Questionnaire, UC=Usual Care, SC=Specialized Care. 
1Since UC is coded as 0 and SC as 1, a negative B shows lower scores in UC than SC at the follow-up 
measurements. The B’s displayed are the group*time effects as shown in appendix B, where time=0  for 
baseline· time=1 for follow-up 1, time=2  for follow-up 2, and time=3  for follow-up 3 
2 E.S.=Effect size (absolute  values), calculated by dividing the B’s (ignoring their sign) by the square root of 
the average of residual variances at follow-up 1, 2 and 3, giving a mixed regression version of Cohen’s d. 
aAdjusted for the main effects of both stratifiers (hearing loss and tinnitus severity at baseline), and of time 
(using dummy coding with baseline as reference category); b Adjusted for the main effects of education, 
hearing loss, and time ; cAdjusted for the main effects of age, duration, education, tinnitus severity at baseline 
and time, and for interaction effects of  time by education and by  tinnitus severity at baseline; dAdjusted for 
the main effects of duration, both stratifiers, time, and for interaction effects of  time by duration and by  
tinnitus severity at baseline; e Adjusted for the main effects of education, tinnitus severity at baseline, time, 
and for the interaction effects of  time by education and  by tinnitus severity at baseline; fAdjusted for the 
main effects tinnitus severity at baseline, time, ,and for the interaction effects of  time by  tinnitus severity at 
baseline 
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Figure 3. Graphs depicting changes over time in primary and secondary outcomes for both 
Usual Care (UC) and Specialized Care (SC); using predicting values from the final general 
models 
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Discussion 
This study demonstrates that stepped-care tinnitus management, combining elements of TRT 
within a CBT-framework (SC), is more effective than usual care (UC) in increasing health-
related quality of life, and reducing tinnitus-severity and tinnitus impairment. Additionally, 
SC compared to UC generates greater improvements in general negative emotional states, 
level of tinnitus-related catastrophic thinking and tinnitus-related fear. The effectiveness of 
SC as compared to UC has been demonstrated not only after the first 3 months of step-1 
treatment, but also after the more intensive step-2 treatment approach, as well as after 4 
months of no-treatment. Results are even more striking in that patients with mild tinnitus 
complaints, receiving step-1 treatment only, were included in all analyses. Furthermore, mild 
and severe tinnitus sufferers, as measured with the Tinnitus Questionnaire at baseline, 
appeared to benefit equally from getting SC treatment instead of UC treatment. These 
findings support our main hypothesis that a CBT based stepped care approach with elements 
from TRT, is effective in tinnitus management, both for milder forms of tinnitus suffering as 
well as for more severe tinnitus incapacitation.  
Two main treatment-approaches have dominated the management of patients with tinnitus 
complaints. The TRT approach, with a focus on sound habituation, as well as the CBT 
approach, with a focus on dysfunctional beliefs about tinnitus and associated safety behaviors, 
have been widely applied and studied (Hesser et al., 2011; Hoare et al., 2010; Martinez-
Devesa et al., 2010; Phillips & McFerran, 2010). However, a combination of the two, though 
previously proposed (Cima, et al., 2011; Seydel et al., 2010), has never before been 
investigated in a randomized controlled trial of this scale.  
Particular strengths of our study are a relatively large sample size, the blinding of assessors, 
the assessment of treatment fidelity strengthening internal validity, and the delivery of the 
treatments according to protocols. Other strengths are the zero dropouts from step-2 
treatment, the fact that both generic and tinnitus-specific outcome measures reveal consistent  
findings, and moreover, the differences between UC and SC treatment over time are likely to 
be clinically relevant. The percentage of patients reporting clinically relevant changes (Rief et 
al., 2005; Samsa et al., 1999) after 12 months in health-related quality of life and in tinnitus-
severity was larger in the SC group.   
There are also some limitations. First, our specialized care treatment consisted of several 
elements, and it is unclear which of those contributed to the overall effectiveness. Future 
studies might adopt a dismantling approach, leaving out potentially redundant treatment 
components in subsequent trials. Second, the treatment was carried out in an outpatient clinic 
for audiological rehabilitation. The question remains whether our results can be generalized to 
other healthcare settings, where generalizability is dependent on their similarity to the present 
setting. We are currently investigating implementation routes in both primary and secondary 
care.  
Next to the analyses reported presently, first, moderation and mediation analyses are being 
carried out, providing additional information about underlying mechanisms of change, 
contributing to further refinement, tailoring, and increased effectiveness of the treatment. 
Second, cost-effectiveness data of SC compared to UC are not included currently, but are 
planned to be reported separately. Third, data was gathered using a seventh measure, the 
Tinnitus Coping and Cognitions List (TCCL). The main reason for including this measure 
was to test the psychometric properties of this new measure in patients with tinnitus. The 
TCCL has considerable content overlap with the TCS, therefore by omitting the TCCL from 
effect-analyses, crucial information is not missed currently and psychometric analysis is 
planned to be reported separately. 
In conclusion, our findings provide firm evidence for an effective new treatment-approach in 
tinnitus-management. Results are highly relevant for clinical practice, given that best-practice 
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for tinnitus has not been defined yet (Hoare et al., 2010), leading to fragmentized costly 
treatment-trajectories (Cima et al., 2009). Delay of psycho-education and effective treatment 
is expected to aggravate tinnitus-complaints, increasing psychological strain and unnecessary 
prolongation of suffering. Current findings could lead to consensus in policy about best-
practice in tinnitus-treatment, standard choices in referral-trajectories and the implementation 
of standardized tinnitus assessment and thereby comparable outcomes. 
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Appendix A. 
 
The mixed model for testing treatment effects on outcomes 
Due to the randomization, pre-stratified on hearing loss and tinnitus severity, no significant baseline 
differences were expected between treatment conditions. However age, gender, education, hearing 
loss and tinnitus severity were included as covariates as to improve power. Since duration of 
complaints was a potentially relevant prognostic variable, this was added to the model as wella. The 
repeated measures per outcome were checked for multivariate outliers (mahalanobis distance, p < 
.001), and no such outliers were found for any outcome. Collinearity between covariates was checked 
but not found either, as all covariates had a variance inflation factor (VIF) below 1.5.  
Since there were 4 repeated measures, time was entered in the mixed regression as a categorical 
variable using dummy codingb, with the baseline as a reference category and a dummy indicator for 
every other time point (giving three dummies),  to assess group differences in change from baseline, 
allowing for possible nonlinear change. To correct for multiple testing α=.05 and α=.01 (two-tailed) 
were used for primary and secondary outcomes, respectively. 
The initial model included group, time, covariates, group by time, and covariate by time effectsc. Each 
model change was tested for significance using Maximum Likelihood (ML) estimation and a 
likelihood ratio test with ‘k’ degrees of freedom (k=the difference in number of parameters between 
two successive models).  
To enhance parsimony and increase interpretability of the model the following modelling steps were 
taken. First, every non-significant covariate by time interaction was removed, treating terms 
concerning the same predictor as one block with d.f.=3 (e.g. cov*followup1, cov*followup2, and 
cov*followup3 in the panel below). Second, covariates that were neither significant nor involved in a 
cov*time term, were stepwise removed with d.f.=1, again using the same restrictive α’s. Third, the 
‘main’ group effect (β1  in the equation) was dropped from the model, which is a valid and power-
improving step in randomized trials.  
Since baseline is the reference point, the ‘main ‘effect of ‘group’ actually reflects the group difference 
at baseline (see panel below).  This effect is zero apart from sampling error due to randomization. The 
final mixed model per outcome was re-run with the restricted maximum likelihood method (REML) 
instead of ML to obtain better estimates of the standard errors.  
 
1 Categorical covariates were entered in the model using dummy coding, for Gender: 0 = male, 1 = female; 
Education dummy 1:  0 = low, 1 = middle, 0 = high; education dummy 2: 0 = low, 0 = middle, 1 = high. Each 
quantitative covariate was centred (Cov – sample mean = CovCen) and its quadratic form (CovCen * CovCen = 
CovCen2) was added to the model to assess possible nonlinear effects of the covariates on the outcomes. 
b For each time point except baseline (the reference category) a dummy indicator was entered in the model.   
c Prior to the initial models we tested each covariate by treatment interaction over time with a separate mixed 
regression model per covariate, with three way interactions of group, covariate and time and all corresponding 
lower order terms. No such three way interactions were found. 
 
 
The mixed model equation for testing treatment effects on outcomes 
yti =  β0 + β1 group + β2 cov + β3 followup1 + β4 followup2 + β5 followup3 + β6 group x followup1 + β7 group x 
followup2 + β8 group x followup3 + β9 cov x followup1 + β10 cov x followup2 + β11 cov x followup3 + eti 
Where:   
t = Time  
i = Patient identifier 
group = 0 for patients assigned to UC and 1 for patients assigned to SC 
cov = The covariates: hearing level and tinnitus severity at baseline, age, gender, 
education, duration of complaints (see table 4) (the actual model contained multiple 
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covariates and covariate by time effects) 
followup1 = 1 if t = 1 and 0 if else (see footnote 2 in section statistical analysis, treatment 
outcome), and likewise for followup2 (=1 if t=2 and 0 else) and followup 3 (= 1 if 
t=3 and 0 else) 
eti = The random effect of patient i at time point t 
 With the following interpretation: 
β0 = The mean baseline in group 0 (UC) 
β1 = The mean baseline difference between groups (SC-UC) , expected to be zero due to 
the randomization 
β2 = The association between the specific covariate and the outcome at baseline 
β3 = The mean change from baseline to follow-up 1 (3 months after baseline) within 
patients who score 0 on all predictors included in the final model (e.g. group = UC, 
Gender = male, mean score on covariates), and likewise for β4 (change from 
baseline to follow-up 2) and β5 (change from baseline to follow-up 3) 
β6 = The group difference (SC-UC) in mean change from baseline to follow-up 1 (3 
months after baseline), which is also the group difference at follow-up 1 since there 
is no difference at baseline, and likewise for β7 (group difference in change from 
baseline to follow-up 2) and β8 (group difference in change from baseline to follow-
up 3) 
β9 = The effect of a specific covariate on the change from baseline to follow-up 1 in both 
treatment conditions, and likewise for β10 (covariate effect on change from baseline 
to follow-up 2) and β11 (covariate effect on change from baseline to follow-up 3) 
The covariate * time interactions were dropped  from the model if not significant, as assessed by a likelihood 
ratio test.  
The null hypothesis of no difference between UC and SC implies that β6=β7=β8= 0.. This null hypothesis was 
tested against the alternative of a difference between treatments at follow-up 1, 2, and 3, with a likelihood test, 
df = 3 
The null hypothesis of no difference between UC and SC at time point 1, follow-up 1, and an equal difference at 
time points 2 and 3, follow-up 2, and follow-up 3, implies that β6 =0; and β7 = β8 ≠ 0.  This hypothesis was tested 
against the general model, with a likelihood ratio test, df = 2 
The null hypothesis of linear increase in difference at the first 2 time points, follow-up 1, and follow-up 2, and 
an equal difference at follow-up 3, implies that 2β6  = β7 = β8 ≠ 0.  This hypothesis was tested against the  general 
model, with a likelihood ratio test, df = 2. The 4 random effects (e1i, e2i, e3i, e4i) were assumed to be multivariate 
normally distributed with an unspecified covariance matrix, which is the most general covariance structure. 
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Appendix B. 
 
Data collection for treatment effect 
Baseline measurements were completed at the off-centre site, where respondents were 
assisted by one of four research assistants in using an internet-based environment. Two 
weeks prior to follow-up 1 (3 months after baseline), follow-up 2 (8 months after baseline), 
and follow-up 3 (12 months after baseline), personal log-in codes were sent by postal mail to 
every participant, enabling test completion online. If participants were not able to use the 
online system, either a paper version was sent to them by postal mail, or they were invited to 
the centre to receive help from a research assistant.  
 
Data collection for treatment fidelity check 
A trial specific measure was developed (Leeuw et al., 2009) enabling 2 independent assessors 
to rate whether specific treatment elements took place or not, without revealing whether or 
not these were required, allowed or prohibited and to assess the rater’s judgement which 
treatment condition the treatment elements belonged to, and if Step-2 treatment was 
delivered. First, specific treatment elements were listed by two experts of both treatment 
protocols. Second, these experts categorized these elements into 5 categories; 1) Essential 
and unique, 2) Essential but not unique, 3) Unique but not essential, 4) Compatible, and 5) 
Prohibited. The content validity of this measure was supported by sufficient independent 
agreement (kappa=.83) between the two experts I categorizing all identified elements. 
Independent raters, both postgraduates in psychology, not involved in treatment, and not 
affiliated with the centre, rated a random sample of 40 CRF’s per treatment condition and 
cross-checked occurrence of elements, using this measure. Imperative before treatment 
fidelity analysis were the following criteria. First, sufficient interrater reliability of the trial 
specific fidelity check instrument had to be established between the two independent raters 
(Cohen’s Kappa>.70). Second, sufficient protocol adherence requires at least 70% of 
essential treatment elements have actually occurred (essential and unique, and essential but 
not unique). Third, contamination can be considered ignorable when no more than 10% of 
prohibited treatment elements occur.  
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Abstract  
Objective Up to 21% of adults will develop tinnitus, manifesting the perception of a noxious 
disabling internal sound. Many different treatments are offered, but evidence on their 
effectiveness and cost-effectiveness is scarce or absent. Recently, the effectiveness of a 
specialized treatment of tinnitus based on cognitive behavioral therapy was demonstrated. The 
present study evaluates the cost-effectiveness of this treatment compared to care as usual, in 
an audiological centre. 
Methods An economic evaluation was carried out alongside a randomized controlled clinical 
trial. The economic evaluation was conducted from a societal perspective, using a one-year 
time horizon. The incremental cost effectiveness ratio (ICER) was calculated by dividing the 
difference in costs by the difference in quality-adjusted life years (QALYs) based on the HUI 
Mark III. Non-parametric bootstrapping and sensitivity analyses were used to asses 
uncertainty in costs and effects. Sensitivity analysis included a complete cases analysis and 
analysis on data were missing values on the HUI Mark III were imputed based on a mixed 
regression model from the clinical effectiveness analysis.  
Results Compared to patients receiving usual care, patients who received specialized care 
gained on average 0.015 QALYs (BCI:-0.028-0.055). The incremental costs from a societal 
perspective are $357 (95% BCI:-$1,034-$1,785).  The incremental cost per QALY from a 
societal perspective amounted to $24,580. The probability that SC is cost-effective from a 
societal perspective is 58% for a willingness-to-pay for a QALY of $45,000.  
Conclusion Specialized multidisciplinary tinnitus based on cognitive behavioral therapy 
may be cost-effective as compared to usual care.  
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Introduction 
Tinnitus is the perception of a pernicious, and for some disabling sound for which there is no 
acoustic source. The prevalence of tinnitus in the western world is between 10-20% 
(Andersson, 2002; Davis & El Refaie, 2000) and approximately 3-5% of the general 
population is severely impaired by the tinnitus (Davis & El Refaie, 2000; Vesterager, 1997). 
There are several theories on the potential mechanisms that underlie tinnitus but none of these 
have been demonstrated scientifically (Henry et al., 2005). As a result there is no known drug 
or curative therapy at present (Ahmad & Seidman, 2004; Andersson et al., 2005) and tinnitus 
care is often fragmentized and costly (Lockwood et al., 2002). Tinnitus is known to cause 
affective problems, sleep difficulties and major impact upon concentration (Bartels et al., 
2008; Davis & El Refaie, 2000; Henry et al., 2005). The combination of these complaints 
makes tinnitus sufferers feel exhausted and frustrated, resulting in diminished quality of life 
for the sufferers and sometimes their extended family (El Refaie et al., 2004; Erlandsson & 
Hallberg, 2000; Jastreboff et al., 1996; Kroner-Herwig et al., 2003; Scott et al., 1990). 
Therefore, almost all therapies are focused on alleviating tinnitus related distress and 
improving quality of life (Henry et al., 2005). The most frequent used approaches in relieving 
tinnitus distress and improving quality of life involve counseling, and hearing aid fitting to 
compensate hearing loss or provide sound generators or tinnitus maskers,  but there is mixed 
evidence to support their clinical effectiveness (Hoare et al., 2010; Hobson et al., 2010). 
Evidence regarding the efficacy of clinical interventions remains sparse, but there are 
indications of benefit from Tinnitus Retraining Therapy (Forti et al., 2009; Henry et al., 2007; 
Henry et al., 2002; Herraiz et al., 2007; Phillips & McFerran, 2010), Cognitive Behavioral 
Therapy (El Refaie et al., 2004; Gudex et al., 2009; Hesser et al., 2011; Martinez Devesa et 
al., 2007) and a combination of therapies (Hoare et al., 2010). Tinnitus Retraining Therapy 
(TRT) is based on the neurophysiologic model of tinnitus developed by Jastreboff (Jastreboff 
et al., 1996). TRT involves [1] extensive directive counseling about tinnitus to reduce 
aversive reactions to the symptom and [2] sound therapy to facilitate habituation to the 
tinnitus signal (Jastreboff et al., 1996). Cognitive behavioral therapy is used to alter 
psychological processes that are considered to maintain or contribute to tinnitus-related 
complaints. Treatments that combine counseling and a listening device are also effective (El 
Refaie et al., 2004; Gudex et al., 2009). A study by El Refaie et al. (El Refaie et al., 2004) 
even found a significant effect on the SF-6D health state utilities. In the recent literature an 
integrated approach to treatment that combines insights from audiology, otology, psychology 
and other disciplines is promoted (Andersson et al., 2005). Recently, the first convincing 
results were demonstrated that such a multidisciplinary approach is effective in the treatment 
of tinnitus (R. F. Cima et al., 2012; Langguth, 2012). Patients improved in health-related 
quality of life, tinnitus severity and disability due to tinnitus. However, several regulatory 
authorities also emphasize the impact of assessing the value in healthcare programs (NICE, 
2008; RVZ, 2006), to assess whether health is improved at a reasonable price. This is 
critically important in a condition like tinnitus since it is known to be costly to people who 
have it and to society at large (Maes et al., 2013). To our knowledge this is the first study of a 
multidisciplinary tinnitus treatment that involves a complete health economic evaluation. The 
objective of this study was to determine the cost-effectiveness of a specialized 
multidisciplinary tinnitus treatment based on cognitive behavioral therapy, compared to care 
as usual, in an audiological centre.  
 
Methods 
Study Design 
An economic evaluation was performed alongside a randomized controlled clinical trial in an 
audiological centre in the Netherlands (Adelante Audiology and Communication, location 
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Hoensbroek). Patients were allocated to specialized multidisciplinary treatment based on 
cognitive behavioral therapy, which will be referred to as Specialized Care (SC), or Usual 
Care (UC), both provided by the audiological centre. Measures were taken for blinding 
patients to treatment assignment. Follow-up took place at three, eight and twelve months after 
randomization, with a no-contact period in the last 4 months in the trial. Non responders were 
monitored and at follow-up measurements contacted by telephone and reminded about the 
follow-up, up to two weeks after expiry of the due date. For assessing the cost-effectiveness, 
the SC group was compared to the UC group. The analyses were performed from a societal 
perspective, meaning that healthcare costs, patient & family costs and productivity losses are 
included.  
 
Interventions 
SC was based on a stepped-care approach, tailored to individual patient needs. The first step 
of SC consists of a multidisciplinary intervention for all patients, including audiological 
diagnostics and intervention (counseling, prescription of hearing aid and/or sound generator), 
a Tinnitus Educational Group session and an individual consult with a psychologist. Based on 
the scores of the TQ patients were classified into three different severity classes: mild 
(TQ≤30), moderate (30<TQ<47) or severe (TQ≥47) complaints and severe tinnitus 
complaints. For patients with mild complaints this basic intervention was expected to be 
sufficient. For patients with moderate to severe complaints a second step was offered that 
consists of two main group programs. Program A for patients suffering from tinnitus on a 
moderate to severe level consisted of 12 weekly group session. Program B for patients with 
severe tinnitus complaints consisted of 24 bi-weekly group sessions. Both programs comprise 
key elements of cognitive-behavioral therapy, education, relaxation techniques, attention 
diversion, exposure in daily life situations, and tinnitus retraining therapy.  
UC consisted of a standardized version of the treatment that is currently applied in 
audiological centers throughout the Netherlands for tinnitus patients. UC was organized in a 
stepped care manner and consisted in step 1 of audiological diagnostics and intervention 
(counseling, prescription of hearing aid and/or sound generator) and, in step 2 if necessary, 
one or more consultations with a social worker with a maximum of ten one-hour-sessions 
(See Cima et al., 2009) for more detailed information). 
 
Participants 
The study population consisted of tinnitus sufferers referred to the audiological centre, with 
subjective tinnitus complaints, aged 18 years and older. Patients were excluded from the study 
if they were not able to read and write in Dutch. Patients who declared in writing to be willing 
to participate were invited for a first off-centre assessment contact, after which they were 
allocated to either to UC or SC. 
 
Effects 
The primary effect parameter in the economic evaluation is the quality-adjusted life year 
(QALY). The QALY is based on health state utilities measured with the Health Utilities Index 
Mark III  (HUI). The HUI is a 17 item questionnaire to assess generic health-related quality of 
life on eight dimensions: vision, hearing, speech, ambulation, dexterity, emotion, cognition, 
and pain/complaints. Patients with tinnitus especially have complaints in the pain, cognition, 
emotion and hearing dimension (Maes et al., 2011). A multiplicative utility scoring function 
was used to determine the utility scores which range from -0.36 to 1.00 (Feeny et al., 2002). 
The minimal clinically relevant difference in these utility scores is considered to be 0.03 
points (Horsman et al., 2003; Marra et al., 2005). The HUI has shown adequate 
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responsiveness in a tinnitus population (Maes et al., 2011). The utility scores were used to 
calculate QALYs using the area under the curve midpoint method (Drummond et al., 2005):  
)(*)2/)(()(*)2/)(()(*)2/)(( 2333,2,1222,1,0111,0, ttTUUttTUUttTUUQALY titititititii   
 
Cost Analysis 
Costs1 in the analysis include healthcare costs, patient and family costs, and indirect costs. 
The healthcare costs consisted of the costs of tinnitus care as provided at the audiological 
centre, and other healthcare costs associated with tinnitus. The exact amount of care 
consumed at the audiological centre by each patient was registered in clinical record forms. 
The unit costs of a hearing aid were taken from the GIP databank2 2009, and the costs of 
hearing aid fitting were based on information from the Dutch Association of Hearing Aid 
Dispensers. The unit cost of a tinnitus masking device was determined based on personal 
communication with several hearing aid dispensers. The unit costs of Treatment Group A and 
B, Individual Treatment and the Tinnitus Educational Group session in SC were determined 
by a cost calculation. This cost calculation was based on a registration of personnel time and 
materials used, after which overhead was included. Salary costs for each discipline were 
based on the average salary per scale (employer’s costs included) that are normally used in 
Dutch audiological centers in 2009. Unit costs of material were market prices from 2009. The 
depreciation period of the variable material costs was 5 years. The rental of the gym was 
based on the invoice from the audiological centre of 2009. As recommended (Hakkaart - van 
Roijen et al., 2010) an overhead of 35.5% was calculated over the total costs. Prices of 
individual treatment were calculated based on the number of contacts the patient had with 
each healthcare professional. The costs of the Tinnitus Educational Group session were 
calculated by multiplying the average hourly salary scale of an audiological assistant ($36.89) 
by 240 minutes (including 120 minutes of group session and 10 minutes indirect time per 
patient). Total costs of the Tinnitus Educational Group session were $197.01 (including 
35.5% overhead costs). Since 12 patients can participate in this group the unit cost per patient 
is $16.42. All remaining unit costs of tinnitus care at the audiological centre were based on an 
anonymous source.3  
Other healthcare costs associated with tinnitus included contacts with the general practitioner 
practice, hospital care, care provided by other healthcare professionals, and medication. This  
resource use was measured using a self-administered cost questionnaire with a recall period of 
three months. The questionnaire was administered at each follow-up measurement. The unit 
costs of the other healthcare costs were adopted from the Dutch guideline for cost research 
(Hakkaart - van Roijen et al., 2010) unless stated otherwise (Table 3). The cost questionnaire 
included items to measure patient and family costs in the three months prior to the follow-up 
measurement (travel expenses, over the counter medication and other expenses). In the final 
analysis these costs were interpolated to yearly costs by using the following formula 
(Drummond et al., 2005): 4*)3/)(5*)3/( 3,2,1, tititii CCCCost  .  
Also included in the cost questionnaire were the PRODISQ items (Koopmanschap, 2005) to 
measure loss of productivity (indirect costs). The costs of loss of productivity were quantified 
using the friction cost method, as recommended in the Netherlands (Hakkaart - van Roijen et 
al., 2010). Whenever necessary, unit costs were converted to the reference year 2009 by 
means of price index figures. 
                                                 
1 All costs were converted to U.S. dollars according to the following exchange rate (1 euro = $ 1.25) 
2 The GIP databank is an information system of the Health Care Insurance containing information on 
expenditure on (extramural) drugs and medical aids under the Health Care insurance act. 
3 In the current Dutch health care system organizations negotiate unit costs of (some of) their products with 
health care insurance companies. Therefore, some unit costs are business confidential. As a result, it was decided 
not  to reveal the source of unit costs for these care components.  
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Statistical analysis 
Baseline data on utilities and costs were tested for normality with a Kolmogorov-Smirnov 
test. Differences between the groups on baseline utility scores and costs were compared with 
an independent samples t-test or a Mann-Whitney U test, depending on the test for normality. 
Analyses were performed from both the societal and the healthcare perspective. First, mean 
incremental (societal or healthcare) costs and QALYs per patient between SC and UC were 
calculated. Incremental cost-utility ratios were calculated by dividing the mean incremental 
(societal or healthcare) costs per patient by the mean incremental QALY per patient. In the 
Netherlands there is no formal threshold for cost-effectiveness therefore a maximum 
willingness-to-pay per QALY of £30.000 (approximately $45.000) was used in accordance 
with the NICE guidelines (Devlin & Parkin, 2004; Raftery, 2001). Incomplete data (missing 
items) on the HUI Mark III were imputed using missing value analysis based on regression in 
SPSS version 18. Complete missing data on HUI Mark III and missing data on the cost 
questionnaires were calculated using Rubin’s multiple imputation (Rubin, 1987) in SPSS 
version 18. This method generates 5 different data sets for imputed data. All analyses were 
performed with each of these 5 data sets and these results were pooled. Uncertainty in the 
incremental costs, outcomes and cost-effectiveness was evaluated using non-parametric 
bootstrapping with 1,000 simulations in Excel. In a non-parametric bootstrap simulation cost 
and effectiveness pairs are randomly drawn, with replacement, from the data to obtain a 
sample equal the original sample size. In order to get 1,000 estimates of the incremental costs 
and effect, this procedure is repeated 1,000 times. Bootstrapped confidence intervals for the 
(incremental) costs and QALYs were determined by taking the 2.5th and 97.5th percentile. 
Uncertainty of the incremental cost-effectiveness ratio is shown in cost-effectiveness planes. 
The probability that specialized tinnitus care provided in a specialized tinnitus centre is more 
cost-effective than usual care, depends on what society is willing to pay per unit of gain in 
effectiveness, the so-called willingness-to-pay threshold. The net monetary benefit for 
different thresholds was calculated by subtracting the incremental costs from the incremental 
effects, multiplied by the ceiling ratio. Cost-effectiveness acceptability curves show the 
probability that an intervention has the highest net monetary benefit, and is thus considered 
cost-effective, given different willingness-to-pay thresholds for a QALY. 
 
Sensitivity analyses 
As recommended by Blough et al. (Blough et al., 2009), sensitivity analyses were used to 
show the impact of different ways of handling missing values. In the clinical effectiveness 
analysis of this trial (Cima et al., 2012) a series of mixed (multilevel) regression analyses 
were carried out, in which all available data are used without the need for imputation of 
missing data (Snijders & Bosker, 1999). In one of these analyses, the HUI utility score was 
used as dependent variable in a repeated measures design with group (US, SC) as the 
between-subject factor and time (baseline, follow-up 1, follow-up 2 and follow-up 3) as the 
within-subject factor. Predicted values were calculated from the regression equation of the 
final model. Since these models did not include cost data there was a small difference 
between these predicted values and the HUI utility scores calculated using multiple 
imputation. In the first sensitivity analysis the predicted values were used to impute missing 
values on the HUI utility scores. The second sensitivity analysis was a complete cases 
analysis, based on participants for whom both a QALY as well as total societal costs were 
available. 
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Results 
Participants 
Figure 1 shows the flow of participants, including drop-outs, non-responders, as well as 
reasons for non-response at one of the follow-up, or drop-out if known. Randomization and 
allocation started in September 2007 and ended in December 2009. Follow-up measurements 
were completed in January 2011. Of the 741 participants who were screened for eligibility, 
626 were invited for participation and 492 were randomized to one of the treatment arms. 247 
were randomized to UC and 245 to SC. Of the 203 participants that finished the first step of 
treatment in the UC, a total of 91 patients (46,9%) were identified as having more severe 
tinnitus complaints and received step 2 UC treatment. Of the 218 patients that finished the 
first step in SC, a total of 93 patients (46,7%) met criteria for step 2 treatment (TQ score > 47) 
and were treated. All patients diagnosed as having mild complaints, either in UC (41, 2%) or 
in SC (40, 7%), remained in the trial for follow-up measurements without treatment in the 
second step. Drop-out and non response rates per time point, and number of patients did not 
differ between groups (α=.01). From randomization to final follow-up, a loss to follow-up as a 
result of measurement attrition of 35% in the UC group and in the SC group of 30% was 
observed. The proportion of missing data and or non-response is acceptable for current 
analyses. The reasons for non-response seem not to be related to treatment content.  
In Table 1 the sample characteristics for the total group and UC and SC separately are 
displayed. There were no significant differences found in demographic variables (p >.20). 
Participants were evenly divided among treatment condition on the basis of hearing loss as 
well (p =.95).  
 
 
Table 1. Summary of demographic characteristic, hearing loss and baseline costs of the all 
participants and for the UC and SC separately 
 Total (n = 492) UC (n = 247) SC (n = 245) p* 
Age in yrs (SD) 54.21  (11.52) 54.60 (11.99) 53.82 (11.05) 0.45 
Gender (% male)  62.8 60.7 64.9 0.38 
Education (%)    0.39 
 Low 45.7 47.4 44.1  
 Middle 27.4 24.7 30.2  
 High 26.8 27.9 25.7  
Employment  (% yes) 53.2 50.2 56.1 0.21 
Duration  (%)    0.26 
 Less than 1 yr 30.3 33.6 27.0  
 1 to 5 yrs 38.7 37.7 39.8  
 More than 5 yrs 31.0 28.7 33.2  
Fletcher index (1, 2 and 4 
kHZ) 30.8 30.8 30.9 0.95 
Costs $ (societal 
perspective) 1749 1848 1651 0.20 
UC = Usual Care, SC = Specialized Care, kHZ = kilohertz 
*Chi square tests (α= .05) for categorical variables, independent t-tests for continuous outcomes, 
Mann-Whitney U Test if data were not normally distributed. 
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UC = Usual Care; SC = Specialized Care; T0 = month 0; T1 = month 3; T2 = month 8;  
T3 = month 12 
* Patients not able to enrol because of other medical issues or life events, moved to another area or started 
another job 
 
Figure 1. Trial profile 
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Effects 
Baseline utility scores were not normally distributed (p =.000, K-S test).  The baseline utility 
scores on the HUI Mark III were 0.64 (SD=0.29) in the UC group and 0.63 (SD=0.28) in the 
SC group. This difference was not statistically significant (Mann-Whitney U Test; p =.503). 
In the base case analysis, the incremental QALY is 0.015 (Bootstrapped 95% confidence 
interval: -0.030 – 0.058). The data in Table 2 show that the way of handling missing values 
impacts the utility scores. The predicted values from the multilevel mixed regression and the 
complete case analysis did indicate a clinically important change in the SC group 
 
Costs 
At baseline, costs were not normally distributed (p =.000, K-S test). The total costs at baseline 
were $1,848 for UC and $1,651 for SC. No significant differences in costs between the groups 
for one of the cost categories (Mann-Whitney U Test; p >.200), or for the total costs were 
observed (Mann-Whitney U Test; p =.828). Table 3 summarizes the number of patients that 
recorded the use of the different resources at least once during the follow-up period and the 
mean costs per patient for each group. The mean total health-costs per patient amount to 
$3,875 in UC and $4,023 in SC. The costs of both first and second level tinnitus care at the 
audiological centre are higher in SC ($2,091 and $865 respectively) than in UC ($1,848 and 
$365 respectively). Other healthcare costs related to tinnitus are lower in SC. The mean total 
societal costs amount to $7,027 in UC and $7,380 in SC. Patient and family costs are similar 
in both groups. Costs of lost productivity are higher in SC. In the base case analysis, the 
incremental costs from a societal perspective are $357 (Bootstrapped 95% confidence 
interval: - $1,034 – $1,782). 
 
 
Table 2. Mean utility scores measured by the HUI Mark III and QALYs for the base case 
analysis and sensitivity analyses that tested different ways of handling missing data. 
 Base case analysis Sensitivity analyses 
 Multiple Imputation 
 
Predicted Values from 
Multilevel Mixed 
Regression 
Complete Cases 
Analysis 
 UC SC UC SC UC SC
N 247 245 247 245 130 140
baseline  0.64 (0.29) 0.63 (0.28) 0.64 (0.29) 0.63 (0.28) 0.64 (0.30) 0.65 (0.26)
3 months 0.62 (0.31) 0.62 (0.28) 0.63 (0.26) 0.63 (0.25) 0.64 (0.28) 0.64 (0.26)
8 months 0.62 (0.31) 0.64 (0.29) 0.63 (0.23) 0.66 (0.22) 0.63 (0.28) 0.68 (0.23)
12 months 0.61 (0.31) 0.65 (0.29) 0.63 (0.23) 0.68 (0.21) 0.63 (0.28) 0.69 (0.24)
QALY 0.62 (0.25) 0.64 (0.22) 0.63 (0.22) 0.65 (0.20) 0.64 (0.26) 0.66 (0.22)
HUI=Health Utilities Index, QALY=quality-adjusted life year , UC=Usual Care, SC=Specialized 
Care 
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 Table 3. Total mean costs per cost item per patient in usual care (N=247) and specialized 
care (N=245) 
Cost component Unit costs $ Mean costs* 
 N SC N UC
Healthcare costs 
increment 
4034
152
 3882
First level tinnitus care 2091  1848
Pure tone audiometry 40.48a 240 82.78 242 81.44
Speech audiometry 28.29a 240 57.86 242 56.93
Tympanometry: incl. stapdial 
reflexes 
33.63a 240 68.78 242 67.68
Tinnitus analysis: PMF, MML 18.57a 240 37.97 242 37.36
Uncomfortable Loudness Levels 74.71a 240 152.78 242 150.33
Individual consult by clinical 
physicist in audiology 
 
181.06a
 
240
 
370.24
 
242 
 
364.31
Hearing aid fitting 438.22 c 63 193.39 63 187.52
New hearing aid  1037.50b 46 338.78 45 315.03
Hearing aid check and optimisation 122.35a 90 75.41 125 107.50
Fitting tinnitus masker 438.22 d 45 128.42 55 139.76
New tinnitus masker 1248.50d 37 315.95 46 323.50
BERA 190.66a 19 14.78 19 14.67
Intake psychologist 277.79a 211 239.24 1 0.81
Tinnitus Educational Group session 16.42e 211 14.35 2 1.12
 
Second level tinnitus care 
694  365
Individual trajectory 434.79 e 10 17.74 - -
Treatment group A 1481.28e 41 247.89 - -
Treatment group B 2526.18e 34 352.30 - -
Social work trajectory (incl. intake) 397.26a 22 76.36 96 365.10
General practitioner practice 97  166
GP visit 34.96f 95 50.20 129 84.57
GP home visit 53.69f 45 21.61 65 38.79
GP assistant visit 17.48f 62 13.28 76 21.66
GP weekend and evening  74.36g 22 12.76 32 21.11
Hospital care 479  562
ENT specialist visit 161.06f 95 215.40 117 240.56
Neurologist visit 161.06f 37 52.03 45 67.56
Dental surgeon visit 161.06f 14 16.95 19 27.82
Other medical specialist 161.06f 55 195.28 79 226.30
Other healthcare professionals 674  941
Physiotherapist 44.95f 104 151.24 122 224.29
Psychologist 213.49f 74 149.42 94 227.64
Psychiatrist 161.06f 42 60.02 53 73.34
Social worker 81.15f 48 39.53 74 60.19
Occupational therapist 27.47f 19 4.88 30 10.25
Company doctor 161.06f 79 179.72 87 207.96
Homeopath 12.49 – 103.00h 54 24.61 67 42.14
Acupuncturist 24.97 – 116.53h 54 28.50 71 41.30
Haptonomist 15.61 – 49.94h 36 5.28 48 14.82
Magnetizer / Faith healer 34.96 – 62.43 h 38 1.15 45 2.90
Prescribed medication  
Medication Variousb 79 29.40 84 36.43
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Patient & family costs 
 
106  135
Over the counter medication Varioush 78 6.18 84 10.21
Traveling expenses Varioush 138 4.51 153 5.71
Sports, meditation or other costs 6.24 - 1198.20h 112 95.77 119 119.61
Productivity losses 
 
3252  3018
Loss of productivity at paid labour Mean /hourf 128 3252.14 128 3018.16
Total societal costs 7392  7035
increment 357  
* Missing value analysis based on multiple imputation 
PMF = Pitch Match Frequency; MML = Minimum Masking Level 
a Anonymous source; b GIP databank 2009; c www.nvab.nl; d oral communication with several hearing 
aid dispensers; e cost calculation; f Hakkaart et al. 2010; g www.nza.nl/regelgeving/tarieven; average 
tariff 2009 calculated for Limburg; h cost questionnaire. 
 
 
Cost-effectiveness 
In the base case analysis the mean incremental cost-effectiveness ratio amounts to $10,456 
per QALY gained from a healthcare perspective, and $24,580 per QALY gained from a 
societal perspective (Table 4). Based on these results, SC can be considered cost-effective as 
opposed to UC. The sensitivity analyses show slightly more beneficial results. When using 
the predicted values from the mixed regression to handle missing values in the HUI scores, 
the incremental cost-effectiveness ratios are slightly lower. In the complete cases analysis the 
incremental cost-effectiveness ratio is lower from a healthcare perspective, but higher when 
adopting the societal perspective. 
In the analyses conducted from a societal perspective, the uncertainty surrounding the 
incremental costs and effects is considerable (Figure 2). From a healthcare perspective, 
especially the uncertainty surrounding the incremental effects are considerable (Figure 3). In 
the base case analysis, from the healthcare perspective the probability that SC is cost-effective 
is 68% for a willingness-to-pay for a QALY of $45,000 (Figure 4). From the societal 
perspective, the probability that SC is cost-effective is 58% for a willingness-to-pay for a 
QALY of $45,000 (Figure 4). The sensitivity analyses show slightly more favorable results 
for SC, except for the complete cases analysis from a societal perspective for which the 
probability that SC is cost-effective is 52% for a willingness-to-pay for a QALY $45,000 
(Appendix A). 
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Table 4. Results of the cost-effectiveness analysis from the healthcare and societal perspective 
for the base case and two sensitivity analyses.
Analysis  Increments Uncertainty 
  Mean/
patient
Bootstrap 
95% CI 
Distribution on the cost-
effectiveness plane 
    NE SE SW NW
Base case 
analysis  
Healthcare 
Costs 
 
$ 152
 
$ -333 to $ 643
  
Multiple  QALY 0.0145 -0.028 to 0.055   
imputation iCER $ 10,456 52% 22% 4% 22%
 Societal Costs $ 357 $ -1,034 to $ 1,782   
 QALY 0.0145 -0.028 to 0.055   
 iCER $ 24,580 48% 20% 6% 27%
Sensitivity 
analysis I  
Healthcare 
Costs 
 
$ 152
 
$ -333 to $ 643
  
QALY based on  QALY 0.017 -0.019 to 0.057   
predicted values of  iCER $ 9,200 60% 13% 6% 21%
MMR used in the  Societal Costs $ 357 $ -1,034 to $ 1,782   
effectiveness QALY 0.017   
paper iCER $ 21,628 55% 13% 6% 21%
Sensitivity 
analysis II 
Healthcare 
Costs 
 
$ 288
 
$ -320 to $ 883
  
Complete cases  QALY 0.029 -0.028 to 0.080   
analysis iCER $ 10,069 68% 15% 1% 16%
 Societal Costs $ 1,001 $ -941 to $ 2,983   
 QALY 0.029 -0.028 to 0.080   
 iCER $ 35,009 67% 15% 1% 17%
CI = Confidence Interval, MMR = Mixed Multilevel Regression, QALY = quality-adjusted life year, 
iCER = incremental Cost Effectiveness Ratio 
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Figure 2. Cost-effectiveness plane of base case analysis from healthcare perspective 
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Figure 3. Cost-effectiveness plane of base case analysis from societal perspective 
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Figure 4. Cost-effectiveness acceptability curves of the base case analysis 
 
 
Discussion 
This article reports on what is, to our knowledge, the first full economic evaluation of a  
multidisciplinary stepped care approach to tinnitus treatment combining TRT and CBT. In the 
clinical effectiveness study of this trial it was shown that there was a significant improvement 
in quality of life (Cima et al., 2012). Other studies found that treatments based on TRT or 
CBT, which were an important part of the SC, were effective up to 15 years after the therapy 
ended (Forti et al., 2009; Goebel et al., 2006; Lux-Wellenhof & Hellweg, 2002; Zachriat & 
Kroner-Herwig, 2004). It would be interesting to know the longer term effects of SC and UC 
on health-related quality of life. Costs associated with the tinnitus care in the audiological 
centre were considerably higher in SC. This was partly compensated by lower costs in SC for 
other tinnitus related healthcare costs. Productivity costs were higher in SC. This could be due 
to the fact that the SC is more time-consuming than the UC. Participants with paid jobs in one 
of the treatment groups of SC, were often absent from work during the  treatment days.  
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Moreover, in second level tinnitus care in SC it is advised to participants to, if on sick leave, 
resume their paid work only after the intervention is completed. With regard to cost-
effectiveness, the results show that SC costs society $24,580 per QALY gained based on the 
base case estimates of input parameters. Although there is no consensus about a reasonable 
threshold value for cost-effectiveness, the NICE guideline state that the reimbursement of 
interventions costing less than £30,000 (approximately $46.453) are generally never 
questioned  (Devlin & Parkin, 2004; Raftery, 2001). The Dutch Council for Public Health and 
Health Care has set the threshold at €80.000 (approximately $99,880) for diseases with a high 
burden (RVZ, 2006). The low quality of life scores at baseline (0.63) indicate that tinnitus is a 
relatively high burden to the patients that suffer from it. Therefore we consider the treatment 
to be cost-effective, despite the uncertainty surrounding the incremental costs and effects was 
substantial, mainly for the analyses from a societal perspective. If willingness-to-pay for an 
additional QALY amounts to $100.000, the probabilities that SC is the most cost-effective 
treatment are 67% (societal perspective) and 72% (healthcare perspective). Sensitivity 
analyses showed that the approach to handling missing values impacted on the results. 
However, it did not alter the conclusions. 
Some limitations of this study need to be considered. First, the proportion of missing data and 
non-response was acceptable, however larger than expected. In the base case analysis it was 
assumed  that data were missing at random but, at this level of missing data, we cannot rule 
out the possibility of non-random causes for dropout. Fortunately, the sensitivity analyses 
show that, although the approach to handling missing values does impact the results, the 
conclusions remain the same. Second, a longer time horizon may be necessary to identify 
relevant longer-term outcomes; especially since quality of life slightly improves at the last 
follow-up in the SC, and deteriorates in the UC. It is expected that a longer time horizon 
would show even more favorable results for the SC. Third, because SC had several elements 
it is unclear which of these elements contributed to the overall effectiveness. A dismantling 
approach in which potentially redundant factors are left out are expected to result in a more 
cost-effective treatment. 
In conclusion, this economic evaluation, conducted from a societal perspective using a one 
year follow-up period, shows that a specialized multidisciplinary tinnitus treatment based on 
cognitive behavioral therapy may be more cost-effective than usual care.  
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Appendix A. Results of sensitivity analysis 
 
Sensitivity analysis I 
 
Figure 1. Cost-effectiveness plane from the societal perspective of sensitivity analysis in 
which missing values on HUI were based on predicted values from multiple mixed 
regression in the clinical effectiveness analysis 
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Figure 2. Cost-effectiveness plane from healthcare perspective of sensitivity analysis in 
which missing values on HUI were based on predicted values from multiple mixed regression 
in the clinical effectiveness analysis 
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Figure 3. Cost-effectiveness acceptability curves based on sensitivity analysis in which 
missing values on HUI were based on predicted values from multiple mixed regression in the 
clinical effectiveness analysis 
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Sensitivity analysis II 
 
 
Figure 4. Cost-effectiveness plane from societal perspective of complete cases analysis  
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Figure 5. Cost-effectiveness plane from healthcare perspective of complete cases analysis  
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Figure 6. Cost-effectiveness acceptability curves based on complete cases analysis 
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Abstract 
Objectives To explore the potential value of obtaining momentary, instead of retrospective, 
accounts of the description and valuation of a person’s own health-related quality of life 
(HRQOL). 
Methods Momentary HRQOL was examined with the Experience Sampling Method (ESM) 
in 139 participants from 4 different samples. The ESM consists of a beep questionnaire that 
was administered 10 times a day. Feasibility of was determined by assessing willingness to 
participate in the study and by analyzing the percentage of drop-outs and the number of 
completed beep questionnaires. Bivariate correlations and multilevel analysis were used to 
investigate the relation between momentary HRQOL and momentary feelings and symptoms. 
The relation between momentary outcomes and the EQ VAS was investigated with a multiple 
regression model.  
Results The overall participation rate was low but there were no drop-outs and the number 
of completed beeps was comparable to other studies. Multilevel analysis showed that feelings 
and symptoms were significant predictors of momentary HRQOL. The strength of these 
relations differed between the groups. The EQ VAS was not predicted by momentary 
feelings, symptoms and HRQOL. 
Conclusion We can conclude that the use of the ESM to measure accounts of the 
momentary experience of health in different populations is feasible. Retrospective measures 
may provide a biased account of the impact of health problems in the daily lives of people 
who are affected. Moreover, the bias may be different in different conditions.
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Introduction 
The quantification of the subjective experience of health, or health-related quality of life 
(HRQOL), outcome is crucial to the evaluation of health care technologies. To assign 
meaningful numbers to health outcomes, the experience needs to be described in terms of 
severity, and assigned a value. Instruments to obtain patient descriptions and valuations of 
their own health, such as the EQ-5D health description and visual analogue scale (EQ VAS), 
rely on retrospective self-report. A problem with retrospective self-report is that it is likely to 
give a biased account of real-world experiences due to imperfect recollection of past 
experiences (Reis, 2012; Stone & Shiffman, 2002). In other words, it does not reflect the 
impact of health problems in the daily lives of people who are affected. An alternative to 
retrospective self-report, is to study outcomes from moment to moment, in the context of 
daily life. The objective of the present study was to explore the potential value of obtaining 
momentary, instead of retrospective, accounts of the description and valuation of a person’s 
own health.  
 
Retrospective versus momentary self-report 
Robinson & Clore (2002) reviewed several studies describing discrepancies between 
momentary and retrospective self-reports. Retrospective self-reports are not accurate 
reflections of experience because feelings are not always accurately represented in memory. If 
not measured directly, the affective experience needs to be reconstructed on the basis of 
episodic or semantic memory. Episodic memory is the recollection of past personal 
experiences that occurred at a particular time and space. Semantic memory is a more 
structured record of facts and knowledge about the external world that is independent of 
personal experience. With regard to episodic memory, Kahneman et al. (1993) found that 
more memorable moments or details of an emotional event disproportionately affect 
retrospective estimates of emotion. It also has been shown that there is a gradual decline in 
episodic memory (Rubin & Wetzel, 1996), which leads to a reliance on semantic memory to 
fill in the memory gap of hedonic experience (or experiential knowledge). Semantic memory 
relies more on generalized beliefs than on experiences. In this regard, there is a distinction 
between retrospective self-reports of global concepts and retrospective self-reports of specific 
feelings and symptoms. Global reports of past health will rely more on beliefs (semantic 
memory), while reports on specific feelings and symptoms may more easily be recovered by 
detailed episodic recall (Kahneman et al., 2004; Robinson & Clore, 2002; Stone et al., 2006). 
As a result, the retrospective global valuation of health may be more prone to bias than the 
retrospective description of detailed aspects of health such as specific feelings or symptoms. 
Methodological literature on self-report measures has highlighted that many of the problems 
described above will be reduced when questions are asked in close temporal proximity to the 
event of interest (Schwarz, 2011). More fundamentally, there is an increasing awareness that 
experiences are dynamic, situated, and highly context driven (see the contributions in 
Mesquita, Barrett, & Smith, 2010) thereby providing a powerful rationale for investigating 
experiences in the context in which they occur (Robbins & Aydede, 2008). It could be that 
bias in retrospective self-report is different in different patient populations. For instance, 
depression has been shown to have an effect on memory performance (Burt et al., 1995; 
Kizilbash et al., 2002). In addition, feelings are fleeting and thus not available through 
introspection once the feeling dissipated. Therefore, retrospective reports of affective 
experiences may be especially prone to bias. As a result, a higher discrepancy between 
retrospective self-report and actual experiences may occur in persons suffering from 
psychological complaints. It is also well know that people do not adapt well to the presence of 
noise (Loewenstein & Schkade, 1999; Weinstein, 1992). This could mean that patients with a 
complaint like tinnitus, which is the experience of a sound without an acoustic source, or pain 
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disproportionately focus on this aspect when evaluating their health-related quality of life 
retrospectively. 
 
Experience Sampling Method 
In the present study we used a real-time method, the Experience Sampling Method (ESM) 
(Larson & Csikszentmihalyi, 1983), to obtain momentary accounts of feelings, physical 
symptoms and HRQOL. The ESM was developed in the 1970s. It is characterized by the 
collection of multiple self-reports of an individual’s (near) real-time feelings, thoughts and 
activities in real-world environments. ESM studies are conducted using paper diaries or 
(increasingly) electronic devices (Trull & Ebner-Priemer, 2009). These devices beep at 
random moments, when participants are asked to complete a questionnaire. A potential 
limitation of the ESM is that it can be time consuming and intrusive, and as a result 
burdensome to participants (Conner et al., 2009).  
 
Objectives 
In this study, first we assessed the feasibility of using the ESM to obtain accounts of the 
momentary valuation of HRQOL in different patient populations. Next, it was hypothesized 
that if the momentary valuation of HRQOL would vary over time, this would be an indication 
that the momentary valuation of a global concept like HRQOL is influenced by the 
momentary experience of more specific feelings and symptoms. Therefore, we assessed 
whether the momentary valuation of HRQOL is variable from moment to moment within 
persons. Furthermore, we examined the relation between momentary accounts of specific 
feelings and symptoms and the momentary valuation of HRQOL. Finally, we examined the 
relation between the global retrospective valuation of HRQOL (as obtained by the EQ VAS) 
and the momentary accounts of feelings and symptoms and valuation of HRQOL.  
 
Methods 
Study population 
The study population consisted of 139 participants. To ensure a variety of experienced health 
states in the study population, participants were recruited from three patient groups 
(experiencing somatic complaints with a known cause, somatic complaints without a known 
cause, and psychological complaints) and a  population based sample. All participants were 
18 years or older. Exclusion criteria were not being able to read and write in Dutch or not 
being able to handle the electronic ESM device because of impaired motor skills. 
The population based sample consisted of members of the general public. These participants 
were recruited through advertisements/posters in the Maastricht University Hospital.  
The patient group with psychological complaints consisted of patients with anxiety or 
depressive complaints. Specific inclusion criteria for this sample were a referral to a mental 
health care setting because of anxiety or depressive complaints, or a score of >8 points at 
either the anxiety or depression scale, or >12 points on the total score of the Hospital Anxiety 
and Depression Scale (Spinhoven et al., 1997). This group was interesting, as noted above, 
because there may be larger discrepancies in momentary versus retrospective assessments. 
These patients were recruited from PsyQ Maastricht, a secondary mental health care facility. 
During the intake the psychologist introduced the study, and patients were asked whether they 
agreed to being approached. Patients in this sample were also recruited by flyers in several 
mental health care centres and an advertisement in a local newspaper.  
The group of patients with somatic complaints without a known cause consisted of patients 
with tinnitus. As noted above people find it difficult to adapt to noise so this was a 
particularly interesting group. A specific inclusion criterion for this sample was referral to an 
audiological centre because of tinnitus complaints. Specific exclusion criterion was an organic 
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cause of the tinnitus. These participants were recruited from a completed randomized 
controlled trial investigating the (cost-)effectiveness of a multidisciplinary treatment for 
tinnitus versus care as usual (Cima et al., 2009; Cima et al., 2012). Participants in the vicinity 
of the Maastricht University Medical Centre received a letter in which their participation was 
requested.  
The group of patients with somatic (bodily) complaints with a known cause consisted of 
patients diagnosed with atherosclerosis or venous insufficiency. In instances where patients 
underwent a leg amputation as a result of these complaints, the clinical rehabilitation had to 
be finished before participating in the trial. Participants were recruited from Adelante, a centre 
of expertise in rehabilitation and audiology and the department of surgery from the Maastricht 
University Medical Centre. The treating physician introduced patients to the study and asked 
whether they would be interested to learn more about participating in the study from the 
research team. 
All potential participants received written information. If they were willing to participate in 
this study they returned the informed consent by mail. The study protocol was reviewed and 
approved by the Medical Ethical Board of the Maastricht University Medical Centre.  
 
Measures 
Experience Sampling Method using the Maastricht routine described by Delespaul (1995).  
The ESM consists of a beep questionnaire that participants are required to fill out at several 
unpredictable moments during the day. They will also have to answer additional question in 
the morning when they wake up and in the evening when they go to sleep. The validity and 
reliability of the Maastricht routine has been documented elsewhere (Delespaul, 1995). In this 
study we used the PsyMate, a small user-friendly device programmed to generate beeps (and 
vibrations) between 07.30h and 22.30h randomly in two-hour intervals. The beep 
questionnaire consists of 11 items on current emotional state; six for positive affect (PA) and 
five for negative affect (NA). Four items were included to measure physical symptoms. 
Contextual items, regarding location of the participants, social interactions and activities were 
also included in the beep questionnaire. Items on activities and social interaction consisted of 
predetermined categories (see Appendix A). For all remaining items a 7-point Likert-scale 
was used. 5- or 7-point Likert-scales are most commonly used, but a 7-point Likert scale has 
greater potential sensitivity (Colman et al., 1997). To measure the meaningfulness of the 
(social) activities, again a 7-point Likert-scale was used. To obtain a valuation of momentary 
HRQOL, a VAS anchored in the same way as the EQ VAS (0 being the worst imaginable 
health state and 100 being the best imaginable health state) was included in the beep 
questionnaire (The EuroQol Group, 1990). Items were formulated to be as neutral as possible 
in order to minimize framing effects. So, for instance, questions such as ‘are you bothered by 
(e.g. pain)’, that can be considered leading, were replaced with items that ask people to 
simply state a) how much pain they are in and b) how frustrated/sad they are at the moment. 
By analyzing the co-occurrence of emotional states we can draw conclusions about the degree 
to which the existence of pain is related to emotional well-being. In terms of question order, 
respondents were asked to comment on their emotional states before being asked about what 
they were doing or who they were with to reduce potential focusing effects (appendix A). In 
total 37 items were included in the ESM beep questionnaire. The average time to complete the 
questionnaire was between 2 and 3 minutes. 
 
Global measures 
Global retrospective valuation of health, or HRQOL as measured with the EQVAS (24); 
- Anxiety and depression as measured with the Hospital Anxiety and Depression Scale 
(HADS) (19); 
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- A questionnaire on personal characteristics. 
 
Data collection 
The study consisted of three phases planned individually for each participant. All participants 
received € 25 for their participation. 
 
Briefing session  
Day 1 consisted of a briefing and collection of baseline global data, and took around 3 hours 
per participant. During the briefing the rationale of the study was explained and an instruction 
on the use of the PsyMate was given. A try-out sampling moment was simulated in which the 
participants were coached in answering the questions on the PsyMate. After the try-out the 
EQ VAS, the HADS and the questionnaire on personal characteristics were administered.  
 
ESM period  
The ESM period comprised 6 days, starting the day after the briefing and ending the day 
before the debriefing a week later. During this week the participants were asked to continue 
their normal life. Additional questions had to be answered in the evening just before they 
went to sleep (end-of-day questionnaire).    
 
Debriefing  
On the 8th day participants returned for a debriefing session. In this session the ESM period 
was reviewed by means of a questionnaire. In this questionnaire participants had to answer 
whether the PsyMate had influenced their mood, activities, thoughts or contacts with other 
people and if they had been annoyed by the beeps. Furthermore participants were asked 
whether the ESM week had been a typical week or if any unusual incidents had occurred, if 
items were unclear and if they thought they could give a good representation of their 
experiences during the day. The EQ VAS, and the HADS were administered again.   
 
Analyses 
Feasibility 
To determine the willingness to participate in an ESM study, in the patient samples the 
number of participants that was approached for participation was compared with the number 
of participants that actually participated in the study. For both the patient samples and the 
population based sample the percentage of dropouts was recorded and analyzed. Furthermore, 
we assessed the feasibility by analyzing the number of completed beep questionnaires. Also 
the responses to the debriefing questionnaire were analyzed.  
 
Construction of scales 
Appendix A gives an overview of the items in the ESM. A principal components exploratory 
factor analysis on positive and negative affect (PA & NA) items and physical symptoms (PS) 
was used to examine the underlying factor structure (White & Dolan, 2009). A principal 
components exploratory factor analysis on these items confirmed a three factor solution. To 
aid the interpretation of these three components, a non-orthogonal (oblique) solution was 
used. The 6 items on positive affect loaded onto the first factor (Eigen value = 3.547; variance 
explained 23.6%; all item factor loadings > .643). A positive affect (PA) scale was created by 
calculating the mean of these items. The 5 items on negative affect loaded onto the second 
factor (Eigen value = 1.330; variance explained 8.9%; all item factor loadings > .408). We 
created a negative affect (NA) scale by calculating the mean of these five items. The four 
physical symptom items loaded onto the third factor (Eigen Value=1.229; variance 
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explained=8.2%: all item factor loadings >.384). We created a physical symptoms (PS) scale 
by calculating the mean of these four items.  
 
Variability of the momentary valuation of HRQOL within and between persons.  
To determine if there was variability in the momentary valuation of HRQOL within persons, 
for each respondent a standard deviation (SD) was determined over the responses to the beep 
questionnaires. A histogram of the different SD’s was made to display the differences 
between persons. In addition, a repeated measures ANOVA with a Greenhouse-Geisser 
correction was used to explore whether the variability in valuations differed over the days in 
the ESM week. A linear regression was used to examine the relation between mean HRQOL 
and mean SD of HRQOL. 
 
Relation between the momentary valuation of HRQOL and the simultaneous experience of 
feelings and symptoms.  
Bivariate correlations between the momentary valuation of HRQOL and PA, NA and PS for 
each participant were computed and displayed in a histogram. Correlations were interpreted 
according to the following benchmarks: 0.1 to 0.3 was interpreted as small, 0.3 to 0.5 as 
medium and >0.5 as large (Cohen, 1988). To examine whether momentary feelings and 
symptoms predict the momentary valuation of HRQOL a multilevel random regression model 
was estimated with the momentary HRQOL as the dependent variable and momentary PA, 
NA and PS as independent variables. A multilevel (or hierarchical) regression analysis is 
ideally suited for data obtained with the ESM since beep level data (level 1) are nested within 
persons (level 2). In multilevel analysis a curve is fitted for the dependent variable for each 
participant, thereby taking into account the fact that beep-level measures of within patients 
measures tend to be more alike than randomly chosen beep level measurement. All multilevel 
analyses were computed with the XTMIXED modules of STATA 11.0. Since different scales 
were used, all variables were standardized. The analyses were corrected for age, sex and 
group difference by including three dummy variables for the different groups. Group was 
entered in the mixed regression as a categorical variable using dummy coding with the 
general population sample as a reference category and a dummy indicator for every other 
group4. The general population sample was treated as the reference group. To determine the 
explained variance of PA, NA and PS separately, these variables were first added separately 
to the basic model (which included momentary HRQOL and the covariates). A final model 
was fitted with the momentary HRQOL as dependent variable and momentary PA, NA, PS 
and their interaction with the dummy variables as independent variables. We expected a 
positive relation between PA and HRQOL, and a negative relation between NA and PS and 
HRQOL.   
 
Relation between the EQ VAS and momentary HRQOL, feelings and symptoms.  
Aggregated means and standard deviations of momentary HRQOL, PA, NA and PS were 
calculated and compared with the EQ-5D VAS at briefing and debriefing. This was done for 
the total group and for all four subgroups. Furthermore, correlations between momentary 
HRQOL, PA, NA and PS on the one hand and the retrospective valuation of HRQOL  (EQ 
VAS) on the other hand were computed. Correlations were interpreted according to the same 
benchmarks as mentioned in the previous paragraph. To examine how much of the variance in 
the EQ VAS at debriefing was explained by momentary PA, NA, PS and momentary HRQOL 
a multiple regression model was fitted to the aggregated data. All the variables were 
                                                 
4 Dummy 1: 1=Psychological complaint sample, 0=Tinnitus sample, 0=Somatic complaints sample. Dummy 2: 
1=Tinnitus sample, 0= Psychological complaint sample, 0=Somatic complaints sample. Dummy 3: 1=Somatic 
complaints sample, 0=Tinnitus sample, 0=Psychological complaint sample 
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standardized. The EQ VAS at debriefing was the dependent variable and momentary PA, NA, 
PS and HRQOL were the independent variables. Age, sex, EQ VAS at briefing and sample 
(by including three dummy variables with general population as reference group) were taken 
into account as covariates.  
 
Results 
Feasibility 
Demographic characteristics of the total sample and sub-samples are displayed in table 1. 
Mean age of the total sample was 50 years and 50% was male.  
 
 
Table 1. Demographic characteristics of the participants 
Characteristics Total  
sample  
General 
population
Psychological 
complaints
Tinnitus  Somatic 
complaints
N 139 40 27 40 32
Age (SD) 50.2 (16.7) 38.6 (14.6) 38.4 (12.7) 58.2 (10.0) 64.8 (10.4)
Sex (% male) 69 (49.6) 29 (72.5) 12 (44.4) 11 (27.5) 17 (53.1)
Living situation 
(% alone) 
 
42 (30.2) 13 (32.5) 11 (40.7)
 
4 (10.0) 14 (43.8)
Education (%)   
Low 34 (24.5) 4 (10.0) 2 (7.4) 14 (35.0) 14 (43.8)
Middle 53 (38.1) 9 (22.5) 15 (55.6) 14 (35.0) 15 (46.9)
High 52 (37.4) 27 (67.5) 10 (37.0) 12 (30.0) 3 (9.4)
SD = standard deviation 
 
 
Population based sample. With regard to the population based sample, 44 subjects responded 
to the poster and received the information on the study. Four persons declined participation 
after they received the information. One person found the study too burdensome and one 
person had a bad experience in another study. Two persons did not respond to the information 
letter and could not be reached by phone. In this sample 26 participants reported no physical 
conditions and 36 reported no psychological complaints. Physical conditions included asthma 
(4), back pain (3), hearing impairment (2), vision impairment (1), back pain (3), high blood 
pressure (2), arthritis (2), arthrosis (2), bladder carcinoma (1) and stroke (2). Four participants 
reported more than 1 condition. Psychological complaints included: eating disorder, burn-out 
(2), depressive complaints (1).    
 
Psychological complaints sample. The information on the study was sent to 59 patients with 
anxiety or depressive complaints and 36 were willing to participate. Two patients did not 
meet the inclusion criteria. Reasons for not participating were not interested in study objective 
(N=2), too burdensome (N=8), not able to combine with work (N=6), transportation problems 
(N=2). Five patients did not respond to the information letter or telephone calls.  Six patients 
did not show up at the briefing or cancelled their participation before the briefing. One patient 
was irritated by the questions in the PsyMate during the try-out sampling moment, resulting in 
a final sample of 27 (or 46% of those originally approached).   
 
Tinnitus sample. For the sample of tinnitus patients, the study information was sent to 326 
patients who had previously participated in a randomized controlled trial (20, 21). Forty-five 
patients were willing to participate in this study. Reasons for not participating were not 
interested in study objective (N=80), too burdensome (N=27), not able to combine with work 
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(N=21), other health complaints (N=20), no more tinnitus complaints (N=8), distance to 
research centre (N=9), afraid that attention to tinnitus during ESM week would make 
complaints worse (N=8). Hundred-seven patients (35%) did not respond to the information 
letter or telephone calls. Of 45 patients that were willing to participate, four did not come to 
the briefing or cancelled their participation before the briefing. One patient was not able to 
read the PsyMate because the font size was too small. In other words, only 14% of tinnitus 
patients approached, were willing or able to take part in this ESM study. 
 
Somatic complaints sample. For the group of patients with atherosclerosis or venous 
insufficiency, the information was sent to 121 patients. Forty-four patients were willing to 
participate. Reasons for not participating were too burdensome (N=27), not interested in study 
objective (N=18), not satisfied with the treatment (N=2), other physical complaints (N=8), 
distance to research centre (N=3), not meeting inclusion criteria (N=5), no more complaints 
(N=2), not able to combine with work (N=1), already participating in another study (N=2). 
Nine patients did not respond to the information letter or telephone calls. Of the 44 patients 
that were willing to participate 10 patients did not show up at the briefing or cancelled their 
participation before the briefing. One patient cancelled participation during the briefing 
because the font size was too small and another person cancelled because the PsyMate made 
her nervous. The final sample was thus 32 (26% of those originally approached). 
 
All participants that finished the briefing completed the ESM week. Participants responded to 
5994 of the 8340 possible beeps (72%). On average participants responded to 7.2 beeps per 
day with a minimum of zero and maximum of 10. Over the six days the total mean number of 
beeps recorded per patient was 43.1 with a minimum of 17 and a maximum of 59. The 
majority (76%) of participant’s thought of their week as being representative of a normal 
week and only twenty percent reported the occurrence of unusual incidents. Twenty-two 
percent of participants found the PsyMate annoying, ranging from nineteen percent in the 
psychological complaints sample to twenty-eight percent in the population based sample. In 
all the sub-samples more than ninety percent of the participants reported that the PsyMate did 
not influence their mood, social interactions or activities. Seventy-five percent of the 
participants reported that the PsyMate did not influence their thoughts, ranging from sixty-
three percent in the psychological complaints sample to eighty percent in the tinnitus sample. 
The large majority of the participants (92%) reported that they were able to give a good 
representation of their experiences during the day. Fourteen percent of the participants found 
some of the questions unclear.  
 
Variability of the momentary valuation of HRQOL within and between persons  
In Table 2 the aggregated means and SD of momentary HRQOL for the total group and the 
subgroups are displayed. The SD’s of momentary HRQOL per participant are displayed in 
Figure 1. The mean of the within person SD’s was 5.64, with a range from 0.94 to 18.22. The 
mean SD at day 1 was 5.2 and decreased to 3.9 at day 6. A repeated measures ANOVA 
determined there was a statistically significant difference between the mean SD’s over the 6 
days (F=3.545, df=4.417, p=.005). Post-hoc tests using the Bonferroni correction revealed 
there only was a statistically significant difference between day 1 and day 6. In participants 
with a higher mean momentary HRQOL, there was less variance in responses than in 
participants with a lower momentary HRQOL (Figure. 2). This relation was confirmed by a 
linear regression that showed a significant negative relation of the mean and SD of the 
momentary HRQOL per participant (β=-0.388; p=0.000; R2=0.150).   
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Table 2. Descriptive of momentary outcomes and global retrospective EQ VAS at briefing 
and debriefing 
 Total 
 
General 
population 
Psychological 
complaints 
Tinnitus Somatic 
complaints 
P-
value*
 Mean 
(SD) 
Mean 
(SD)
Mean 
(SD)
Mean 
(SD)
Mean 
(SD) 
Retrospective at 
briefing 
  
EQ-5D VAS 72.85 
(19.4) 
88.25 
(10.4)
61.26 
(16.6)
69.50 
(19.4)
67.56 
(19.1) 
.000
Momentary     
HRQOL 70.16 
(17.4) 
81.05 
(13.8)
59.39 
(16.22)
67.44 
(18.3)
69.03 
(14.1) 
.000
Positive affect 4.67 
(1.5) 
5.19 
(1.1)
3.51 
(1.5)
4.70 
(1.5)
4.89 
(1.3) 
.000
Negative affect 1.66 
(1.1) 
1.33 
(0.6)
2.52 
(1.3)
1.63 
(1.1)
1.45 
(0.8) 
.000
Physical symptoms 2.41 
(1.2) 
1.67 
(0.8)
2.15 
(0.9)
3.28 
(1.1)
2.45 
(1.3) 
.000
Retrospective at 
debriefing  
  
EQ-5D VAS  74.37 
(19.6) 
90.50 
(8.8)
56.93 
(19.2)
72.75 
(17.5)
70.73 
(17.4) 
.000
SD=standard deviation; VAS=visual analogue scale; HRQOL= health-related quality of life 
measured with a VAS;  
* One-way ANOVA on retrospective and aggregated momentary data 
 
 
            
Figure 1. Frequency of within person SD’s of momentary HRQOL 
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Figure 2. Relation between mean momentary HRQOL and SD of momentary HRQOL per 
subject. 
 
 
Relation between momentary experienced feelings and symptoms and 
momentary valuation of HRQOL  
The aggregated means of PA, NA and PS are displayed in Table 2. Six participants showed no 
variance in PA, NA or PS, so data for these participants are not included in the following 
analyses. The mean correlation between momentary HRQOL and PA, NA and PS were 
respectively 0.35 (range -0.28 to 0.91), -0.22 (range -0.86 to 0.30) and -0.26 (range -0.90 to 
0.30). The within person correlations between the HRQOL and feelings (PA and NA) and 
physical symptoms (PS) for the total sample are displayed in Figure 3. In 86% of the total 
sample the relation between momentary HRQOL and PA was positive. In 37% of the patients 
with a positive relation between momentary HRQOL and PA this correlation was high (>.50). 
The highest proportion of patients with a negative correlation between the HRQOL and PA 
was in the somatic complaints sample (22%). The difference between the samples in the 
proportion of patients with a positive or negative correlation between momentary HRQOL 
and PA was not statistically significant (χ2=4.2; p=0.240).  In 75% of all participants the 
relation between momentary HRQOL and NA was negative and in 17% of all participants this 
correlation was high. The highest proportion of participants with a positive correlation 
between momentary HRQOL and NA was again in the somatic complaints sample (47%). 
The difference between the samples in the proportion of participants with a positive or 
negative correlation between momentary HRQOL and and NA was statistically significant 
(χ2=15.5; p=0.001). In 81% of the participants the relation between momentary HRQOL and 
PS was negative and in 19% this was a high correlation (>.50). In 25% of the tinnitus sample 
and the somatic complaints sample a positive correlation between momentary HRQOL and 
PS was found. There was no significant difference between the different samples regarding 
the proportion of participants with a positive or negative relation between momentary 
HRQOL and PS (χ2=6.2; p=0.101). In Table 3 the results of the multilevel analysis are 
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displayed. The results of the final model showed that all variable estimates were in the 
expected direction. At the .05 level a significant main effect for PA and PS was found when 
controlling for age, sex and sample. A significant for NA was found at the .10 level. PA had 
significant interaction effects with psychological complaints and tinnitus sample. This means 
that PA is a stronger predictor of momentary HRQOL among those with psychological and 
tinnitus complaints, than other complaints. Although the main effect of NA was not 
significant at the .05 level, NA had a significant interaction with psychological complaints 
sample. This means that NA is a stronger predictor of momentary HRQOL in this sample 
compared to other samples. With regard to PS, a significant interaction was found with the 
psychological complaints sample and the tinnitus sample. This implies that PS is a stronger 
predictor of HRQOL in these samples than in the other samples.  
 
 
 
Figure 3. Frequencies of within person correlations between mom-HRQOL and PA, NA and 
PC. 
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Table 4. Correlations between momentary outcomes and the EQ-5D VAS 
Group Momentary outcomes Global retrospective outcome 
 ESM EQ VAS EQ-VAS
 Briefing Debriefing
 Health-related quality of life  
Total sample 0.810 0.826
General population sample 0.56 0.62
Tinnitus sample 0.86 0.88
Psychological complaints 0.80 0.85
Somatic complaints 0.69 0.65
 Positive affect  
Total sample 0.630 0.686
General population sample 0.52 0.48
Tinnitus 0.62 0.68
Psychological complaints 0.58 0.64
Somatic complaints 0.69 0.65
 Negative affect  
Total sample -0.562 -0.628
General population sample -0.28 -0.21
Tinnitus -0.60 -0.59
Psychological complaints -0.55 -0.68
Somatic complaints -0.40 -0.50
 Physical complaints  
Total sample -0.489 -0.519
General population sample -0.32 -0.36
Tinnitus -0.62 -0.68
Psychological complaints -0.14 -0.47
Somatic complaints -0.53 -0.68
VAS = visual analogue scale 
 
 
Relation between momentary HRQOL, feelings and symptoms and global 
retrospective HRQOL.  
Table 2 gives an overview of the mean and SD’s for the aggregated momentary HRQOL, PA, 
NA and PS and the EQ VAS at briefing and debriefing, for the total sample. There was a 
significant difference between mean momentary HRQOL (70.16) and mean EQ VAS (72.85) 
at briefing (paired samples t-test; t=-3.111; p=.002), but not between mean momentary 
HRQOL and mean EQ VAS (74.37) at debriefing (paired samples t-test; t=1.010; p=.314). 
Table 5 displays the correlations between momentary ESM data and the  EQ VAS for the total 
sample and the different sub-samples. The correlation between PS and EQ VAS at briefing 
was low in the psychological complaints group. The correlations between mean NA and the 
EQ VAS were low for the population based sample. When EQ VAS at debriefing was 
predicted by momentary experiences (and corrected for group differences, age, sex and EQ 
VAS at briefing) without taking into account the interaction effects between momentary 
experiences and sample, it was found that only PS (α<.05) and NA (α<.10) were significant 
predictors of EQ VAS (Table 5). If the interaction terms were added to the model, only the 
relationship between NA and EQ VAS in the somatic complaints group was significant (Table 
5). This means that NA is a stronger predictor of EQ VAS among persons with somatic 
complaints than in the other samples.  
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Table 5. Variance in EQ VAS explained by positive affect, negative affect and physical 
symptoms (model 1) and their interaction with group represented in three dummy variables 
(model 2). 
 Model 1  Model 2  
N=139 β P-value β P-value
Dummy 1 (Psychological) -0.023 .839 -0.086 .514
Dummy 2 (Tinnitus) 0.216 .130 -0.051 .750
Dummy 3 (Somatic) -0.156 .245 -0.381 .007
Age -0.072 .522 -0.014 .898
Sex -0.128 .162 -0.090 .315
EQ VAS -0.092 .520 -0.193 .191
Positive affect -0.088 .561 0.111 .785
Negative affect -0.247 .076 0.099 .832
Physical symptoms -0.359 .008 0.212 .691
Momentary HRQOL -0.041 .823 0.302 .521
Dummy 1 * Positive affect -0.045 .863
Dummy 2 * Positive affect -0.090 .731
Dummy 3 * Positive affect -0.220 .328
Dummy 1 * Negative affect -0.038 .903
Dummy 2 * Negative affect -0.086 .770
Dummy 3 * Negative affect -0.552 .013
Dummy 1 * Physical symptoms -0.080 .691
Dummy 2 * Physical symptoms -0.099 .774
Dummy 3 * Physical symptoms -0.376 .201
Dummy 1 * Momentary HRQOL 0.001 .996
Dummy 2 * Momentary HRQOL 0.025 .928
Dummy 3 * Momentary HRQOL -0.217 0.327
Explained variance   
 R2 0.197 0.370  
 Adjusted R2 0.134 0.269  
HRQOL=health-related quality of life 
Dummy 1: 1=Psychological complaint sample, 0=Tinnitus sample, 0=Somatic complaints 
sample. Dummy 2: 1=Tinnitus sample, 0= Psychological complaint sample, 0=Somatic 
complaints sample. Dummy 3: 1=Somatic complaints sample, 0=Tinnitus sample, 
0=Psychological complaint sample. Reference group = general population sample.  
 
 
Discussion 
This article reports on what is, to our knowledge, the first study that uses the ESM to obtain 
accounts of the momentary experience of HRQOL and compare these with measures used to 
calculate QALYs. The results for each research question will be discussed in the next 
paragraphs.  
 
In answering the first research question regarding the feasibility of using the ESM approach to 
obtain accounts of momentary experience of HRQOL, two things need to be considered: the 
overall participation rate and the response rate in the persons that agreed to participate. The 
overall participation rate was low in the patient groups, especially in the tinnitus population 
and the atherosclerosis/venous insufficiency group. The most common reason for not wanting 
to participate was that people were not interested in the study objective, which was measuring 
quality of life in daily life instead of retrospectively and thus not a particular problem for the 
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methodology. It was an observational study and therefore not part of any treatment that could 
be of interest to the patients. More research has to be done to learn more about the feasibility 
of using the ESM to obtain accounts of the momentary experience of HRQOL as part of a 
randomized controlled trial. Another common reason for not participating was ‘too 
burdensome’, which is related to the method. The low participation rate in the tinnitus 
population was probably a result of the fact they had just completed a 12-month RCT in 
which they had to answer a substantial amount of questionnaires. For the 
atherosclerosis/venous insufficiency group the higher mean age of the group could be an 
explanation for the low participation rate. Although it was clearly stated in the information 
letter that the PsyMate is a user-friendly device, a lack of experience with these electronic 
devices (Olson et al., 2011) could deter older participants. Furthermore, part of the group that 
was approached just underwent an intensive (clinical) rehabilitation programme because of a 
leg amputation. With regard to the response rate to the data collected during the study all 
participants that finished the briefing also finished the ESM week and the debriefing (with the 
exception of only 1 participant). The participants on average answered to 72% of the beeps, 
which is comparable to other studies (Knouse et al., 2008; Roelofs et al., 2004; Thewissen et 
al., 2008). The fact that beeps are missing is not problematic for the statistical analysis, since 
the major advantages of the ESM is that it collects several data points for each respondent. 
Therefore the respondent can miss about two third of the beeps without being excluded from 
the analyses. Furthermore the majority of the participants reported the week was 
representative of a typical week in and that the PsyMate did not influence their health or 
mood. In this respect, feasibility is more than satisfactory. We can conclude that the low 
participation rate in this study might be the result of a motivational problem related to not 
knowing what to expect from the ESM. 
 
With regard to the second research question we can conclude that there is some variability 
from moment to moment in momentary HRQOL. This indicates that people take different 
things into consideration when making a momentary assessment of their HRQOL during the 
day. A significant within-person relation between mean momentary experienced HRQOL and 
the variability from moment to moment was found: the lower mean momentary HRQOL, the 
more variability during the ESM week. This could be a result of a ceiling effect on 
momentary HRQOL. To explore whether this was the case, we computed the SD for 
participants with a ceiling effect on momentary HRQOL (>90), and the correlations between 
mean and SD. The results show that the SD was 1.1, and the correlations were equal in the 
four groups (tested with a fisher z-transformation; χ2=6.93). These findings suggest that a 
ceiling effect only has a limited effect on the data. Moreover, the findings are in line with 
other research that found more variability in patients with worse mood levels (higher on NA 
and lower on PA) (Hedeker et al., 2012). With regard to this research question, there is at 
least one possible drawback of the study. Momentary assessment of experienced HRQOL was 
one of the last questions in the beep questionnaire. The reason for this is that feelings can be 
influenced by preceding questions and therefore have to be measured first after the beep. 
Because of this it could be that the variability found in momentary experienced HRQOL is the 
result of a framing effect. Further research should focus on the question whether the 
variability found in momentary experienced HRQOL reflects real differences in experienced 
health. Also order effects of the different questions in the ESM could be investigated.  
 
The third research question focused on the relation between momentary HRQOL and feelings 
and symptoms during the same period. The analyses showed that PA, PS (α<.05) and NA 
(α<.10) are significant predictors of momentary HRQOL. This means that momentary specific 
feelings and symptoms predict the momentary valuation of HRQOL. In addition it was found 
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that these relations are  stronger among those with psychological complaints (PA, PS and NA) 
and tinnitus (PA and PS), than among persons with somatic complaints and the population 
based sample. This may imply that persons who experience psychological complaints and 
tinnitus rely more on the momentary experience of feelings and symptoms, when valuing their 
global momentary HRQOL than persons in the other samples. Recent literature has stressed 
the conceptual differences between momentary and global assessment (Tay et al., in press). 
Momentary reports reflect current affective or physical states, whereas global assessment is 
based upon some self-reflection processes like introspection and self-observation. In other 
words, global assessments of HRQOL rely more on general beliefs, whereas momentary 
reports rely on experience (Schwarz et al., 2009). Perhaps, in the psychological complaints 
and tinnitus sample a global concept like momentary HRQOL is influenced more by 
experience, while in persons with somatic complaints and the population based sample the 
momentary valuation of HRQOL may be more linked to general beliefs. Further research 
should focus on whether groups differ with regard to specific valuation strategies used to 
value momentary HRQOL, for instance by using a follow-up question directly after the 
valuation task.  
 
In the fourth research question the relations between a retrospective global measure of 
HRQOL (EQ VAS) and the moment-to-moment valuation of HRQOL, and experience of 
feelings and symptoms, were examined. High correlations were found between the EQ VAS 
and momentary HRQOL. This finding was expected since the framing of the questions was 
similar in both methods. The multiple regression model that was fitted to the data revealed 
that if the interaction terms were added to model, none of the momentary feelings and 
symptoms were significant predictors of EQ VAS. Also, momentary experienced HRQOL 
was not a significant predictor of EQ VAS. This supports earlier findings that global reports 
of past health will rely more on beliefs (semantic memory) than on specific feelings and 
symptoms (Kahneman et al., 2004; Robinson & Clore, 2002; Stone et al., 2006). However, 
NA was a stronger predictor of EQ VAS among persons with somatic complaints than in the 
other samples. This may suggest that somatic complaints are more associated with a 
retrospective global valuation of HRQOL, such as EQ VAS, than psychological and tinnitus 
complaints. Perhaps somatic complaints are more related to semantic memory and 
psychological and tinnitus complaints are more related to episodic memory. This highlights 
the problem that global measures do not reflect the actual impact of health problems, 
particularly in populations with psychological or tinnitus complaints. More research is 
necessary to examine this finding.  
 
In this paper we only focused on momentary HRQOL and feelings and symptoms. However, 
ESM data also hold information on contextual items that could look more in detail at the 
different dimensions of health in the retrospective questionnaires. For instance, is the mobility 
dimension as measured by the EQ-5D reflected by the different locations a person is at during 
the day as measured by the ESM. These questions are beyond the scope of this paper, but 
need to be considered in future papers. Although this paper focuses on the patient perspective, 
the ESM could also have added value when a societal perspective is adopted. From a societal 
perspective health state values need to be obtained in the general public. The ESM could be 
useful in describing a health state since it may be more able to capture what is important to a 
patient in terms of health and HRQOL than a retrospective descriptive system like the EQ-5D. 
Future research should focus on how the ESM data can be used to inform members of the 
general public on different health states so the valuation of a health state may become more 
accurate.  
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We can conclude that the use of the ESM to measure accounts of the momentary experience 
of health in different populations is feasible. The results showed that within persons the 
valuation of global HRQOL and specific feelings and symptoms are variable from moment to 
moment. Also, the relation between momentary specific feelings and symptoms and the 
momentary valuation of HRQOL differed among populations. A global retrospective 
valuation of HRQOL was not predicted by momentary feelings, symptoms and HRQOL. This 
highlights that retrospective measures may provide a biased account of the impact of health 
problems in the daily lives of people who are affected. Moreover, the bias may be different in 
different conditions. 
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APPENDIX A 
 
I am feeling        
 Not   Moderate   Very 
1. Cheerful 1 2 3 4 5 6 7 
2. Insecure 1 2 3 4 5 6 7 
3. Relaxed 1 2 3 4 5 6 7 
4. Anxious 1 2 3 4 5 6 7 
5. Enthusiastic  1 2 3 4 5 6 7 
6. Satisfied 1 2 3 4 5 6 7 
7. Sad 1 2 3 4 5 6 7 
8. Happy 1 2 3 4 5 6 7 
        
9. Tired 1 2 3 4 5 6 7 
10. Sick 1 2 3 4 5 6 7 
        
I am/have 
 Not   Moderate   Very 
11. Hungry 1 2 3 4 5 6 7 
12. Pain 1 2 3 4 5 6 7 
13. Tinnitus 1 2 3 4 5 6 7 
        
14. Overall I am feeling good 1 2 3 4 5 6 7 
        
15. What am I doing (right before the beep)? 
Answering categories: Relaxing/Active; Relaxing Passive; Nothing; Work/Study; 
Household; Talking; Self-care; Care for others; Medical care;  Eating/Drinking; In transit; 
Other 
 
16. Where am I?  
Answering categories: at home; at work; at someone else’s home; public place; healthcare 
setting; outside; other 
 
17. Who am I with (including telephone contacts, chatting etc.)? 
Answering categories: partner; people living at home; family living somewhere else; friends; 
colleagues; acquaintances; unknown others; nobody (3 possibilities) 
 
18. Number of people you are with? (Answering categories: 1-6 />6) 
        
 Not   Moderate   Very 
19. This company is pleasant 1 2 3 4 5 6 7 
20. I would rather be alone 1 2 3 4 5 6 7 
21. We are doing something 
together   
1 2 3 4 5 6 7 
        
When alone:        
22. I like being alone 1 2 3 4 5 6 7 
23. I would rather be in company 1 2 3 4 5 6 7 
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24. My health state right now is: 
(Please mark an X on the line that shows how good or bad your health is at this moment): 
 
       
Worst       Best  
imaginable      imaginable 
health state 0                               50   100 health state 
       
 
Think about the most important event that happened since the last beep. 
This was: 
25. Very unpleasant -3 -2 -1 0 1 2 3 Very pleasant 
26. Very unimportant -3 -2 -1 0 1 2 3 Very important
 
27. This event was something: 
That happened to me; something I had an influence on; Something regular / routine; a feeling 
or thought; other 
 
29. This was the result of: 
Contact with others; The surroundings; own condition; activity; new information; other 
 
30. This beep disturbed me: Yes No 
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Abstract 
Objectives The aim of this study is to explore whether emotions, activities and social 
interactions in daily life of patients with tinnitus are different from a population based sample. 
Furthermore, the association between effects of tinnitus severity and the level of positive 
affect, negative affect, physical complaints, activity and social interactions in daily life is 
examined.  
Methods Forty patients with tinnitus and forty persons from a population based sample were 
studied with the Experience Sampling Method (ESM). ESM is a structured diary technique in 
which participants are prompted with a beep (and vibrations) to complete assessments of their 
current emotions, physical complaints and contextual items at random times during the day.  
Results Multilevel regression analysis confirmed a significant difference between the 
samples with regard to positive affect, negative affect and physical symptoms, but not with 
regard to activities or social interactions. When tinnitus intensity is experienced as more 
severe, there is a concomitant increase in pain and fatigue. In addition, more severe tinnitus is 
accompanied by more negative and less positive mood. 
Conclusion Tinnitus has a major impact on daily life. Patients suffering from tinnitus 
experience more emotional and physical complaints than a population based sample, and with 
increasing tinnitus severity there is a worsening of  these complaints.  
 
Keywords Tinnitus, Experience Sampling Method, Negative affect, Positive affect, Physical 
symptoms 
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Introduction 
Tinnitus is often described as an auditory phantom sound, a sound in the ear or in the head 
without the presence of an external source. The prevalence of tinnitus in the western world is 
estimated between 10-20% (Andersson, 2002; Davis & El Refaie, 2000) and approximately 3-
5% of the general population is severely impaired by the tinnitus (Davis & El Refaie, 2000; 
Vesterager, 1997).Patients often report cognitive impairments (problems with attention and 
concentration) and negative emotions (anxiety and depressive symptoms) (El Refaie et al., 
2004; Hallam et al., 2004). In most cases tinnitus is a subjective experience for which there is 
no detectable organic cause. But some somatic conditions can cause objective tinnitus (e.g. a 
vestibular schwannoma, cholesteotoma or temporal bone trauma (Newman et al., 2011)). It is 
important to rule out these conditions as they can be life threatening and treatment may 
eliminate the tinnitus. Tinnitus without a known organic cause cannot be eliminated. In this 
situation most treatments focus on eliminating the subject’s reactions induced by the tinnitus 
(Henry et al., 2005; Jastreboff & Jastreboff, 2006; Martinez-Devesa et al., 2010). Some 
treatments are based on Jastreboff’s neurophysiological model of tinnitus, an integral heuristic 
(Jastreboff et al., 1996). In this model emotional reactions such as anxiety, depression and 
cognitive problems as concentration, are the result of an inappropriate activation of the limbic 
and sympathetic part of the autonomic nervous system (Jastreboff et al., 1996; Jastreboff & 
Jastreboff, 2006; Zenner & Zalaman, 2004). Other treatments are based on cognitive 
behavioral therapy. They assume that faulty thought patterns (cognitions) about the tinnitus 
cause maladaptive behavior and emotional responses that maintain or contribute to tinnitus-
related problems (Cima et al., 2012; El Refaie et al., 2004; Gudex et al., 2009; Hesser et al., 
2011; Martinez-Devesa et al., 2010).  
Several studies have confirmed that tinnitus annoyance correlates closely with a patients 
degree of anxiety, depression and sleep disturbance (Erlandsson et al., 1991; Folmer et al., 
2001; Langenbach, 2005; Zoger et al., 2006). Anxiety and depression scores were elevated in 
tinnitus patients, compared to healthy controls or non-help seeking tinnitus sufferers (Attias et 
al., 1995; Scott & Lindberg, 2000). Also, patients with tinnitus display increased somatic 
attention and somatisation (Hiller et al., 1994; Hiller et al., 1997; Newman et al., 1997). They 
often experience social withdrawal and seem reluctant to participate in "normal" interpersonal 
contacts of day-to-day life (Davis & El Refaie, 2000; Folmer et al., 1999; Hiller & Haerkotter, 
2005; Newman et al., 2011). Interference with other daily activities such as self-care 
activities, occupational activities and leisure time activities has been demonstrated as well 
(Cima et al., 2011).  
Most studies on the influence of tinnitus on daily life were conducted using self-report 
questionnaires. These rely on retrospective assessment of past experiences. Several studies 
have shown that recalled information is prone to bias (see Robinson & Clore, 2002). The 
Experience Sampling Method (ESM) was designed to reduce the influence of biases due to 
less than perfect recollection. It contains a measure of hedonic and affective experience 
derived from immediate reports of current subjective experience. Moreover, ESM enables to 
not only assess associations between the tinnitus experience and emotional and physical 
complaints across individuals, but also within a single individual. This yields information 
regarding the question whether fluctuations in tinnitus severity are related to emotional, social 
and behavioral interference. Furthermore time-lag analyses can be used to determine the 
prospective and bi-directional relation between symptoms of tinnitus and emotional, social 
and behavioral precursors or consequences.   
The ESM has some potential limitations. It can be time consuming and potentially 
burdensome to participants and therefore it is important to minimize the length of the 
questionnaires. Furthermore, ESM could evoke ‘reactivity’, which means that the experience 
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being measured is changed by the fact that it is measured. Reactivity can be minimized by 
framing questions as neutral as possible (Conner et al., 2009).  
The objective of this study is to explore differences in emotions, activities and social 
interactions in daily life of patients with tinnitus and a population based sample. It was 
expected that patients with tinnitus report higher levels of negative affect and lower levels of 
positive affect. Also, it was expected that patients with tinnitus report more physical 
complaints, experience more social withdrawal and are less active than a population based 
sample. Within patients with tinnitus the association between effects of tinnitus intensity and 
the level of positive affect, negative affect, physical complaints, activity and social 
interactions in daily life is examined. It is expected that there is a significant relation between 
the intensity of tinnitus and positive affect, negative affect, physical complaints, activity level 
and social interactions. Time-lag analysis will be used to determine whether tinnitus intensity 
at one moment predicts positive affect, negative affect, physical complaints, activity level and 
social interactions at the next moment and/or whether increases in positive affect, negative 
affect, physical complaints, activity level and social interactions precede increases in tinnitus 
intensity.  
 
Methods 
Participants 
Forty patients with tinnitus and a population based sample of 40 persons were included in this 
study. The patients with tinnitus were recruited from a completed randomized controlled trial 
investigating a multidisciplinary treatment for tinnitus versus care as usual (Cima et al., 2009; 
Cima et al., 2012). Inclusion criteria were (a) referral to an audiological centre because of 
tinnitus complaints, and (b) being 18 years or older. Exclusion criteria were (a) an organic 
cause of tinnitus, (b) not able to read in Dutch, and (c) not able to handle the ESM device 
because of impaired motor skills. Of the 325 patients that received the study information, 45 
were willing to participate in this study and returned a written informed consent. Of these 45 
patients, four did not come to the briefing or cancelled their participation before the briefing. 
One patient was not able to read the text on the ESM device because the font size was too 
small. The population based sample was recruited through advertisements/posters in the 
Maastricht University Hospital. Forty-four persons responded to this poster and received the 
study information. Forty participants returned the written informed consent. All 80 
participants that finished the briefing, completed the ESM week. Participants received €25 
remuneration for their full participation. The Ethics Committee of the Maastricht University 
Hospital approved the study protocol.        
 
Measures 
Experience Sampling Method 
ESM studies are usually performed with a digitized wrist watch or pager and a pocket sized 
question booklet, PDA’s or smart phones. In this study we used the PsyMate 
(www.psymate.eu), a small user-friendly device programmed to generate beeps (and 
vibrations) at unpredictable moments of the day between 7.30h and 22.30h over 6 consecutive 
days. Subjects use a touch screen to fill out the questions and response-logs were time- and 
date-stamped. Data captured from the PsyMate were transferred to a PC where software 
turned data into STATA data files.  
Current tinnitus intensity was assessed with the item ‘Right now, I experience tinnitus’, rated 
on 7-point Likert scales from 1=’not at all’ to 7=’very much’. Other current physical 
symptoms were assessed using ratings on pain, tiredness and feeling sick. Current positive 
affect was assessed using ratings on the items cheerful, relaxed, enthusiastic, satisfied, 
energetic and happy. Current negative affect was assessed by means of the items insecure, 
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anxious, lonely, down, and irritated. All items were rated on the same 7-point Likert scale. 
Positive and negative affect were determined by calculating the mean of the relevant items. 
For assessing their current actual activity, participants could choose from 10 different 
descriptive categories or the category “other” in case none of the categories was suitable (see 
Figure 1). Current perceived activity level was measured with the item ‘I find myself active’ 
also on the same 7-point Likert scale. Current social interactions were assessed by choosing 
from 8 different descriptive categories (see Figure 2).  
 
Retrospective measures 
The Hospital Anxiety and Depression Scale (HADS) was administered in the total sample to 
measure severity of anxiety and depressive complaints (Spinhoven et al., 1997). Tinnitus 
burden and severity was assessed in the patient group with the Tinnitus Questionnaire (TQ). 
The Dutch validated TQ (Meeus et al., 2007) was administered during the follow-up of the 
RCT from which the patients of the present study were recruited. At the beginning of this 
RCT a mean pure tone threshold at 1, 2 and 4 kilohertz was determined.   
 
Procedure 
Before the start of the ESM week participants were carefully instructed during an individual  
briefing session. The rationale of the study was explained and subjects were instructed how to 
use the PsyMate. Anticipated problems were discussed and the questionnaires on the device 
were reviewed during a simulated try-out sampling moment.  
 
Data analysis 
A multilevel (or hierarchical) regression analysis is ideally suited for data obtained with the 
ESM since beep level data (level 1) are nested within persons (level 2). In multilevel analysis 
a curve is fitted for the dependent variable for each participant, thereby taking into account 
the fact that beep-level measures of within patients measures tend to be more alike than 
randomly chosen beep level measurement. The odds ratio (for dichotomous variables) and B’s 
(for continuous variables) reflect the association between the independent and dependent 
variables in the multilevel model. All analyses involving the ESM data were therefore 
computed with the XTMIXED (for continuous variables) and XTMELOGIT (for 
dichotomous variables) modules of STATA 11.0. 
To explore whether patients with tinnitus differed from the population based sample in overall 
symptom level, multilevel regression analyses were conducted using group (0=population 
based sample, 1=tinnitus sample) as the independent variable, and using negative and positive 
affect items and physical complaint items as dependent variables in consecutive models. To 
examine whether there were differences between patients and the population based sample, 
perceived activity level, actual activity level (dichotomized as: 0=doing nothing or passive 
relaxing; 1= any other activity) and social interactions (0=alone; 1=not alone) were assessed 
as dependent variables in the multilevel regression analyses and group as independent 
variable. Since differences between the samples in age, sex, hearing loss (as measured by 
having a hearing aid or not) and having a paid job could influence the relations under 
investigation, all analyses were corrected for these variables.  
 
To examine whether tinnitus intensity was associated with positive affect, negative affect, 
physical symptoms, perceived activity level, actual activity level and social interactions in 
patients with tinnitus, a multilevel random regression model was estimated with tinnitus 
intensity as the dependent variable and the other variables as independent variables. To 
correct for hearing loss, the mean pure tone threshold at 1, 2 and 4 kilohertz was included in 
the analysis as a covariate. A stepwise procedure was used to add variables to the model. If 
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there was a significant change in the model, the variable was included in the model. If there 
was no significant change the variable was excluded. Each model change was tested for 
significance using a likelihood ratio test with ‘k’ degrees of freedom (k=the difference in 
number of parameters between 2 successive models).  
 
To determine the extent to which positive affect, negative affect, physical symptoms, activity 
level and social interactions at one moment (t-1) predicted tinnitus at the next moment (t), 
between 20 and 120 minutes later on the same day, a time-lag function was determined for all 
the relevant variables. The first beep of each day was removed from the data, to minimize the 
interval between two subsequent beeps. If one beep was not responded to, then the consequent 
data in the next beep was removed from the analysis. As a result 445 beep measurements 
were removed from the analysis. A model was fitted to the remaining data (N=1310) with 
tinnitus as the dependent variable. Both positive affect, negative affect, physical symptoms, 
activity level and social interactions (t), as their time-lagged variants (t-1) were included into 
the model following a stepwise procedure. Since it is expected that tinnitus intensity at one 
moment also has an effect on tinnitus intensity at the next moment, the analysis were 
corrected for this so called autoregressive effect. A time-lag function for tinnitus intensity (t-
1) was therefore included in the analysis as a covariate. The analysis were also corrected for 
hearing loss by including the mean pure tone threshold at 1, 2 and 4 kilohertz as a covariate. 
Each model change was tested for significance using a likelihood ratio test with ‘k’ degrees of 
freedom (k=the difference in number of parameters between 2 successive models).  
To examine if tinnitus intensity at one moment (t-1) predicted positive affect, negative affect, 
pain, tiredness, feeling sick, (actual and perceived) activity level and social interactions at the 
following moment (t) (dependent variables). Separate linear multilevel models were estimated 
with positive affect, negative affect, several physical symptoms, activity level or social 
interactions as the dependent variable and tinnitus intensity at t and t-1 as independent 
variables. These models were corrected for an autoregressive effect of the dependent variables 
by including a time-lag function of these variables into the analysis. The independent 
variables were included in the models following a stepwise procedure. Each model change 
was tested for significance using a likelihood ratio test with ‘k’ degrees of freedom (k=the 
difference in number of parameters between two successive models).  
 
Results 
With regard to the tinnitus sample, differences between the group of patients that received the 
study information and those that were willing to participate are displayed in Table 1. There 
were no significant differences with regard to age, sex and education, but the TQ score was 
significantly higher in the patients that were willing to participate. Demographic 
characteristics of the tinnitus and the population based sample are summarized in Table 2. 
There were significant differences between the patients with tinnitus and the population based 
sample with regard to all demographic variables. In addition, the score on the HADS was 
significantly higher in the tinnitus sample. Patients with tinnitus on average responded to 42 
beeps, with a minimum of 25 and a maximum of 55. The participants in the population based 
sample on average responded to 44 beeps, with a minimum of 17 and maximum of 59. In total 
71.3% of the beeps were completed; 69.5% in the population based sample and 73.2% in the 
tinnitus population.  
Overall, patients with tinnitus reported significantly lower levels of positive affect and higher 
levels of negative affect than participants from the population based sample (Table 3). 
Positive affect items that were significantly different between both groups were feeling 
cheerful (B=-0.89, P=0.02), relaxed (B=-1.07, P=0.00), satisfied (B=-1.00; P=0.00) and 
energetic (B=-0.98; P=0.025). Negative affect items that were significantly different between  
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Table 1. Demographic characteristics of patients with tinnitus who were willing to 
participate and patients with tinnitus who were not willing to participate in this study 
based on data collected during a completed randomized controlled trial  
Characteristics Included in 
this study 
Not willing to 
participate / 
drop-out  
P-value*
N 40 285 
Age (SD) 56.0 (11.4) 54.0 (11.9) .291
Sex (% male) 29 (72.5) 171 (60.0) .128
Mean PTT at 1, 2 & 4 kHz (in decibel) 34.6 (19.7) 31.1 (18.0) .309
Education (%)  .570
Low 14 (35.0) 82 (28.8) 
Middle 14 (35.0) 124 (43.5) 
High 12 (30.0) 79 (27.7) 
Available data at end of trial  
     N (% missing data) 35 (12.5) 196 (31.2) 
     TQ score (SD) 46.2 (20.5) 37.4 (19.4) .023
* Independent samples t-test for continuous variables and χ2 for categorical variables 
SD=Standard Deviation ; TQ=Tinnitus Questionnair; PTT=Pure Tone Treshold; kHz=kilohertz  
 
 
Table 2. Demographic characteristics of the participants in this study 
Characteristics Population based 
sample
Tinnitus  
sample  
P-value*
N 40 40 
Age (SD) 38.6 (14.6) 58.2 (10.0) .000
Sex (% male) 11 (27.5) 29 (72.5) .000
Paid job / student (% yes) 38 (95.0) 23 (57.5) .000
Living situation (% alone) 13 (32.5) 4 (10.0) .014
Education (%)  .002
Low 4 (10.0) 14 (35.0) 
Middle 9 (22.5) 14 (35.0) 
High 27 (67.5) 12 (30.0) 
HADS score 12.1 (4.0) 16.9 (6.7) .000
Hearing aid (% yes) 1 (2.5) 20 (50.0) .000
SD = Standard Deviation; HADS = Hospital Anxiety and Depression Scale 
* Independent samples t-test for continuous variables and χ2 for categorical variables 
 
 
groups were feeling insecure (B=0.98; P=0.03) and anxious (B=0.71; P=0.07). With regard to 
physical complaints, patients with tinnitus reported, as expected, significantly more tinnitus 
but also more pain than participants from the population based sample (Table 3). They also 
reported being more tired and sick (Table 3).  
Figure 1 shows that there was a significant difference between the groups in the type of 
activity they were involved in (χ2=168; p<.000). Participants from the population based 
sample more often indicated to be working/studying at the time of the beep compared to 
tinnitus patients, while patients with tinnitus more often indicated to be doing nothing 
(standardized residuals>1.96). However, there were no significant differences in the perceived 
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activity level and the dichotomized actual activity level between the two groups. The 
difference in actual activity level was mostly predicted by having a job or not (Odds 
ratio=1.526). There was no difference between patients with tinnitus and the population based 
sample in the number of beeps spent alone or in the company of another person. Figure 2 
displays that there is a difference between the groups in the type of relationship with the 
persons with whom participants interacted (χ2=274; p<.000). Patients more often indicated to 
be with their partner and less with colleagues, residents and strangers (standardized 
residuals>1.96).  
 
Figure 1. Pie charts representing the percentage of beeps participants registered one of the 
possible activities 
 
 
Figure 2. Pie charts representing the percentage of beeps participants registered one of the 
possible categories of whom they interacted with 
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First, a cross-sectional model based on all beep measurements was tested to determine the 
extent to which positive affect, negative affect, physical symptoms, activity level and social 
interactions at one moment (t-1) predicted tinnitus at the next moment (t) (Table 4). In the 
intercept only model, 67.8% of the variance in tinnitus intensity was explained by between 
person differences and 32.2% by within person differences. In the final model there was a 
significant cross-sectional relation between tinnitus intensity, positive affect, pain and 
tiredness. In this model, 65.8% of the variance was explained by between person differences 
and 34.2% by within person differences. Second, a prospective model was tested to determine 
if positive affect, negative affect, physical symptoms, activity level and social interactions (t-
1) was related to subsequent tinnitus (t) by including the time-lagged functions of these 
variables in the model (Table 4). In the intercept only model, 68.3% of the variance in tinnitus 
intensity was explained by between person difference and 31.7% of the variance by within 
person differences. In the final model there was a significant positive prospective relation 
between tinnitus intensity and negative affect and pain. There was a significant negative 
prospective relation between tinnitus intensity and time-lagged positive affect and pain (t-1). 
These analyses were corrected for an autoregressive effect of tinnitus. In the final model, 
49.1% of the variance in tinnitus intensity was explained by between person differences and 
50.9% by within person differences.  
 
 
Table 4. Variance in tinnitus explained by positive affect, negative affect and pain at one 
moment (t) and at the previous moment (t-1). 
 Model 1 (intercept only) Final model 
N=1755 Estimate SE P-value Estimate SE P-value
Intercept 5.370 0.22 .000 4.777 0.437 .000
Mean PTT at 1,2 and 4 kHz 0.024 .010 .016
Positive affect    -0.130 .028 .000
Negative affect 0.069 .036 .057
Pain 0.061 .019 .002
Tiredness 0.032 .014 .022
Variance Random Random  
 Person level 1.39 1.25  
 Beep level 0.66 0.65  
Model fit -1859.44 -1837.90  
   
 Model 1 (intercept only) Final model 
N=1310 Estimate SE P-value Estimate SE P-
Value
Intercept 5.376 0.223 .000 2.104 0.252 .000
Mean PTT at 1,2 and 4 kHz 0.011 0.004 .012
Positive affect -0.087 0.027 .001
Negative affect 0.081 0.034 .018
Lag Tinnitus (t-1) 0.587 0.022 .000
Pain 0.094 0.025 .000
Lag Pain (t-1) -0.089 0.025 .000
Variance Random Random  
 Person level 1.40 0.52  
 Beep level 0.65 0.54  
Model fit -1404.99 -1141.28  
PTT=Pure Tone Threshold; kHz=kilohertz; SE=Standard Error 
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Third, several prospective models were tested to determine if there was a relation between 
tinnitus (t-1) and subsequent positive affect, negative affect, physical symptoms, activity level 
and social interactions (t). With regard to positive affect, there was a significant negative 
association with tinnitus intensity and negative affect and a significant positive association 
with time lagged tinnitus intensity (t-1) (Table 5). This analysis was controlled for an 
autoregressive effect of positive affect by including a time-lagged variable of positive affect 
in the analysis. In the model with pain as dependent variable there was a significant positive 
association between tinnitus and pain and a significant negative association between time-
lagged tinnitus (t-1) and pain (Table 5). For negative affect, there was only a significant 
association with tinnitus and positive affect at the same moment after controlling for an 
autoregressive effect of negative affect. There was no prospective association between 
tinnitus intensity (t-1) and subsequent negative affect (t) (Table 5). No significant effects were 
found between between tinnitus (t-1) and subsequent tiredness, feeling sick, activity level or 
social interactions (t). 
 
Discussion 
This study reports on the effects of tinnitus on daily life as measured with the ESM. The first 
part of the study focuses on differences between patients with tinnitus and a general 
population sample. As expected, patients with tinnitus experienced significantly higher levels 
of negative affect and physical complaints and lower levels of positive affect. Compared to 
subjects from a general population sample, patients with tinnitus felt more anxious and 
insecure and less cheerful, energetic, relaxed and satisfied. These findings are in line with 
other studies that found elevated anxiety and depression scores on retrospective measures in 
patients with tinnitus compared to healthy controls or non-help seeking tinnitus sufferers 
(Attias et al., 1995; Scott & Lindberg, 2000; Stouffer & Tyler, 1990). The difference in 
reported physical complaints was also expected and could be the result of the increased 
somatic attention and somatisation in patients with tinnitus which is described in several 
studies (Hiller et al., 1994; Hiller et al., 1997; Newman et al., 1997). There was a difference 
between patients with tinnitus and the general population sample in the type of activity they 
were involved in. Participants from the general population sample more often indicated to be 
at work, whereas patients with tinnitus more often indicated doing nothing. This difference 
was especially the result of differences between both samples with regard to having a paid job 
or not. There were no differences between patients with tinnitus and the general population 
sample in perceived activity level and actual activity level as measured in daily life. This was 
not in line with our expectations, since another study reported that tinnitus patients experience 
difficulties in daily life activities (Cima et al., 2011). Because patients had to choose their 
actual activity from relatively broad categories there is no exact information on what 
participants were actually doing, or on the intensity or effortfulness of these activities. 
Moreover, perceived activity level could reflect the effort that a certain activity poses for an 
individual. For example, an activity that is rated as low on intensity by a healthy person could 
be rated as high on intensity by a patient since the activity is more challenging and therefore 
costing more energy. In future research an actometer could be used to measure the difference 
in objective activity level between patients with tinnitus and a non-tinnitus control group. 
With regard to the social interactions no differences were measured between patients with 
tinnitus and the general population sample in being alone or not. Other studies have shown 
that patients with tinnitus experience social withdrawal (Folmer et al., 1999; Hiller & 
Haerkotter, 2005), but this was not confirmed by the present study. However, the results show 
that patients with tinnitus more often indicated to be with their partner and less often with 
colleagues and strangers. The difference in time spent with colleagues is probably explained 
by the fact that there were more participants with a paid job in the general population sample.  
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Table 5. Variance in positive affect and pain explained by tinnitus at one moment (t) and 
at the previous moment (t-1). 
 Positive affect (dependent variable) 
 Model 1 (intercept only) Final model 
N=1310 Estimate SE P-value Estimate SE P-value
Intercept 5.370 0.218 .000 3.416 0.205 .000
Tinnitus -0.086 0.025 .000
Lag Tinnitus (t-1)    0.056 0.025 .024
Lag Positive affect  (t-1) 0.434 0.023 .000
Negative affect -0.353 0.029 .000
Variance Random Random  
 Person level 1.377 .565  
 Beep level 0.576 .485  
Model fit -1240.56 -997.13  
  
 Negative affect (dependent variable) 
 Model 1 (intercept only) Final model 
N=1310 Estimate SE P-value Estimate SE P-value
Intercept 1.659 0.164 .000 2.082 0.170 .000
Tinnitus 0.043 0.017 .013
Lag Negative affect (t-1) 0.033 0.026 .000
Positive affect -0.253 0.020 .000
Variance Random Random  
Person level 1.032 .494  
Beep level .0464 .413  
Model fit -954.35 -787.07  
  
 Pain (dependent variable) 
 Model 1 (intercept only) Final model 
N=1310 Estimate SE P-value Estimate SE P-value
Intercept 2.336 0.231 .000 0.229 0.141 .105
Tinnitus 0.115 0.030 .000
Lag Pain (t-1) 0.742 0.019 .000
Lag Tinnitus (t-1) -0.089 0.030 .000
Negative affect 0.136 0.031 .000
Variance  
 Person level 1.456 0.318  
 Beep level 0.814 0.606  
Model fit -1681.76 -1259.96  
SE=Standard error  
 
 
The difference in time spent with strangers could indicate there is less outgoing behavior in 
patients with tinnitus. In this study no data is available on the intensity of the interactions. It 
could be that although patients with tinnitus are spending time with other people, they remain 
in the background and do not actually interact with others. Future research could include more 
specific questions on the intensity of the social interactions.  
The second part of the study focuses on the relations between severity of tinnitus and mood, 
physical symptoms, activity level and social interactions in patients with tinnitus. The results 
                                          TINNITUS IN DAILY LIFE                         
115 
 
show that at moments when tinnitus intensity is experienced as more severe, there is a 
concomitant increase in other physical symptoms, i.e. pain and fatigue. In addition, more 
severe tinnitus is accompanied by more negative and less positive mood. No differences were 
found in activity level or social interaction as a function of tinnitus intensity. The time-lagged 
analyses indicate that pain has a positive association with tinnitus at the same moment, but a 
negative association with tinnitus at the following moment. This means that the effect of pain 
on tinnitus decreases over time which could be an indication of habituation to pain. There was 
also a reversed temporary effect of tinnitus intensity on subsequent pain and positive affect. 
That is, there is a positive relation between tinnitus intensity and pain at the same moment, 
but a negative relation between tinnitus intensity and pain the following moment. With regard 
to positive affect, there was a negative relation between tinnitus intensity and  positive affect 
at the same moment, but a negative relation between tinnitus intensity and positive affect at 
the following moment. Thus, the negative effect of tinnitus on pain and positive affect 
decreases over time, thereby indicating habituation to the tinnitus.  
Together these findings suggest that there is no predictive relationship between tinnitus 
intensity, mood and pain. In contrast, the results indicate that there is some habituation to both 
pain and tinnitus. It would be interesting to learn whether these habituation effects are 
stronger in patients who had a treatment aimed at habituation to the tinnitus sound. The 
observed relations implicate that diagnostics and treatment of tinnitus should not only focus 
on the severity of the tinnitus but also on the severity of depressive and anxiety complaints as 
well as on other physical complaints, especially pain.  
The current study has some limitations that need to be addressed. Because of the differences 
in age, sex and having a job, it can not be excluded that these differences have influenced the 
results. However, the relations were still significant after correcting for these variables. Also, 
the relations between tinnitus and positive affect, negative affect and physical complaints 
were confirmed in the within patient analyses, with higher severity of tinnitus being 
associated with lower levels of positive affect and higher levels of negative affect and 
physical symptoms.  
A second limitation might be in the phrasing of the question on tinnitus intensity at a 
particular moment. To avoid reactivity, the question was phrased as neutral as possible, i.e. 
patients indicated whether they experienced tinnitus on a 7-point scale ranging from not at all 
to very much. This neutral formulation of the item could have triggered patients to interpret 
the question either as loudness of the tinnitus or as the amount of annoyance caused by the 
tinnitus. In earlier studies it was shown that tinnitus loudness rarely correlates with 
experienced distress (Andersson et al., 2005) and only a weak association was found between 
tinnitus loudness and tinnitus annoyance (Hazell et al., 1985). However, these are correlation 
studies across individuals and individuals might have their own anchor point for describing 
loudness (Dauman & Tyler, 1992). Nevertheless, differences in interpretation of tinnitus 
intensity could have influenced the results. Since a recent study has shown a lack of reactivity 
in an ESM study as a result of questions about tinnitus annoyance as well as tinnitus loudness,  
future research could focus on both questions separately (Henry et al., 2012). 
Based on the findings above, it can be concluded that tinnitus has a major impact on daily life. 
Patients suffering from tinnitus experience more emotional and physical complaints than 
participants from a population based sample, and with increasing tinnitus severity there is a 
worsening of these complaints. However, there was also evidence of habituation to tinnitus 
with regard to the effect on positive affect and pain. Future research should shed more light 
on the temporal relationships and potential causal associations.  
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Summary and discussion 
The general objective of this thesis was to evaluate the effects of tinnitus on health-related 
quality of life (HRQOL) and costs. Furthermore, the effects of a specialized, stepped-care 
cognitive behavioral treatment were compared to care as usual. Chapter 1 to 4 were based on 
data from a randomized controlled trial (RCT). Chapter 5 and 6 were based on a study using 
the Experience Sampling Method (ESM) to measure (aspects of) HRQOL in daily life.  
 
Summary of findings  
In Chapter 1 health state utility scores of a tinnitus population were elicited using two 
preference-based health state utility instruments: EurQol-5D (EQ-5D) and Health Utilities 
Index Mark III (HUI Mark III). These instruments differ in the conceptualization and 
operationalization of health and the valuation method upon which the utility scores are based. 
Agreement, construct validity and responsiveness of both measures were examined to 
determine which utility measure was preferred in a tinnitus population. Corresponding 
dimensions of both measures showed large correlations, but in the EQ-5D health state 
description ceiling effects were much more frequently observed. The HUI Mark III utility 
scores were lower than the EQ-5D utility scores and agreement was poor to moderate. Both 
the EQ-5D and the HUI Mark III showed evidence of construct validity and both measured 
statistically significant change in the mean utility scores of improved patients after three 
months of treatment. The HUI Mark III was the most sensitive to change in the condition. The 
study concluded that despite considerable overlap between both instruments, the HUI Mark 
III was considered as the best tool for utility elicitation in patients with tinnitus.  
In Chapter 2 the societal cost-of-illness (COI) of tinnitus in the Netherlands was determined. 
A bottom-up approach was used in which healthcare consumption or cost data were measured 
by a cost-questionnaire among the patients in a sample and subsequently extrapolated to the 
total Dutch population. Furthermore, the impact of both disease and demographic 
characteristics on the healthcare costs and the societal costs were examined. The mean 
societal cost of illness was €6.7 billion, or €5,315 per patient per year. Sensitivity analyses 
showed that differences in tinnitus prevalence especially impacted on the societal costs. The 
healthcare costs ranged from €1.0 billion to €2,9 billion, while the societal costs ranged from 
€3,3 billion to €10,0 billion. Reported severity of tinnitus was the most important positive 
predictor of healthcare costs and societal costs. Other significant predictors were duration of 
complaints, depression scores and age (only for societal costs). We concluded that the 
economic burden of tinnitus to society is substantial.  
In Chapter 3 the effectiveness of a novel specialized stepped-care multidisciplinary treatment 
protocol (SC) versus Usual Care (UC) for tinnitus was investigated. The first step of the SC 
included audiological diagnostics and rehabilitation, counseling based on Tinnitus Retraining 
Therapy, psycho-education and psychological analysis and advice. The second step of SC 
included counseling, psycho-education, applied relaxation, cognitive behavioral therapy, 
elements of acceptance and commitment therapy and mindfulness based approaches. The first 
step of UC consisted mainly of audiological diagnostics and rehabilitation, including the 
prescription of hearing aids and sound-generators. The second step of UC included one or 
more consultations with a social worker with a maximum of ten one-hour-sessions, if 
necessary. A RCT was carried out with 492 adult tinnitus patients of whom 247 were 
allocated to UC, and 245 to SC. All patients were pre-stratified on tinnitus-severity and 
hearing impairment. Primary outcomes were HRQOL (HUI Mark III), tinnitus severity (TQ), 
and tinnitus impairment (THI). Secondary outcomes were negative affect (HADS), 
catastrophic misinterpretations of the tinnitus sound (TCS) and fear of tinnitus (FTQ). 
Assessments took place pre-treatment, and at 3, 8 and 12 months after randomization. 
Multilevel mixed regression was used for intention to treat analyses and showed that SC was 
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more effective than UC in improving HRQOL and reducing tinnitus severity and tinnitus 
impairment. Moreover, SC showed more favorable results with regard to improvements in 
general negative emotional states, level of tinnitus-related catastrophic thinking, and tinnitus-
related fear, than UC.  
Chapter 4 assessed the cost-effectiveness of SC compared with UC from a societal 
perspective alongside the above-mentioned RCT. The calculation of the societal costs was 
based on measurements with a cost-questionnaire and Dutch standard unit prices or other 
sources if these were not available.  Quality-adjusted life years (QALYs) were based on 
measurements with the HUI Mark III. Total mean bootstrapped costs were €5,636 in UC and 
€5,921 in SC. Costs associated with the tinnitus care in an audiological centre were 
considerably higher in SC. This was partly compensated by lower costs in SC for other 
tinnitus related healthcare costs. Productivity costs were higher in SC. The results showed that 
SC costs society €19,688 per QALY gained. The probability that SC is cost-effective from a 
societal perspective was 58% for a willingness-to-pay for a QALY of €35,000. The NICE 
guideline states that the reimbursement of interventions costing less than £30,000 
(approximately € 45,000) is generally never questioned (Devlin & Parkin, 2004; Raftery, 
2001). The Dutch Council for Public Health and Health Care has set the threshold at € 80,000 
for diseases with a high burden (RVZ, 2006). Based on this SC was considered more cost-
effective than UC. However, the uncertainty surrounding the incremental costs and effects 
was substantial. 
Chapter 5 explored the potential value of obtaining momentary, instead of retrospective, 
accounts of the description and valuation of a person’s own health-related quality of life 
(HRQOL). The study population consisted of 139 participants. To ensure a variety of 
experienced health states in the study population, participants were recruited from three 
patient groups (experiencing somatic complaints with a known cause, somatic complaints 
without a known cause, and psychological complaints) and a general population sample. 
Momentary HRQOL, positive affect (PA), negative affect (NA) and physical symptoms (PS) 
were examined with the Experience Sampling Method (ESM). The ESM consists of a beep 
questionnaire that was administered randomly 10 times a day. Bivariate correlations and 
multilevel analysis were used to investigate the relation between momentary HRQOL and 
momentary PA, NA and PS. The relation between momentary outcomes and the EQ VAS was 
investigated with a multiple regression model. With regard to the feasibility, the overall 
primary participation rate was low but there were no drop-outs and the number of completed 
beeps was comparable to other studies. Analysis showed that momentary PA, NA and PS 
predict the momentary valuation of HRQOL. In addition it was found that these relations are  
stronger among those with psychological complaints (PA, PS and NA) and tinnitus (PA and 
PS), than among persons with somatic complaints and the population based sample. Multiple 
regression analysis showed that if the interaction terms were added to model, none of the 
momentary feelings and symptoms were significant predictors of retrospective EQ VAS. 
Also, momentary experienced HRQOL was not a significant predictor of EQ VAS. This 
supports earlier findings that global reports of past health will rely more on beliefs (semantic 
memory) than on specific feelings and symptoms (Kahneman et al., 2004; Robinson & Clore, 
2002; Stone et al., 2006). We concluded that the use of the ESM to measure accounts of the 
momentary experience of health in different populations is feasible. The results showed that 
within persons the valuation of global HRQOL and specific feelings and symptoms are 
variable from moment to moment. Also, the relation between momentary specific feelings and 
symptoms and the momentary valuation of HRQOL differed among populations.  
In Chapter 6 the aim was to compare patients with tinnitus to a non-tinnitus control sample 
with regard to emotions, activities and social interactions in daily life as measured with the 
ESM. Although there is some knowledge on these relation based on previous research, these 
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studies have all relied on retrospective assessment of past experiences which is can be prone 
to several types of bias (Robinson & Clore, 2002; Stiggelbout & de Vogel-Voogt, 2008). 
Within patients with tinnitus the associations between effects of tinnitus severity and the level 
of PA, NA, PS, activity and social interactions in daily life were examined. Forty patients 
with tinnitus and a convenience (control) sample of 40 persons were included in this study. 
Multilevel regression analysis confirmed a significant difference between the samples with 
regard to PA, NA and PS, but not with regard to activities or social interactions. When 
tinnitus intensity is experienced as more severe, there is a concomitant increase in pain and 
fatigue. In addition, more severe tinnitus is accompanied by more negative and less positive 
mood. The time-lagged analyses indicate that pain has a positive association with tinnitus at 
the same moment, but a negative association with tinnitus at the following moment. This 
means that the effect of pain on tinnitus decreases over time which could be an indication of 
habituation to pain. Furthermore, there was a reversed temporary effect of tinnitus intensity 
on subsequent pain and positive affect. This means that the negative effect of tinnitus on pain 
and positive affect decreases over time, thereby indicating habituation to the tinnitus. It can be 
concluded that tinnitus has a major impact on emotions and symptoms in daily life. 
  
 
Discussion 
Economic burden 
Tinnitus treatment has been frequently described as costly to both the patients who suffer 
from it and the society at large (Henry et al., 2005; Lockwood et al., 2002; Reich, 2002). 
However, up till now there was no empirical evidence to sustain these statements. In Chapter 
2 the first study to examine the costs of illness of tinnitus from a societal perspective was 
described. The sample included in this study might not be representative for the total tinnitus 
population since it was a help seeking population in one single audiological centre in the 
south of the Netherlands. However, sensitivity analysis showed that even when the data were 
extrapolated to the total population based on more conservative prevalence figures, the burden 
to society was substantial. Nevertheless, COI studies in broader defined tinnitus populations 
(regarding level of severity, help seeking, part of the Netherlands) are needed to check the 
generalizability of our results. 
COI studies are important to inform decision makers on the economic burden of a disease. 
Although its usefulness as a decision-making tool in resource allocation has been questioned, 
it can be useful in drawing decision-makers interest for conditions whose burden has been 
somehow underestimated (Tarricone, 2006). This might also be the case for a condition like 
tinnitus, which is often described as a symptom and not a disease (Noell & Meyerhoff, 2003) 
and might therefore not be recognized as a formal diagnosis. In 2010 The Dutch Health Care 
Insurance Board (CVZ) decided that multidisciplinary tinnitus treatment was not covered by 
the Health Care Insurance Act (CVZ, 2010). Tinnitus treatments that are covered by the 
Health Insurance Act are scarce and non-evidence based, as these include the prescription of 
sound maskers for which no clear evidence of efficacy has been found (Hobson et al., 2012). 
The results of our study (Chapter 2) showed that the economic burden of tinnitus to society is 
substantial. Implementing a cost-effective treatment could improve healthcare resource 
allocation. Our study also showed that the reported severity of tinnitus is an important 
predictor of the costs that patients make. Other significant predictors of costs were shorter 
duration of tinnitus and more severe depression. This implies that adequate referral and early 
intervention are necessary in order to prevent tinnitus and depression becoming more severe, 
thereby inflating the costs of tinnitus.  
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Health-related quality of life 
In Chapter 1, the EQ-5D and the HUI Mark III showed evidence of construct validity and 
both measures were able to detect a statistically significant change in the mean utility scores 
of improved patients after three months of treatment. However, the effect sizes were small 
and the chance of being able to distinguish between improved and unimproved patients was 
only 61% in the HUI Mark III and 58% in the EQ-5D. Since this was the first study to 
determine which utility measure would be preferred in a tinnitus population, more research is 
necessary to check the reproducibility of our results. Also, other multi-attribute utility 
measures, like for instance the SF-6D (Brazier et al., 2002), ICECAP-A (Al-Janabi et al., 
2011; Al-Janabi et al., Published online ahead of print Oct, 2012) and Quality of Well-Being 
Scale (Kaplan & Anderson, 1988) are available. To our knowledge, these instruments have 
not been tested in tinnitus patients. A comparative review of different multi-attribute utility 
measures instruments did not find a uniformly best performing instrument and it was 
suggested to base the instrument selection on the characteristics that are most relevant to the 
particular measurement needs (Coons et al., 2000). In the case of tinnitus both the HUI Mark 
III and the SF-6D include dimensions that are relevant for measuring change after tinnitus 
treatment. The SF-6D addresses physical, mental and social functioning while the HUI Mark 
III includes impairments in hearing, emotion and cognition among other things. The SF-6D 
might have been more responsive than the instruments used in our study, since increasing 
physical, mental and social functioning was ultimately the focus of treatment, especially in 
the SC. Improvements in cognition and hearing as measured by the HUI Mark III were also a 
desired effect of treatment but not the main focus. However, more research is necessary to 
assess the responsiveness of the SF-6D in a population with tinnitus. Moreover, the validity of 
multi-attribute utility instruments that result in a population preference for health can be 
questioned. When these instruments are used it is assumed that members of the public are able 
to imagine what it would be like if they were experiencing a certain health state. Several 
authors have discussed different types of problems that could lead to biases when multi-
attribute measures or direct utility measures such as the time trade-off (TTO) are used to 
determine health state utilities (Robinson & Clore, 2002; Stiggelbout & de Vogel-Voogt, 
2008). It was suggested that measuring experienced utility by studying actual momentary 
experience of a health state with the ESM, could solve these problems (Kahneman et al., 
1997). However, when performing a cost-effectiveness analysis from a societal perspective, 
preference for different health states are preferably derived from the general population (Gold 
et al., 1996; Torrance et al., 1996). Since experienced utility can only be derived from a 
person who is actually experiencing a health state, it is no longer possible to perform an 
economic evaluation from a societal perspective. A two-step procedure to inform those doing 
ex ante health state preferences about the descriptions of patients based on experienced utility 
was suggested (Drummond et al., 2009). However this does not solve the problems regarding 
a focusing illusion (Stiggelbout & de Vogel-Voogt, 2008; Ubel et al., 2001). The focusing 
illusion is a bias that leads subjects to focus disproportionately on what would be different 
between their own health state and the health state under investigation. On the other hand, 
data on experienced utility collected with the ESM is also able to give a more detailed 
description of the influence of a certain health state on daily life than other generic health-
related quality of life measures. Future research should focus on the use of ESM data to 
inform those doing ex ante health state preferences and the impact of this information on the 
eventual health state evaluation.  
In Chapter 5 we reported on the results of a study that, to our knowledge for the first time, 
used the Experience Sampling Method (ESM) to obtain accounts of the momentary 
experience of HRQOL (overall HRQOL, PA, NA, PS). A global retrospective valuation of 
HRQOL was not predicted by momentary feelings, symptoms and HRQOL. This highlights 
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that retrospective measures may provide a biased account of the impact of health problems in 
the daily lives of people who are affected. Moreover, the bias may be different in different 
conditions. Given the relation between momentary experienced HRQOL and momentary PA, 
NA and PS, it is expected that the ESM is able to detect changes over time, but this has to be 
confirmed in future research. It is unclear how the results of our effectiveness and cost-
effectiveness study would have been affected if we would have used momentary experienced 
HRQOL as measured with the ESM as an outcome measure instead of retrospective global 
measures of HRQOL such as the EQ-5D. More research is necessary to determine the ability 
of the ESM for detecting changes in HRQOL over time for use in (cost-)effectiveness 
research.  
 
Effectiveness and cost-effectiveness of treatment 
In the RCT the effectiveness of SC as compared to UC was investigated. Although one of the 
treatment arms was designed to represent usual care in a Dutch audiological centre, it is very 
likely that this therapy does not fully represent the therapy that is usually offered to tinnitus 
patients in the Netherlands. Current usual care practices often result in communicating to 
patients that nothing can be done about the tinnitus, but learn to live with it (Cima et al., 
2009). A considerable proportion of the patients might not be referred to an audiological 
centre or an ENT specialist at all. This made it difficult to identify care as usual in this 
population of patients who seek help in different levels of health care. The advantage of 
including patients in an audiological centre, instead of for instance a general practitioner is 
that patients could be stratified on hearing loss and tinnitus severity thereby ensuring an equal 
allocation to both treatment arms.  
Another important consideration that has to be taken into account when evaluating the results 
of this RCT is the fact that SC consisted of several elements and it is unclear which of these 
elements have contributed most to the overall effectiveness. For example, it has been 
suggested that TRT has no additional beneficial effects as an additional treatment approach to 
CBT. On the other hand there are also elements that are not explicitly part of the treatment 
that could have contributed to the overall effectiveness, like for instance peer contact. To get 
more insight into the effectiveness of the different elements in SC as evaluated in the RCT 
described in this thesis, future studies should adopt a dismantling approach leaving out 
potentially redundant treatment components in subsequent trials thereby fine-tuning current 
treatment strategies.  
The ESM study described in chapter 6 has shown that tinnitus is associated with many 
problems and interferences in daily life. It is expected that the SC based on cognitive 
behavioral therapy is effective in reducing these problems as was also evidenced by the 
significant decrease in tinnitus impairment. Although more research is necessary to determine 
temporal relationships and potential causal associations between tinnitus severity, mood and 
physical symptoms, the observed relations implicate that diagnosis and treatment of tinnitus 
should not only focus on the severity of the tinnitus but also on the severity of depressive and 
anxiety complaints as well as on physical complaints. Post-hoc analyses of the trial data that 
were published separately, have shown that addressing tinnitus-related fear and fear-
responses, which is part of SC, is important in the management of patients with disabling 
tinnitus (Cima, 2013).  
Another consideration with regard to the results of the RCT relates to the fact that the study 
was done in an outpatient clinic for audiological rehabilitation where different disciplines 
have the ability to work integrally. As a result, it is unclear whether the results can be 
generalised to other healthcare settings and whether this might be a threat for implementing 
SC across these settings. More research into the effective elements of treatment could assist 
the development of implementation strategies tailored to different healthcare settings.  
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The results of the cost-effectiveness analysis showed that SC costs society €19,688  per 
QALY gained based on the base case estimates of input parameters. The SC was considered 
more cost-effective than UC despite that the uncertainty surrounding the incremental costs 
and effects was substantial. However, this is the first cost-effectiveness analysis alongside a 
randomized clinical trial (RCT) in tinnitus treatment and decision-makers need to be informed 
about costs and effects for the full range of alternative interventions as a basis for decision-
making (Sculpher et al., 2006). Therefore, more RCTs need to be conducted in the field of 
tinnitus treatment to adequately inform decision makers.  
The time horizon in the RCT described in this thesis was relatively short: 12 months. Other 
studies found that treatments based on TRT or CBT, which were an important part of SC, 
were effective up to 15 years after the therapy ended (Forti et al., 2009; Goebel et al., 2006; 
Lux-Wellenhof & Hellweg, 2002; Zachriat & Kroner-Herwig, 2004). This may imply that the 
effectiveness and cost-effectiveness of SC is underestimated. Currently, we are investigating 
the long-term effects and costs of treatment at three and five years after baseline. With regard 
to the costs, not only a cost-questionnaire with a three-month recall period was administered 
but also large expenses since the end of trial were recorded. It is expected that patients in the 
SC group have less expenses than patients in the UC group.  
There are some other factors that need to be considered when interpreting the results of the 
economic evaluation. First, incremental effectiveness was determined by using a generic 
health-related quality of life measure. In the previous section it was already discussed that the 
HUI Mark III might not have been responsive enough to detect changes as a result of the 
treatment. It is expected that the use of a disease specific preference based instrument would 
have resulted in more favourable results for SC. However, for tinnitus such an instrument is 
not available. The Tinnitus Disability Index (TDI) (Cima et al., 2011), a self-report measure 
for disability due to tinnitus on daily life activities, might be a useful instrument as an 
outcome measure in CEA. The questionnaire consists of 7 items corresponding to 7 major 
dimensions of daily life, which have to be rated on a horizontal VAS (0-10) anchored as 0 
corresponding to ‘no disability’ and 10 to ‘total disability’. To develop a preference based 
measure this answering scale needs to be reduced into several levels. Then, a time trade-off or 
standard gamble study should be conducted in the general public to obtain weights associated 
with the dimensions and levels of this questionnaire. Using such an instrument as a tool to aid 
decision-making for resource allocation decisions only has value if all studies evaluating the 
cost-effectiveness of tinnitus treatments would use this measure of outcome. This way, the 
relative effectiveness of new tinnitus treatments could be evaluated. However, the 
disadvantage of using disease specific utility instruments is that decision makers cannot make 
any comparisons across diseases. Moreover, as a threshold for ‘a year without tinnitus 
disability’ is lacking, it is impossible to judge whether a tinnitus treatment would be cost-
effective or not.  
Second, there may be elements that did not have any contribution to the overall effectiveness, 
like for instance the prescription of tinnitus maskers. Evidence regarding the effectiveness of 
these expensive devices in tinnitus treatment is not clear (Hobson et al., 2012) and might have 
had a negative influence on the overall cost-effectiveness of SC. Another cost saving might 
result from dividing the first step of treatment into smaller steps. At this time, in SC every 
patient receives a counseling session with a clinical physicist in audiology, an intake with a 
clinical psychologist and an educational group session. The question is whether this extensive 
first level is needed for patients that report a mild tinnitus at baseline. Perhaps these patients 
just need some reassurance that the tinnitus is not the result of some kind of serious deficit. 
Furthermore, although patients in the second level of SC were advised to resume their paid 
work only after the intervention was completed, there is no scientific evidence that earlier 
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return to work would have a negative impact on the effectiveness of treatment. When these 
issues would be taken into consideration, SC may be more cost-effective. 
Recent interventions that investigated the effectiveness of alternative treatment strategies in 
tinnitus treatment include drug therapy (Elgoyhen & Langguth, 2012; Langguth & Elgoyhen, 
2012), neurological brain stimulation (Meng et al., 2011) or cochlear implants (Arts et al., 
2012). Results indicate benefits of these treatment to be absent, minor or particular to a small 
group of patients. There is no evidence regarding the cost-effectiveness of these treatments, 
but some of them are thought to be more expensive than SC like for instance neurological 
brain stimulation and cochlear implants. The additional effects of these treatments therefore 
need to be considerable to compensate for the expected higher costs.   
 
Areas for future research 
Economic burden 
A problem in bottom-up COI studies is that cost-questionnaires entirely rely on the patient’s 
memory and also on the patient’s judgment of which costs are related to the tinnitus and 
which costs are not. Another option for measuring healthcare utilization and costs is the use of 
cost diaries. However, problems with this method like for instance low completion rates were 
reported (Wolfs et al., 2009). This problem could be solved by being able to prompt patients 
to answer a set of questions about resource use in close proximity to the event. The ESM 
described in chapter 5 and 6 could not only be of use in measuring HRQOL in daily life but 
also in determining resource use. Applications for an ESM device or mobile phones could be 
used to prompt patients on a daily basis to fill out their resource use and costs with regard to 
the tinnitus. Further research could focus on determining the optimal ESM period and 
frequency has to be determined to ensure the inclusion of all relevant costs as well as 
adherence to the study.  
 
Experience Sampling Method in economic evaluation 
There are some challenges that need to be addressed before utility data based on the ESM can 
be used as an outcome variable in economic evaluations of health care.  
First, momentary HRQOL data collected during the ESM week needs to be expressed into 
one single utility score to be useful for assessing cost-effectiveness of different treatments. 
Currently we are investigating different ways to aggregate ESM data into a utility score by 
using duration-weighting approaches. One example is the U-index, which was suggested by 
Kahneman and Krueger (2006). The U-index looks at the highest rating (if this is a negative 
feeling, the time in that activity is scored as one; otherwise it is scored as zero) and then 
calculates the proportion of time that people spend in an unpleasant state. The ability of such 
an index to detect changes over time needs to be determined in future prospective studies.   
Second, the conceptualisation of HRQOL as part of the ESM needs to be evaluated. In our 
study HRQOL was assessed with a question anchored in the same way as the EQ-5D VAS. 
The question remains whether this item accurately measures HRQOL or whether other data in 
the ESM can be aggregated to an experienced utility score, like for instance the ability of a 
person to perform their daily activities, to engage in social interactions and their overall PA, 
NA and PS. 
Third, although using the ESM is advocated to overcome challenges regarding different types 
of bias in retrospective measures, recent literature has stressed the conceptual differences 
between momentary and global assessment (Tay et al., in press). Momentary reports reflect 
current affective or physical states, whereas global assessment is based upon some self-
reflection processes like introspection and self-observation. In other words, global 
assessments of HRQOL rely more on general beliefs, whereas momentary reports rely on 
experience (Schwarz et al., 2009). From this point of view, one method is not necessarily 
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superior to the other but instead they might complement each other. Future research should 
focus on the use of a multi-method perspective that incorporates all relevant information for 
determining HRQOL as an outcome measure in economic evaluation of health care.  
Finally, the ESM has previously been described as time-consuming and invasive and it was 
suggested that these problems could be solved by using the Day Reconstruction Method 
(DRM) (Kahneman et al., 2004). In the DRM respondents are asked to divide the previous 
day into a number of episodes and to then rate several mood and contextual items for each 
episode (Kahneman et al., 2004). Although, evidence was provided that DRM data is a good 
approximation for ESM data when measuring mood (Kahneman et al., 2004), there is also 
evidence that the correlations between both methods is only moderate (Tay et al., in press). In 
our study on the use of the ESM in measuring HRQOL, the DRM was also administered. We 
are currently analyzing whether the DRM would be a good approximation of the ESM in 
measuring HRQOL. However, even when this is the case one should keep in mind that the 
ESM aims to capture event-based experiences, while the DRM aims to approximate 
momentary experiences through daily retrospective reporting (Tay et al., in press). 
Furthermore, it is questionable whether participants indeed thought the DRM to be less 
invasive. In our ESM study, the participants were asked to fill out beep questionnaires 10 
times a day for a period of 6 days. This may seem as a large burden, but it took participants 
only 2 minutes to complete a beep questionnaire, probably because they did not have to rely 
on their memory. Also, the drop out percentage was satisfactory and in most participants the 
ESM did not influence their mood or daily routines. Completing the DRM took the 
respondents in our study on average 2,5 hours (data on file). Further research is necessary to 
determine the relative burden of both methods by asking patients in future research which 
method they prefer.   
 
Conclusion 
Overall, we can conclude that the burden of tinnitus should not be underestimated. Not only 
does tinnitus have an impact on quality of life, mood and physical symptoms, it is also 
associated with high costs. Both the healthcare costs and the societal costs increase with 
increasing tinnitus severity. Adequate treatment is therefore imperative. SC is a promising 
intervention that is not only effective when compared to UC, but also cost-effective. It is 
important to further investigate which elements of SC have contributed to the overall 
effectiveness and which have not, to improve (cost-)effectiveness and implementation. 
Furthermore, we can conclude that the ESM is a promising new method for measuring 
momentary experienced HRQOL for use in comparative effectiveness research and economic 
evaluations although there are still issues that need to be addressed in future studies. 
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Het algemene doel van dit proefschrift was om de invloed van tinnitus op gezondheid 
gerelateerde kwaliteit van leven en kosten te evalueren. Ook werd de effectiviteit van een 
gespecialiseerde trapsgewijze cognitieve gedragstherapie (CGT) behandeling vergeleken met 
de gebruikelijke zorg. Hoofdstuk 1 t/m 4 zijn gebaseerd op data van een gerandomiseerd 
gecontroleerde trial (RCT). Hoofdstuk 5 en 6 zijn gebaseerd op een studie waarin de 
Experience Sampling Method (ESM) is gebruikt om (aspecten van) gezondheid gerelateerde 
kwaliteit van leven in het dagelijkse leven te meten.    
 
In hoofdstuk 1 werden utiliteitsscores gemeten in een populatie patiënten met tinnitus met 
twee utiliteitsinstrumenten: de EuroQol 5D (EQ-5D) en de Health Utilities Index Mark III. 
Deze instrumenten verschillen in de conceptualisatie en operationalisering van gezondheid en 
de waarderingsmethode waarop de utiliteitscores worden gebaseerd. Overeenstemming, 
constructvaliditeit en responsiviteit van beide meetinstrumenten werden onderzocht om te 
bepalen welk instrument de voorkeur heeft bij tinnitus patiënten. Corresponderende dimensies 
van beide maten lieten hoge correlaties zien, maar bij de EQ-5D werd veel vaker een 
plafondeffect gevonden. De HUI Mark III utiliteitsscores waren lager dan de EQ-5D 
utiliteitsscores en de overeenstemming was matig tot slecht. Zowel de EQ-5D als de HUI 
Mark III vertoonden tekenen van constructvaliditeit en beide maten lieten een statistisch 
significante verandering in de gemiddelde utiliteitsscores van verbeterde patiënten zien na 
drie maanden behandeling. De HUI Mark III is het meest sensitief voor verandering in 
patiënten met tinnitus. Er werd geconcludeerd dat ondanks aanzienlijke overlap tussen beide 
instrumenten, de HUI Mark III het beste utiliteitsinstrument is voor patiënten met tinnitus.      
In hoofdstuk 2 werd de maatschappelijke ‘cost-of-illness’ (COI) van tinnitus in Nederland 
bepaald. De berekeningen werden ‘bottom-up’ uitgevoerd waarbij de consumptie van 
gezondheidszorg en gegevens over kosten werden gemeten met behulp van een 
kostenvragenlijst onder patiënten in een steekproef en vervolgens geëxtrapoleerd naar de 
gehele Nederlandse bevolking. Daarnaast werd de impact van demografische en ziekte 
kenmerken op de gezondheidszorgkosten en de maatschappelijke kosten onderzocht. De 
gemiddelde maatschappelijke ‘cost of illness’ was €6.7 miljard, of €5,315 per patiënt per jaar. 
Sensitiviteitsanalyses lieten zien dat verschillen in prevalentie van tinnitus vooral de 
maatschappelijke kosten beïnvloedde. De gezondheidszorgkosten varieerden van €1.0 miljard 
tot 2.9 miljard, terwijl de maatschappelijke kosten varieerden van €3.3 miljard tot €10.0 
miljard. Gerapporteerde ernst van de tinnitus was de belangrijkste positieve voorspeller van 
gezondheidszorgkosten en maatschappelijke kosten. Andere significante voorspellers waren 
duur van klachten, depressieve scores en leeftijd (alleen voor maatschappelijke kosten). Er 
werd geconcludeerd dat de economische last van tinnitus substantieel is. 
In hoofdstuk 3 werd de effectiviteit van een nieuw gespecialiseerd stapsgewijs 
multidisciplinair protocol (SC) vergeleken met de gebruikelijke zorg voor tinnitus (UC). De 
eerste stap van de SC bestond uit audiologische diagnostiek en revalidatie, begeleiding 
gebaseerd op Tinnitus Retraining Therapy, psycho-educatie en psychologische analyse en 
advies. De tweede stap van de SC bestond uit begeleiding, psycho-educatie, toegepaste 
relaxatie, CGT, elementen van acceptance and commitment therapy en mindfullness. De 
eerste stap van de UC bestond vooral uit audiologische diagnostiek en revalidatie zoals het 
voorschrijven van hoortoestellen en tinnitusmaskeerders. De tweede stap van de UC bestond 
indien noodzakelijk uit een of meerdere consulten bij een maatschappelijk werker met een 
maximum van tien sessies van 60 minuten. Een RCT werd uitgevoerd met 492 volwassen 
tinnitus patiënten waarvan er 247 werden toegewezen aan de UC en 245 aan de SC. Alle 
patiënten werden gestratificeerd op ernst van de tinnitus en gehoorverlies. De primaire 
uitkomsten waren gezondheid gerelateerde kwaliteit van leven (HUI Mark III), tinnitus ernst 
(TQ), en beperking door de tinnitus (THI). Secundaire uitkomstmaten waren negatief affect
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(HADS), catastrofale misinterpretatie (TCS) en angst voor tinnitus (FTQ). Metingen vonden 
plaats voor behandeling en 3, 8 en 12 maanden na randomisatie. Multilevel regressie 
technieken werden gebruikt om de data te analyseren. De analyse toonde aan dat de SC meer 
effectief was dan de UC met betrekking tot het verbeteren van kwaliteit van leven, het 
verminderen van tinnitus ernst en ervaren beperkingen door de tinnitus. Bovendien liet de SC 
betere resultaten zien dan de UC met betrekking tot verbeteringen in algemene negatieve 
emotionele toestand, niveau van tinnitus gerelateerd catastrofaal denken, en tinnitus 
gerelateerde angst. 
Hoofdstuk 4 bepaalde de kosteneffectiviteit van de SC vergeleken met de UC vanuit een 
maatschappelijk perspectief naast de bovengenoemde RCT. De berekening van de 
maatschappelijke kosten was gebaseerd op metingen uit een kostenvragenlijst en Nederlandse 
standaard prijzen of andere bronnen als deze niet aanwezig waren. De voor kwaliteit van 
leven gecorrigeerde levensjaren (QALYs) werden gebaseerd op metingen met de HUI Mark 
III. Totale gemiddelde gebootstrapte kosten ware €5,636 in de UC en €5,921 in de SC. Kosten 
geassocieerd met de tinnituszorg in het audiologische centrum waren behoorlijk hoger in de 
SC. Dit werd deels gecompenseerd door lagere kosten in de SC voor andere tinnitus 
gerelateerde gezondheidszorgkosten. Productiviteitskosten waren hoger in de SC. De 
resultaten toonden dat SC de maatschappij €19,688 kost per gewonnen QALY. De 
waarschijnlijkheid dat de SC kosteneffectief is vanuit een maatschappelijk perspectief, is 58% 
als de maatschappij bereidheid zou zijn om €35,000 voor een QALY te bepalen. De NICE 
richtlijn stelt dat de vergoeding van een interventie die minder kost dan £30,000 (ongeveer 
€45,000) over het algemeen nooit wordt betwist. De Nederlandse raad voor volksgezondheid 
en zorg (RVZ) heeft de drempel vastgesteld op €80,000 voor ziekten met een hoge last. 
Gebaseerd op deze gegevens werd SC gezien als meer kosteneffectief dan UC. Echter, de 
onzekerheid rond de incrementele kosten en effecten was aanzienlijk.  
Hoofdstuk 5 exploreerde de mogelijke waarde van het verkrijgen van een momentane, in 
plaats van een retrospectieve beschrijving en waardering van de eigen gezondheid gerelateerd 
kwaliteit van leven (HRQOL) van een persoon. De studiepopulatie bestond uit 139 
deelnemers. Om een verscheidenheid aan ervaren gezondheidstoestanden te waarborgen 
werden deelnemers gerekruteerd uit drie verschillende patiënten populaties (lichamelijke 
klachten met een bekende oorzaak, lichamelijke klachten zonder bekende oorzaak en 
psychologische klachten) en een steekproef van het algemene publiek. Momentane HRQOL, 
positief affect (PA, negatief affect (NA) en fysieke symptomen (PS) werden onderzocht met 
de Experience Sampling Method (ESM). De ESM bestond uit een zogenaamde beep 
vragenlijst die 10 keer per dag at random werd afgenomen. Bivariate correlaties en multilevel 
analyses werden gebruikt om de relatie tussen momentane HRQOL en momentane PA, NA en 
PS te onderzoeken. Met betrekking tot de uitvoerbaarheid, was de algemene primaire 
participatie laag maar er waren geen uitvallers en het aantal afgeronde vragenlijsten was 
vergelijkbaar met dat van andere studies. De analyses lieten zien dat PA, NA en PS, 
momentane HRQOL voorspellen. Ook werd er gevonden dat deze relaties sterker zijn bij 
patiënten met psychologische klachten (PA, NA en PS) en tinnitus (PA en PS), dan bij 
patiënten met lichamelijke klachten en personen van de algemene populatie. Multiple 
regressie analyses lieten zien dat bij het toevoegen van interactietermen aan het model, geen 
enkele momentane gevoelens en symptomen significante voorspellers waren van de EQ VAS. 
Dit steunt eerdere bevindingen dat een globale rapportage van gezondheid in het verleden 
meer aansluit bij ‘beliefs’ (semantisch geheugen) dan op specifieke gevoelens en symptomen. 
We concludeerden dat het gebruik van de ESM om momentane ervaring van gezondheid in 
verschillende populaties uitvoerbaar is. De resultaten lieten zien dat binnen personen de 
waardering van globale gezondheid HRQOL en specifieke symptomen variabel zijn van 
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moment tot moment. Ook verschilt de relatie tussen specifieke momentane gevoelens en 
symptomen en de momentane waardering van HRQOL per populatie.     
In hoofdstuk 6 was het doel om patiënten met tinnitus te vergelijken met een steekproef van 
het algemene publiek met betrekking tot emoties, activiteiten en sociale interacties in het 
dagelijkse leven zoals die gemeten werden met de ESM. Hoewel er enige kennis is over deze 
relaties vanuit eerder onderzoek, hebben deze studies allemaal gebruik gemaakt van 
retrospectieve vragenlijsten over gebeurtenissen uit het verleden wat kan leiden tot 
verschillende soorten onzuiverheden in de metingen. Binnen de patiënten met tinnitus werd 
gekeken naar de associatie tussen van tinnitus ernst en het niveau van PA, NA, PS, 
activiteiten en sociale interactie in het dagelijkse leven. Veertig patiënten met tinnitus en een 
steekproef van veertig personen van het algemene publiek werden geïncludeerd in deze 
studie. Multilevel analyses bevestigden een significant verschil tussen de steekproeven met 
betrekking tot PA, NA en PS, maar niet met betrekking tot activiteiten en sociale interacties. 
Als tinnitus werd ervaren als meer ernstig, was er een gelijktijdig verhoging in pijn en 
vermoeidheid. Daarnaast ging meer ernstige tinnitus gepaard met meer negatieve en minder 
positieve stemming. De time-lagged analyses lieten zien dat pijn een positieve associatie heeft 
met tinnitus op een moment, maar een negatieve associatie met tinnitus op het volgende 
moment. Dit betekent dat het effect van pijn op tinnitus vermindert over de tijd. Dit kan 
wijzen op gewenning aan pijn. Verder was er een omgekeerd tijdelijk effect van tinnitus 
intensiteit op navolgende pijn en positief affect. Dit betekent dat het negatieve effect van 
tinnitus op pijn en positief affect afneemt over de tijd wat wijst op gewenning aan de tinnitus.      
Er kan worden geconcludeerd dat tinnitus een belangrijke impact heeft op emoties en 
symptomen in het dagelijkse leven.  
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Eindelijk is het klaar: mijn boekje is af! Nu is de tijd aangebroken om te reflecteren op een 
fantastische tijd waarin ik veel heb geleerd en vele bijzondere mensen heb mogen ontmoeten.  
Dit boekje was niet tot stand gekomen zonder een aantal van hen.   
 
Allereerst dank aan alle patiënten die hebben meegedaan aan dit onderzoek en vaak vele 
vragenlijsten hebben ingevuld. Daarnaast dank aan alle medewerkers van Adelante, PsyQ en 
het azM die betrokken zijn geweest bij de inclusie van al deze patiënten.  
 
Ten eerste wil ik graag mijn promotieteam bedanken, te weten mijn copromotoren Manuela 
Joore en Lucien Anteunis en mijn promotoren Madelon Peters en Bernd Kremer. Manuela, 
zonder jou was dit proefschrift er niet geweest. Jouw kennis en ideeën over de 
gezondheidszorg, en in het bijzonder HTA, is volgens mij door niemand te evenaren. Je hebt 
daarbij ook nog de gave om de meest ingewikkelde zaken op een begrijpelijke manier uit te 
leggen. Ik ben dankbaar voor alles wat ik van je heb mogen leren, zowel op professioneel als 
op persoonlijk vlak. Ik hoop dat er een vervolg komt voor ons kwaliteit van leven project 
zodat we nog heel lang kunnen samenwerken. Lucien, het is een feestje om met je samen te 
werken. Bij alle problemen die tijdens het tinnitus project op ons pad zijn gekomen was jij 
degene die rust en perspectief bracht in het geheel. Daarnaast wacht er, mede dankzij jou, na 
mijn opleiding, een nieuwe uitdaging op mij bij het audiologisch centrum. Bedankt voor alles! 
Madelon, je kwam later bij het team als promotor en daar ben ik nog steeds heel blij mee. 
Door jouw bemoeienis heeft de ESM studie voor mij meer diepgang gekregen. Ik wil je 
bedanken voor de prettige samenwerking en je altijd kritische en zeer waardevolle advies. 
Bernd, bedankt voor je bijdrage aan dit proefschrift.  
 
De leden van de beoordelingscommissie, voorzitter Prof. dr. Carmen Dirksen, prof. dr. Silvia 
Evers, prof. dr. Inez Myin-Germeys, dr. Carsten Leue en prof. dr. Robert Stokroos, wil ik 
bedanken dat ze bereid zijn om zitting te nemen in de commissie en het concept proefschrift 
van commentaar te voorzien.  
 
Rilana, aan jouw enthousiasme en overtuiging kunnen veel mensen een voorbeeld nemen. 
Bedankt dat ik aan je zijde heb mogen staan bij dit project; ik denk dat we trots kunnen zijn 
op het resultaat! 
 
Marianne Nelis, jij was degene die het ESM project draaiende hield toen ik dat door 
persoonlijke omstandigheden niet kon. Door jou kon ik er blind op vertrouwen dat de 
dataverzameling precies zo zou verlopen als ik wilde en misschien nog wel beter: bedankt 
daarvoor! 
 
De overige coauteurs wil ik ook bedanken voor hun waardevolle bijdragen aan de 
verschillende publicaties. In het bijzonder dank aan Johan Vlaeyen, Philippe Delespaul en 
Koen Schruers. Johan, bedankt voor je betrokkenheid bij het tinnitus project en je altijd 
bemoedigende woorden. Philippe, jij verdient een hele dikke dankjewel. Ondanks jouw 
drukke agenda heb je vaak op korte termijn tijd voor me vrij gemaakt om de meest triviale 
vragen over multilevel analyses en andere ESM-zaken te beantwoorden. Mede dankzij jou 
zijn de uiteindelijke ESM-papers naar een hoger plan getild! Koen, jij maakte het niet alleen 
mogelijk om bij PsyQ patiënten te werven, maar je gaf mij ook het vertrouwen om daar als 
psycholoog aan de slag te gaan. Hoewel dit van korte duur was, heb ik er veel van geleerd. 
Bedankt! 
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Aan alle collega’s van KEMTA. Ten eerste mijn kamergenootje Mirjam, ik ben dankbaar dat 
jij er was om mee te ‘zeuren’, mee te lachen en zelfs om mee te huilen. Dankzij jou ging ik 
aan het einde van de dag meestal met een glimlach naar huis. Bedankt daarvoor. En dan mijn 
kamergenootjes Denise en Annemieke. Ook dankzij jullie kan ik terug kijken op een 
geweldige promotietijd. Wat hebben we veel lol gehad: met elkaar en om elkaar. Sanne, een 
kamergenoot voor korte tijd, maar een vriendin voor het leven; bedankt voor je steun. Cecile, 
bedankt voor de gezellige tijd op die enorm saaie luchthaven in Berlijn en voor je hulp bij de 
laatste en zwaarste loodjes! Maar ook Irene, Brigitte, Thea, Fons, Carmen en alle andere 
collega’s van KEMTA: bedankt voor een onvergetelijke tijd! 
 
En dan aan alle collega’s van het AC (Adelante). Op verschillende manieren zijn jullie 
betrokken geweest bij het tinnitus project. Bianca, Karin, Paulien en Marieke, bedankt voor 
de praktische ondersteuning bij het tinnitus project. Dyon, Ingrid, Nele, Math en Lobke, ook 
jullie verdienen om verschillende redenen een dankjewel! 
 
En dan wil ik nog graag de mensen bedanken die niet inhoudelijk betrokken waren maar die 
mij wel enorm hebben gesteund de afgelopen jaren. Mijn lieve vrienden, buren en (schoon)-
familie waar ik vele leuke momenten mee heb mogen beleven. Ik prijs me gelukkig met 
zoveel lieve mensen om me heen.  
 
Mijn collega’s bij de medische psychologie en opleidingsgenootjes van de GZ-opleiding, in 
het bijzonder Nancy, Suzanne, Annette & Sabrine. Jullie betrokkenheid, vrolijkheid en 
enthousiasme hebben ervoor gezorgd dat het afgelopen jaar niet alleen druk was maar ook 
ontzettend leuk en leerzaam.  
 
Lydia & Roy, we leerden elkaar kennen op de NICU, nu alweer bijna 3 jaar geleden. Ik ben 
erg dankbaar dat uit deze moeilijke periode, zo’n fijne vriendschap is ontstaan en ik ben er 
dan ook trots op dat jij, Lydia, de omslag van mijn proefschrift hebt ontworpen. Bedankt! 
 
Sandy, vriendinnetje van het eerste uur. Jouw vrolijke en positieve kijk op de wereld zijn een 
voorbeeld voor mij. Je bent op verschillende momenten een grote steun voor mij geweest. Ik 
hoop dat onze vriendschap voor altijd mag blijven duren en dat jouw droom heel snel 
werkelijkheid mag worden.  
 
Cindy en Aimée, bedankt dat jullie vandaag aan mijn zijde staan. Mede dankzij jullie ben ik 
zelf niet verworden tot patiënt. Cindy, we hebben er samen al een half leven op zitten. Van 
rebelleren in groep 5 tot het eindexamen van Stella Maris. Van vele stapavonden in ‘De Smid’ 
in Reijmerstock tot het uitwisselen van ervaringen als moeder; ik kan me gewoon niet 
voorstellen hoe mijn leven er had uit gezien zonder jou. Aimée, soms botsen onze karakters, 
maar altijd vinden we onze weg terug naar elkaar. Omdat ik peettante mocht worden van je 
prachtige dochter Misja, en omdat je gewoon een fantastisch mens bent.  
 
Andy, grote broer, ik bewonder jou om je eeuwige doorzettingsvermogen en ik ben trots op 
wat je hebt bereikt. Bedankt dat je ondanks je drukke schema altijd tijd voor me hebt vrij 
gemaakt om mij te helpen bij het oplossen van allerlei digitale problemen.  
 
Lieve oma Käthe, onzichtbaar aan mijn zijde. Ondanks dat je al lang niet meer in ons midden 
bent hoor jij in dit dankwoord. Jij legde samen met pap en mam de basis. Ik hoop dat je trots 
op me bent! 
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Lieve pap & mam, dit boekje is opgedragen aan jullie. Omdat ik altijd onvoorwaardelijk op 
jullie kan terugvallen, omdat jullie me vrij hebben gelaten om mijn eigen keuzes en fouten te 
maken, omdat jullie fantastische grootouders zijn voor Mila en Elin… en zo kan ik nog 
oneindig veel redenen noemen waar ik jullie nooit genoeg voor kan bedanken. Ik hou van 
jullie! 
 
Elin en Mila, mijn prachtige, lieve meisjes. Jullie maken het leven zoveel leuker! Dit boekje is 
ook opgedragen aan jullie, omdat er zoveel meer is in het leven dan promoveren en carrière 
maken. Ik geniet van alles wat jullie doen, en kijk elke dag met verwondering naar de manier 
waarop jullie, ieder op je eigen manier, de wereld ontdekken. Ik ben dankbaar dat ik jullie 
mama mag zijn.    
 
Lieve Radek, het laatste woord richt ik aan jou. Hoge pieken en diepe dalen hebben we de 
afgelopen jaren samen overleefd, met als absoluut hoogtepunt de dag dat onze meiden thuis 
kwamen uit het ziekenhuis. Zonder jou had ik na deze periode niet de kracht gevonden om dit 
boekje af te schrijven. Altijd heb je mij gesteund en gestimuleerd en nooit heb je geklaagd als 
ik weer eens achter de computer moest of als het me even teveel werd. Lieve schat, bedankt 
voor alles! 
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